KR102716876B1 - Organic light emitting device - Google Patents
Organic light emitting device Download PDFInfo
- Publication number
- KR102716876B1 KR102716876B1 KR1020210175890A KR20210175890A KR102716876B1 KR 102716876 B1 KR102716876 B1 KR 102716876B1 KR 1020210175890 A KR1020210175890 A KR 1020210175890A KR 20210175890 A KR20210175890 A KR 20210175890A KR 102716876 B1 KR102716876 B1 KR 102716876B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- substituted
- unsubstituted
- compound
- synthesis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims abstract description 124
- 239000000126 substance Substances 0.000 claims abstract description 123
- 239000012044 organic layer Substances 0.000 claims abstract description 84
- 239000010410 layer Substances 0.000 claims description 221
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 81
- 229910052805 deuterium Inorganic materials 0.000 claims description 81
- 125000004432 carbon atom Chemical group C* 0.000 claims description 77
- 125000003118 aryl group Chemical group 0.000 claims description 72
- 125000000217 alkyl group Chemical group 0.000 claims description 40
- 229910052739 hydrogen Inorganic materials 0.000 claims description 31
- 239000001257 hydrogen Substances 0.000 claims description 31
- 125000001072 heteroaryl group Chemical group 0.000 claims description 30
- 125000001424 substituent group Chemical group 0.000 claims description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 23
- 125000000623 heterocyclic group Chemical group 0.000 claims description 22
- 125000003277 amino group Chemical group 0.000 claims description 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 14
- 125000005843 halogen group Chemical group 0.000 claims description 11
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 10
- 125000002560 nitrile group Chemical group 0.000 claims description 9
- 125000002950 monocyclic group Chemical group 0.000 claims description 8
- 125000000732 arylene group Chemical group 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000005549 heteroarylene group Chemical group 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 description 357
- 238000003786 synthesis reaction Methods 0.000 description 357
- 239000000543 intermediate Substances 0.000 description 318
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 134
- 239000000463 material Substances 0.000 description 70
- 238000002347 injection Methods 0.000 description 64
- 239000007924 injection Substances 0.000 description 64
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 62
- 238000006243 chemical reaction Methods 0.000 description 56
- 230000032258 transport Effects 0.000 description 55
- 239000000203 mixture Substances 0.000 description 50
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- MXQOYLRVSVOCQT-UHFFFAOYSA-N palladium;tritert-butylphosphane Chemical compound [Pd].CC(C)(C)P(C(C)(C)C)C(C)(C)C.CC(C)(C)P(C(C)(C)C)C(C)(C)C MXQOYLRVSVOCQT-UHFFFAOYSA-N 0.000 description 40
- 238000010992 reflux Methods 0.000 description 40
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 39
- 230000005525 hole transport Effects 0.000 description 35
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- 238000004440 column chromatography Methods 0.000 description 33
- 239000000243 solution Substances 0.000 description 33
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 32
- 238000000034 method Methods 0.000 description 29
- 239000012153 distilled water Substances 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 26
- 239000007864 aqueous solution Substances 0.000 description 24
- -1 triethylsilyl group Chemical group 0.000 description 23
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 22
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 21
- 239000002019 doping agent Substances 0.000 description 20
- 239000003960 organic solvent Substances 0.000 description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 20
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 238000004821 distillation Methods 0.000 description 18
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 18
- 238000000746 purification Methods 0.000 description 17
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 16
- 150000002430 hydrocarbons Chemical group 0.000 description 15
- 238000001953 recrystallisation Methods 0.000 description 15
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 14
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 13
- 229940126086 compound 21 Drugs 0.000 description 13
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical group C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 13
- 125000001624 naphthyl group Chemical group 0.000 description 12
- 239000012299 nitrogen atmosphere Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 125000006267 biphenyl group Chemical group 0.000 description 11
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 10
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 10
- 229940125851 compound 27 Drugs 0.000 description 10
- 230000001629 suppression Effects 0.000 description 10
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 9
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 9
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 9
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 9
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 9
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 9
- 229940126208 compound 22 Drugs 0.000 description 9
- 229940125833 compound 23 Drugs 0.000 description 9
- 229940125961 compound 24 Drugs 0.000 description 9
- 229940125846 compound 25 Drugs 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- VQSRKMNBWMHJKY-YTEVENLXSA-N n-[3-[(4ar,7as)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide Chemical compound C1=NC(OC)=CN=C1C(=O)NC1=CC=C(F)C([C@@]23[C@@H](CN(C2)C=2N=CC(F)=CN=2)CSC(N)=N3)=C1 VQSRKMNBWMHJKY-YTEVENLXSA-N 0.000 description 9
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 150000001338 aliphatic hydrocarbons Chemical group 0.000 description 8
- 229940125904 compound 1 Drugs 0.000 description 8
- 125000005842 heteroatom Chemical group 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- FTMRMQALUDDFQO-UHFFFAOYSA-N naphtho[2,3-b][1]benzofuran Chemical compound C1=CC=C2C=C3C4=CC=CC=C4OC3=CC2=C1 FTMRMQALUDDFQO-UHFFFAOYSA-N 0.000 description 8
- 235000015320 potassium carbonate Nutrition 0.000 description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 description 8
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 8
- LQJJCCZSSLQQHY-UHFFFAOYSA-N 4a,9a-dimethyl-2,3,4,9-tetrahydro-1h-carbazole Chemical compound C12=CC=CC=C2NC2(C)C1(C)CCCC2 LQJJCCZSSLQQHY-UHFFFAOYSA-N 0.000 description 7
- 125000001931 aliphatic group Chemical group 0.000 description 7
- 229910052782 aluminium Inorganic materials 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 7
- 125000003367 polycyclic group Chemical group 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 6
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 6
- PREHQRCCCIFBPF-UHFFFAOYSA-N (3-hydroxynaphthalen-2-yl)boronic acid Chemical compound C1=CC=C2C=C(O)C(B(O)O)=CC2=C1 PREHQRCCCIFBPF-UHFFFAOYSA-N 0.000 description 6
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 6
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 6
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 6
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 6
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 6
- FKIFDWYMWOJKTQ-UHFFFAOYSA-N 9-bromo-10-naphthalen-2-ylanthracene Chemical compound C12=CC=CC=C2C(Br)=C(C=CC=C2)C2=C1C1=CC=C(C=CC=C2)C2=C1 FKIFDWYMWOJKTQ-UHFFFAOYSA-N 0.000 description 6
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 6
- 229940126657 Compound 17 Drugs 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 6
- 229940125797 compound 12 Drugs 0.000 description 6
- 229940125758 compound 15 Drugs 0.000 description 6
- 229940126142 compound 16 Drugs 0.000 description 6
- 229940117389 dichlorobenzene Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 5
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 5
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 5
- QTYDOAGNYVTLBJ-UHFFFAOYSA-N 1-bromo-4-chloro-3-fluoro-2-iodobenzene Chemical compound Fc1c(Cl)ccc(Br)c1I QTYDOAGNYVTLBJ-UHFFFAOYSA-N 0.000 description 5
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 5
- VWVRASTUFJRTHW-UHFFFAOYSA-N 2-[3-(azetidin-3-yloxy)-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound O=C(CN1C=C(C(OC2CNC2)=N1)C1=CN=C(NC2CC3=C(C2)C=CC=C3)N=C1)N1CCC2=C(C1)N=NN2 VWVRASTUFJRTHW-UHFFFAOYSA-N 0.000 description 5
- IKOKHHBZFDFMJW-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2-morpholin-4-ylethoxy)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCCN1CCOCC1 IKOKHHBZFDFMJW-UHFFFAOYSA-N 0.000 description 5
- WWSJZGAPAVMETJ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethoxypyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCC WWSJZGAPAVMETJ-UHFFFAOYSA-N 0.000 description 5
- NCGIPELWHJKROR-UHFFFAOYSA-N 3-bromonaphthalene-2,7-diol Chemical compound C1=C(Br)C(O)=CC2=CC(O)=CC=C21 NCGIPELWHJKROR-UHFFFAOYSA-N 0.000 description 5
- MGGVALXERJRIRO-UHFFFAOYSA-N 4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-2-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-1H-pyrazol-5-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)O MGGVALXERJRIRO-UHFFFAOYSA-N 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 229940126543 compound 14 Drugs 0.000 description 5
- 229940125810 compound 20 Drugs 0.000 description 5
- 229940126214 compound 3 Drugs 0.000 description 5
- 229940125898 compound 5 Drugs 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 5
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 5
- 238000004020 luminiscence type Methods 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- NXSZSZJWZVLHAY-UHFFFAOYSA-N (2-chloro-6-fluorophenyl)boronic acid Chemical compound OB(O)C1=C(F)C=CC=C1Cl NXSZSZJWZVLHAY-UHFFFAOYSA-N 0.000 description 4
- HVTQDSGGHBWVTR-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-phenylmethoxypyrazol-1-yl]-1-morpholin-4-ylethanone Chemical compound C(C1=CC=CC=C1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CCOCC1 HVTQDSGGHBWVTR-UHFFFAOYSA-N 0.000 description 4
- AEHFFCUGLHHXBO-UHFFFAOYSA-N 4-tert-butyl-N-(3-tert-butylphenyl)-2-phenylaniline Chemical compound C(C)(C)(C)C1=CC=C(C(=C1)C1=CC=CC=C1)NC1=CC(=CC=C1)C(C)(C)C AEHFFCUGLHHXBO-UHFFFAOYSA-N 0.000 description 4
- LUBXLGUQZVKOFP-UHFFFAOYSA-N 9-phenylanthracene Chemical compound C1=CC=CC=C1C1=C(C=CC=C2)C2=CC2=CC=CC=C12 LUBXLGUQZVKOFP-UHFFFAOYSA-N 0.000 description 4
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000010405 anode material Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 150000001716 carbazoles Chemical group 0.000 description 4
- 229940125782 compound 2 Drugs 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- IYYZUPMFVPLQIF-ALWQSETLSA-N dibenzothiophene Chemical group C1=CC=CC=2[34S]C3=C(C=21)C=CC=C3 IYYZUPMFVPLQIF-ALWQSETLSA-N 0.000 description 4
- 150000002391 heterocyclic compounds Chemical class 0.000 description 4
- 238000004770 highest occupied molecular orbital Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 4
- GGTUVWGMCFXUAS-UHFFFAOYSA-N (5-chloro-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=CC=C1F GGTUVWGMCFXUAS-UHFFFAOYSA-N 0.000 description 3
- DZHFFMWJXJBBRG-UHFFFAOYSA-N 1-bromo-3,5-dichlorobenzene Chemical compound ClC1=CC(Cl)=CC(Br)=C1 DZHFFMWJXJBBRG-UHFFFAOYSA-N 0.000 description 3
- WQAABVMKMRFARY-UHFFFAOYSA-N 5-bromo-1-chloro-3-fluoro-2-iodobenzene Chemical compound FC1=CC(Br)=CC(Cl)=C1I WQAABVMKMRFARY-UHFFFAOYSA-N 0.000 description 3
- SYACRXBYRNYMLN-UHFFFAOYSA-N 9-bromo-10-naphthalen-1-ylanthracene Chemical compound C12=CC=CC=C2C(Br)=C(C=CC=C2)C2=C1C1=CC=CC2=CC=CC=C12 SYACRXBYRNYMLN-UHFFFAOYSA-N 0.000 description 3
- WHGGVVHVBFMGSG-UHFFFAOYSA-N 9-bromo-10-phenylanthracene Chemical compound C12=CC=CC=C2C(Br)=C2C=CC=CC2=C1C1=CC=CC=C1 WHGGVVHVBFMGSG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- YMEKEHSRPZAOGO-UHFFFAOYSA-N boron triiodide Chemical compound IB(I)I YMEKEHSRPZAOGO-UHFFFAOYSA-N 0.000 description 3
- 239000010406 cathode material Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 229940125773 compound 10 Drugs 0.000 description 3
- 229920001940 conductive polymer Polymers 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical group C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 3
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- NYESPUIMUJRIAP-UHFFFAOYSA-N naphtho[1,2-e][1]benzofuran Chemical group C1=CC=CC2=C3C(C=CO4)=C4C=CC3=CC=C21 NYESPUIMUJRIAP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- LUYQYZLEHLTPBH-UHFFFAOYSA-N perfluorobutanesulfonyl fluoride Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)S(F)(=O)=O LUYQYZLEHLTPBH-UHFFFAOYSA-N 0.000 description 3
- 229920000553 poly(phenylenevinylene) Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 125000005580 triphenylene group Chemical group 0.000 description 3
- FYFCLFLLJKQYIY-UHFFFAOYSA-N (1-hydroxynaphthalen-2-yl)boronic acid Chemical compound C1=CC=CC2=C(O)C(B(O)O)=CC=C21 FYFCLFLLJKQYIY-UHFFFAOYSA-N 0.000 description 2
- AOYYQPPLTDMTIY-UHFFFAOYSA-N (2-naphthalen-1-ylphenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1C1=CC=CC2=CC=CC=C12 AOYYQPPLTDMTIY-UHFFFAOYSA-N 0.000 description 2
- UVNPEUJXKZFWSJ-LMTQTHQJSA-N (R)-N-[(4S)-8-[6-amino-5-[(3,3-difluoro-2-oxo-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-yl]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N[C@@H]1COCC11CCN(CC1)c1cnc(Sc2ccnc3NC(=O)C(F)(F)c23)c(N)n1 UVNPEUJXKZFWSJ-LMTQTHQJSA-N 0.000 description 2
- YRIKDGJWRMHTJP-UHFFFAOYSA-N 1-bromo-3-chloro-5-methylbenzene Chemical compound CC1=CC(Cl)=CC(Br)=C1 YRIKDGJWRMHTJP-UHFFFAOYSA-N 0.000 description 2
- JRGGUPZKKTVKOV-UHFFFAOYSA-N 1-bromo-3-chlorobenzene Chemical compound ClC1=CC=CC(Br)=C1 JRGGUPZKKTVKOV-UHFFFAOYSA-N 0.000 description 2
- SAYKHJKPYKRMAG-UHFFFAOYSA-N 1-bromo-3-tert-butyl-5-chlorobenzene Chemical compound CC(C)(C)C1=CC(Cl)=CC(Br)=C1 SAYKHJKPYKRMAG-UHFFFAOYSA-N 0.000 description 2
- VBQVHWHWZOUENI-UHFFFAOYSA-N 1-phenyl-2H-quinoline Chemical compound C1C=CC2=CC=CC=C2N1C1=CC=CC=C1 VBQVHWHWZOUENI-UHFFFAOYSA-N 0.000 description 2
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 2
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 2
- OPEKHRGERHDLRK-UHFFFAOYSA-N 4-tert-butyl-n-(4-tert-butylphenyl)aniline Chemical compound C1=CC(C(C)(C)C)=CC=C1NC1=CC=C(C(C)(C)C)C=C1 OPEKHRGERHDLRK-UHFFFAOYSA-N 0.000 description 2
- VCJIOUBBOCVHPE-UHFFFAOYSA-N 9-bromo-10-(4-phenylphenyl)anthracene Chemical compound C12=CC=CC=C2C(Br)=C2C=CC=CC2=C1C(C=C1)=CC=C1C1=CC=CC=C1 VCJIOUBBOCVHPE-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- XQVWYOYUZDUNRW-UHFFFAOYSA-N N-Phenyl-1-naphthylamine Chemical group C=1C=CC2=CC=CC=C2C=1NC1=CC=CC=C1 XQVWYOYUZDUNRW-UHFFFAOYSA-N 0.000 description 2
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 2
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000005332 alkyl sulfoxy group Chemical group 0.000 description 2
- 125000005377 alkyl thioxy group Chemical group 0.000 description 2
- 150000004982 aromatic amines Chemical class 0.000 description 2
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 229910052733 gallium Inorganic materials 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 238000007641 inkjet printing Methods 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- UEEXRMUCXBPYOV-UHFFFAOYSA-N iridium;2-phenylpyridine Chemical compound [Ir].C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1.C1=CC=CC=C1C1=CC=CC=N1 UEEXRMUCXBPYOV-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000007650 screen-printing Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 150000003413 spiro compounds Chemical class 0.000 description 2
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 238000004506 ultrasonic cleaning Methods 0.000 description 2
- 238000001771 vacuum deposition Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- GDVCCKPVARLVLL-UHFFFAOYSA-N (2-hydroxynaphthalen-1-yl)boronic acid Chemical compound C1=CC=C2C(B(O)O)=C(O)C=CC2=C1 GDVCCKPVARLVLL-UHFFFAOYSA-N 0.000 description 1
- YBNDRTRLXPEWKQ-UHFFFAOYSA-N (4-chloro-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1F YBNDRTRLXPEWKQ-UHFFFAOYSA-N 0.000 description 1
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- NYURRNBTANQMIV-UHFFFAOYSA-N 1,2,3a,4-tetrahydrobenzo[e][1]benzofuran Chemical compound C1=CC=CC2=CCC(OCC3)C3=C21 NYURRNBTANQMIV-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- FNKCOUREFBNNHG-UHFFFAOYSA-N 1,3-dibromo-5-chlorobenzene Chemical compound ClC1=CC(Br)=CC(Br)=C1 FNKCOUREFBNNHG-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- WYTHOKJRFKARQK-UHFFFAOYSA-N 1-bromonaphthalene-2,7-diol Chemical compound C1=CC(O)=C(Br)C2=CC(O)=CC=C21 WYTHOKJRFKARQK-UHFFFAOYSA-N 0.000 description 1
- LPCWDYWZIWDTCV-UHFFFAOYSA-N 1-phenylisoquinoline Chemical compound C1=CC=CC=C1C1=NC=CC2=CC=CC=C12 LPCWDYWZIWDTCV-UHFFFAOYSA-N 0.000 description 1
- WGSMVIHKBMAWRN-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1-benzofuran Chemical compound C1C=CC=C2OCCC21 WGSMVIHKBMAWRN-UHFFFAOYSA-N 0.000 description 1
- KELIOZMTDOSCMM-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1-benzothiophene Chemical compound C1C=CC=C2SCCC21 KELIOZMTDOSCMM-UHFFFAOYSA-N 0.000 description 1
- DRKSMCFPUOMHMK-UHFFFAOYSA-N 2,3,4,5,6,9-hexahydro-1h-carbazole Chemical group C1=CCCC2=C1NC1=C2CCCC1 DRKSMCFPUOMHMK-UHFFFAOYSA-N 0.000 description 1
- DMBHHRLKUKUOEG-LHNTUAQVSA-N 2,3,4,5,6-pentadeuterio-n-(2,3,4,5,6-pentadeuteriophenyl)aniline Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1NC1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] DMBHHRLKUKUOEG-LHNTUAQVSA-N 0.000 description 1
- VFMUXPQZKOKPOF-UHFFFAOYSA-N 2,3,7,8,12,13,17,18-octaethyl-21,23-dihydroporphyrin platinum Chemical compound [Pt].CCc1c(CC)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(CC)c5CC)c(CC)c4CC)c(CC)c3CC VFMUXPQZKOKPOF-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
- VXWYQEYFYNAZOD-UHFFFAOYSA-N 2-[3-[(4,4-difluoropiperidin-1-yl)methyl]-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound FC1(F)CCN(CC2=NN(CC(=O)N3CCC4=C(C3)N=NN4)C=C2C2=CN=C(NC3CC4=C(C3)C=CC=C4)N=C2)CC1 VXWYQEYFYNAZOD-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- NPHULPIAPWNOOH-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2,3-dihydroindol-1-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCC2=CC=CC=C12 NPHULPIAPWNOOH-UHFFFAOYSA-N 0.000 description 1
- XXZCIYUJYUESMD-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(morpholin-4-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCOCC1 XXZCIYUJYUESMD-UHFFFAOYSA-N 0.000 description 1
- LPZOCVVDSHQFST-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CC LPZOCVVDSHQFST-UHFFFAOYSA-N 0.000 description 1
- FYELSNVLZVIGTI-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1CC)CC(=O)N1CC2=C(CC1)NN=N2 FYELSNVLZVIGTI-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 1
- VXZBYIWNGKSFOJ-UHFFFAOYSA-N 2-[4-[5-(2,3-dihydro-1H-inden-2-ylamino)pyrazin-2-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC=1N=CC(=NC=1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 VXZBYIWNGKSFOJ-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- YFFUYGSLQXVHMB-UHFFFAOYSA-N 2-bromo-4-chloro-1-fluorobenzene Chemical compound FC1=CC=C(Cl)C=C1Br YFFUYGSLQXVHMB-UHFFFAOYSA-N 0.000 description 1
- LOHOSHDZQVKDPS-UHFFFAOYSA-N 2-bromonaphthalen-1-ol Chemical compound C1=CC=C2C(O)=C(Br)C=CC2=C1 LOHOSHDZQVKDPS-UHFFFAOYSA-N 0.000 description 1
- WONYVCKUEUULQN-UHFFFAOYSA-N 2-methyl-n-(2-methylphenyl)aniline Chemical group CC1=CC=CC=C1NC1=CC=CC=C1C WONYVCKUEUULQN-UHFFFAOYSA-N 0.000 description 1
- JTMODJXOTWYBOZ-UHFFFAOYSA-N 2-methyl-n-phenylaniline Chemical group CC1=CC=CC=C1NC1=CC=CC=C1 JTMODJXOTWYBOZ-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- NPKWKIGBWZJFJS-UHFFFAOYSA-N 3-bromo-5-chloro-2-fluorophenol Chemical compound OC1=CC(Cl)=CC(Br)=C1F NPKWKIGBWZJFJS-UHFFFAOYSA-N 0.000 description 1
- DDTHMESPCBONDT-UHFFFAOYSA-N 4-(4-oxocyclohexa-2,5-dien-1-ylidene)cyclohexa-2,5-dien-1-one Chemical compound C1=CC(=O)C=CC1=C1C=CC(=O)C=C1 DDTHMESPCBONDT-UHFFFAOYSA-N 0.000 description 1
- PANRLVRJUNSUDA-UHFFFAOYSA-N 4-bromonaphthalene-1,3-diol Chemical compound Oc1cc(O)c2ccccc2c1Br PANRLVRJUNSUDA-UHFFFAOYSA-N 0.000 description 1
- NQQPSJDOZDIKTE-UHFFFAOYSA-N 5-bromo-2-chloro-4-fluorophenol Chemical compound OC1=CC(Br)=C(F)C=C1Cl NQQPSJDOZDIKTE-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- SAVNUMQZTKPJBB-UHFFFAOYSA-N 6-bromo-1-iodonaphthalen-2-ol Chemical compound C1=C(Br)C=CC2=C(I)C(O)=CC=C21 SAVNUMQZTKPJBB-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- RJUFYSUNQJMDLZ-UHFFFAOYSA-N 8-bromonaphthalen-1-ol Chemical compound C1=CC(Br)=C2C(O)=CC=CC2=C1 RJUFYSUNQJMDLZ-UHFFFAOYSA-N 0.000 description 1
- WCMCZLIOCXISPX-UHFFFAOYSA-N 9-bromo-10-(3-phenylphenyl)anthracene Chemical compound C12=CC=CC=C2C(Br)=C2C=CC=CC2=C1C(C=1)=CC=CC=1C1=CC=CC=C1 WCMCZLIOCXISPX-UHFFFAOYSA-N 0.000 description 1
- OBIXPXSRUDGFLE-UHFFFAOYSA-N 9-bromo-10-phenanthren-9-ylanthracene Chemical compound C12=CC=CC=C2C(Br)=C(C=CC=C2)C2=C1C1=CC2=CC=CC=C2C2=CC=CC=C12 OBIXPXSRUDGFLE-UHFFFAOYSA-N 0.000 description 1
- ZIRVQSRSPDUEOJ-UHFFFAOYSA-N 9-bromoanthracene Chemical compound C1=CC=C2C(Br)=C(C=CC=C3)C3=CC2=C1 ZIRVQSRSPDUEOJ-UHFFFAOYSA-N 0.000 description 1
- QXDWMAODKPOTKK-UHFFFAOYSA-N 9-methylanthracen-1-amine Chemical group C1=CC(N)=C2C(C)=C(C=CC=C3)C3=CC2=C1 QXDWMAODKPOTKK-UHFFFAOYSA-N 0.000 description 1
- ZYASLTYCYTYKFC-UHFFFAOYSA-N 9-methylidenefluorene Chemical compound C1=CC=C2C(=C)C3=CC=CC=C3C2=C1 ZYASLTYCYTYKFC-UHFFFAOYSA-N 0.000 description 1
- MFDORGWIGJJZEQ-UHFFFAOYSA-N 9-naphthalen-2-ylanthracene Chemical compound C1=CC=C2C(C3=CC4=CC=CC=C4C=C3)=C(C=CC=C3)C3=CC2=C1 MFDORGWIGJJZEQ-UHFFFAOYSA-N 0.000 description 1
- YRIKDGJWRMHTJP-FIBGUPNXSA-N BrC1=CC(=CC(=C1)C([2H])([2H])[2H])Cl Chemical compound BrC1=CC(=CC(=C1)C([2H])([2H])[2H])Cl YRIKDGJWRMHTJP-FIBGUPNXSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- AXYBVZYTYCFWIF-UHFFFAOYSA-N C1CSC2C1=C1C=CC=CC1=CC2 Chemical compound C1CSC2C1=C1C=CC=CC1=CC2 AXYBVZYTYCFWIF-UHFFFAOYSA-N 0.000 description 1
- FNOKDBSGJMNEET-UHFFFAOYSA-N CC1(CCC(C2=C1C=CC(=C2)NC3=CC=C(C=C3)C(C)(C)C)(C)C)C Chemical compound CC1(CCC(C2=C1C=CC(=C2)NC3=CC=C(C=C3)C(C)(C)C)(C)C)C FNOKDBSGJMNEET-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical group CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NFTRAGGUIJBGHD-UHFFFAOYSA-N N-(9H-fluoren-1-yl)phenanthren-1-amine Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC1=2)NC1=CC=CC=2C3=CC=CC=C3CC1=2 NFTRAGGUIJBGHD-UHFFFAOYSA-N 0.000 description 1
- 125000006614 N-arylalkylamine group Chemical group 0.000 description 1
- ACYWVHCCUGTDEW-UHFFFAOYSA-N N-naphthalen-1-yl-9H-fluoren-1-amine Chemical group C1(=CC=CC2=CC=CC=C12)NC1=CC=CC=2C3=CC=CC=C3CC12 ACYWVHCCUGTDEW-UHFFFAOYSA-N 0.000 description 1
- WJOZUXJBWJTHQQ-UHFFFAOYSA-N N-phenyl-2-(2-phenylphenyl)aniline Chemical group C1(=CC=CC=C1)NC=1C(=CC=CC=1)C=1C(=CC=CC=1)C1=CC=CC=C1 WJOZUXJBWJTHQQ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- YXLXNENXOJSQEI-UHFFFAOYSA-L Oxine-copper Chemical compound [Cu+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 YXLXNENXOJSQEI-UHFFFAOYSA-L 0.000 description 1
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- 101100451713 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HTL1 gene Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910006404 SnO 2 Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- YUENFNPLGJCNRB-UHFFFAOYSA-N anthracen-1-amine Chemical group C1=CC=C2C=C3C(N)=CC=CC3=CC2=C1 YUENFNPLGJCNRB-UHFFFAOYSA-N 0.000 description 1
- 125000005577 anthracene group Chemical group 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 125000005264 aryl amine group Chemical group 0.000 description 1
- GQVWHWAWLPCBHB-UHFFFAOYSA-L beryllium;benzo[h]quinolin-10-olate Chemical compound [Be+2].C1=CC=NC2=C3C([O-])=CC=CC3=CC=C21.C1=CC=NC2=C3C([O-])=CC=CC3=CC=C21 GQVWHWAWLPCBHB-UHFFFAOYSA-L 0.000 description 1
- 125000006616 biphenylamine group Chemical group 0.000 description 1
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- XOYLJNJLGBYDTH-UHFFFAOYSA-M chlorogallium Chemical compound [Ga]Cl XOYLJNJLGBYDTH-UHFFFAOYSA-M 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- RCDMUNHSQCVVBJ-UHFFFAOYSA-N dibenzofuran-1-amine Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2N RCDMUNHSQCVVBJ-UHFFFAOYSA-N 0.000 description 1
- DSSBJZCMMKRJTF-UHFFFAOYSA-N dibenzofuran-2-ylboronic acid Chemical compound C1=CC=C2C3=CC(B(O)O)=CC=C3OC2=C1 DSSBJZCMMKRJTF-UHFFFAOYSA-N 0.000 description 1
- 150000004826 dibenzofurans Chemical class 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 150000002219 fluoranthenes Chemical class 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005241 heteroarylamino group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- XNUVVHVFAAQPQY-UHFFFAOYSA-L manganese(2+) quinolin-8-olate Chemical compound N1=CC=CC2=CC=CC(=C12)[O-].[Mn+2].N1=CC=CC2=CC=CC(=C12)[O-] XNUVVHVFAAQPQY-UHFFFAOYSA-L 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- NJVSFOMTEFOHMI-UHFFFAOYSA-N n,2-diphenylaniline Chemical group C=1C=CC=C(C=2C=CC=CC=2)C=1NC1=CC=CC=C1 NJVSFOMTEFOHMI-UHFFFAOYSA-N 0.000 description 1
- KSCGBFWJQRWORE-UHFFFAOYSA-N n-(4-tert-butylphenyl)-4-phenylaniline Chemical compound C1=CC(C(C)(C)C)=CC=C1NC1=CC=C(C=2C=CC=CC=2)C=C1 KSCGBFWJQRWORE-UHFFFAOYSA-N 0.000 description 1
- HCISEFFYVMEPNF-UHFFFAOYSA-N n-phenyl-9h-fluoren-1-amine Chemical group C=12CC3=CC=CC=C3C2=CC=CC=1NC1=CC=CC=C1 HCISEFFYVMEPNF-UHFFFAOYSA-N 0.000 description 1
- UMGBMWFOGBJCJA-UHFFFAOYSA-N n-phenylphenanthren-1-amine Chemical group C=1C=CC(C2=CC=CC=C2C=C2)=C2C=1NC1=CC=CC=C1 UMGBMWFOGBJCJA-UHFFFAOYSA-N 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- UHHKSVZZTYJVEG-UHFFFAOYSA-N oxepane Chemical compound C1CCCOCC1 UHHKSVZZTYJVEG-UHFFFAOYSA-N 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 150000002964 pentacenes Chemical class 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- FVDOBFPYBSDRKH-UHFFFAOYSA-N perylene-3,4,9,10-tetracarboxylic acid Chemical compound C=12C3=CC=C(C(O)=O)C2=C(C(O)=O)C=CC=1C1=CC=C(C(O)=O)C2=C1C3=CC=C2C(=O)O FVDOBFPYBSDRKH-UHFFFAOYSA-N 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 150000002987 phenanthrenes Chemical class 0.000 description 1
- 150000005041 phenanthrolines Chemical class 0.000 description 1
- XPPWLXNXHSNMKC-UHFFFAOYSA-N phenylboron Chemical group [B]C1=CC=CC=C1 XPPWLXNXHSNMKC-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 150000003220 pyrenes Chemical class 0.000 description 1
- 125000001725 pyrenyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- GFOZRCASAHKFFT-UHFFFAOYSA-N spiro[10h-acridine-9,9'-fluorene] Chemical compound C12=CC=CC=C2NC2=CC=CC=C2C11C2=CC=CC=C2C2=CC=CC=C21 GFOZRCASAHKFFT-UHFFFAOYSA-N 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- JLBRGNFGBDNNSF-UHFFFAOYSA-N tert-butyl(dimethyl)borane Chemical group CB(C)C(C)(C)C JLBRGNFGBDNNSF-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- AMIGYDGSJCJWSD-UHFFFAOYSA-N thiocane Chemical compound C1CCCSCCC1 AMIGYDGSJCJWSD-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- IBBLKSWSCDAPIF-UHFFFAOYSA-N thiopyran Chemical compound S1C=CC=C=C1 IBBLKSWSCDAPIF-UHFFFAOYSA-N 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- KWQNQSDKCINQQP-UHFFFAOYSA-K tri(quinolin-8-yloxy)gallane Chemical compound C1=CN=C2C(O[Ga](OC=3C4=NC=CC=C4C=CC=3)OC=3C4=NC=CC=C4C=CC=3)=CC=CC2=C1 KWQNQSDKCINQQP-UHFFFAOYSA-K 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- LALRXNPLTWZJIJ-UHFFFAOYSA-N triethylborane Chemical group CCB(CC)CC LALRXNPLTWZJIJ-UHFFFAOYSA-N 0.000 description 1
- WXRGABKACDFXMG-UHFFFAOYSA-N trimethylborane Chemical group CB(C)C WXRGABKACDFXMG-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000006617 triphenylamine group Chemical group 0.000 description 1
- MXSVLWZRHLXFKH-UHFFFAOYSA-N triphenylborane Chemical group C1=CC=CC=C1B(C=1C=CC=CC=1)C1=CC=CC=C1 MXSVLWZRHLXFKH-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
- HTPBWAPZAJWXKY-UHFFFAOYSA-L zinc;quinolin-8-olate Chemical compound [Zn+2].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 HTPBWAPZAJWXKY-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/321—Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3]
- H10K85/322—Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3] comprising boron
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Inorganic Chemistry (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
본 명세서는 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상이 화학식 1의 화합물 및 화학식 202의 화합물, 또는 화학식 1의 화합물 및 화학식 203의 화합물을 포함하는 유기 발광 소자에 관한 것이다.The present specification relates to an organic light-emitting device including a first electrode; a second electrode provided opposite the first electrode; and at least one organic layer provided between the first electrode and the second electrode, wherein at least one of the organic layers includes a compound of chemical formula 1 and a compound of chemical formula 202, or a compound of chemical formula 1 and a compound of chemical formula 203.
Description
본 명세서는 유기 발광 소자에 관한 것이다. This specification relates to an organic light-emitting device.
본 출원은 2020년 12월 09일 한국특허청에 제출된 한국 특허 출원 제10-2020-0170955호의 출원일의 이익을 주장하며, 그 내용 전부는 본 명세서에 포함된다.This application claims the benefit of Korean Patent Application No. 10-2020-0170955 filed with the Korean Intellectual Property Office on December 9, 2020, the entire contents of which are incorporated herein by reference.
본 명세서에서, 유기 발광 소자란 유기 반도체 물질을 이용한 발광 소자로서, 전극과 유기 반도체 물질 사이에서의 정공 및/또는 전자의 교류를 필요로 한다. 유기 발광 소자는 동작 원리에 따라 하기와 같이 크게 두 가지로 나눌 수 있다. 첫째는 외부의 광원으로부터 소자로 유입된 광자에 의하여 유기물층에서 엑시톤(exiton)이 형성되고, 이 엑시톤이 전자와 정공으로 분리되고, 이 전자와 정공이 각각 다른 전극으로 전달되어 전류원(전압원)으로 사용되는 형태의 발광 소자이다. 둘째는 2개 이상의 전극에 전압 또는 전류를 가하여 전극과 계면을 이루는 유기 반도체 물질층에 정공 및/또는 전자를 주입하고, 주입된 전자와 정공에 의하여 작동하는 형태의 발광 소자이다.In this specification, an organic light-emitting device is a light-emitting device using an organic semiconductor material, and requires the exchange of holes and/or electrons between an electrode and the organic semiconductor material. Organic light-emitting devices can be largely divided into two types according to their operating principles. First, a light-emitting device is a type in which excitons are formed in an organic layer by photons that enter the device from an external light source, the excitons are separated into electrons and holes, and the electrons and holes are each transferred to different electrodes and used as a current source (voltage source). Second, a light-emitting device is a type in which holes and/or electrons are injected into an organic semiconductor material layer forming an interface with the electrodes by applying voltage or current to two or more electrodes, and is operated by the injected electrons and holes.
일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자억제층, 전자수송층, 전자주입층 등으로 이루어 질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. 이러한 유기 발광 소자는 자발광, 고휘도, 고효율, 낮은 구동 전압, 넓은 시야각, 높은 콘트라스트 등의 특성을 갖는 것으로 알려져 있다.In general, the organic luminescence phenomenon refers to the phenomenon of converting electrical energy into light energy using organic materials. Organic light-emitting devices utilizing the organic luminescence phenomenon usually have a structure including an anode, a cathode, and an organic layer therebetween. Here, the organic layer is often composed of a multilayer structure composed of different materials in order to increase the efficiency and stability of the organic light-emitting device, and can be composed of, for example, a hole injection layer, a hole transport layer, a light-emitting layer, an electron suppression layer, an electron transport layer, and an electron injection layer. In the structure of such an organic light-emitting device, when a voltage is applied between the two electrodes, holes are injected into the organic layer from the anode and electrons are injected into the organic layer from the cathode, and when the injected holes and electrons meet, excitons are formed, and when these excitons fall back to the ground state, light is emitted. Such organic light-emitting devices are known to have characteristics such as self-luminescence, high brightness, high efficiency, low operating voltage, wide viewing angle, and high contrast.
유기 발광 소자에서 유기물층으로 사용되는 재료는 기능에 따라, 발광 재료와 전하 수송 재료, 예컨대 정공 주입 재료, 정공 수송 재료, 전자 억제 물질, 전자 수송 재료, 전자 주입 재료 등으로 분류될 수 있다. 발광 재료는 발광색에 따라 청색, 녹색, 적색 발광 재료와 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 재료가 있다.Materials used as organic layers in organic light-emitting devices can be classified into light-emitting materials and charge-transport materials, such as hole injection materials, hole transport materials, electron-blocking materials, electron transport materials, and electron injection materials, depending on their functions. Light-emitting materials include blue, green, and red light-emitting materials according to their emission colors, and yellow and orange light-emitting materials necessary for realizing better natural colors.
또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 재료로서 호스트/도펀트 계를 사용할 수 있다. 그 원리는 발광층을 주로 구성하는 호스트보다 에너지 대역 간극이 작고 발광 효율이 우수한 도펀트를 발광층에 소량 혼합하면, 호스트에서 발생한 엑시톤이 도펀트로 수송되어 효율이 높은 빛을 내는 것이다. 이 때 호스트의 파장이 도펀트의 파장대로 이동하므로, 이용하는 도펀트의 종류에 따라 원하는 파장의 빛을 얻을 수 있다.In addition, in order to increase color purity and luminescence efficiency through energy transfer, a host/dopant system can be used as a luminescent material. The principle is that a small amount of a dopant having a smaller energy band gap and superior luminescence efficiency than the host that mainly composes the luminescent layer is mixed into the luminescent layer, and excitons generated in the host are transported to the dopant to emit light with high efficiency. At this time, the wavelength of the host shifts to the wavelength of the dopant, so light of a desired wavelength can be obtained depending on the type of dopant used.
전술한 유기 발광 소자가 갖는 우수한 특징들을 충분히 발휘하기 위해서는 소자 내 유기물층을 이루는 물질, 예컨대 정공 주입 물질, 정공 수송 물질, 발광 물질, 전자 억제 물질, 전자 수송 물질, 전자 주입 물질 등이 안정하고 효율적인 재료에 의하여 뒷받침되므로 새로운 재료의 개발이 계속 요구되고 있다.In order to fully demonstrate the excellent characteristics of the organic light-emitting device described above, the materials forming the organic layer within the device, such as hole injection materials, hole transport materials, luminescent materials, electron blocking materials, electron transport materials, and electron injection materials, must be supported by stable and efficient materials, and therefore, the development of new materials is continuously required.
본 명세서에는 유기 발광 소자가 기재된다. An organic light-emitting device is described herein.
본 명세서의 일 실시상태는 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상이 하기 화학식 1의 화합물 및 하기 화학식 202의 화합물, 또는 하기 화학식 1의 화합물 및 하기 화학식 203의 화합물을 포함하는 유기 발광 소자를 제공한다.One embodiment of the present specification provides an organic light-emitting device including a first electrode; a second electrode provided opposite the first electrode; and at least one organic layer provided between the first electrode and the second electrode, wherein at least one of the organic layers includes a compound of the following chemical formula 1 and a compound of the following chemical formula 202, or a compound of the following chemical formula 1 and a compound of the following chemical formula 203.
[화학식 1][Chemical Formula 1]
[화학식 202][Chemical formula 202]
[화학식 203][Chemical formula 203]
상기 화학식 1, 화학식 202 및 화학식 203에 있어서,In the above chemical formulas 1, 202 and 203,
Ar1은 치환 또는 비치환된 아릴기; 치환 또는 비치환된 탄화수소고리기; 또는 치환 또는 비치환된 헤테로아릴기이고,Ar1 is a substituted or unsubstituted aryl group; a substituted or unsubstituted hydrocarbon ring group; or a substituted or unsubstituted heteroaryl group,
L은 직접결합, 치환 또는 비치환된 아릴렌기, 또는 치환 또는 비치환된 헤테로아릴렌기이고,L is a direct bond, a substituted or unsubstituted arylene group, or a substituted or unsubstituted heteroarylene group,
R1 내지 R8은 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 니트릴기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이고, R1 to R8 are the same as or different from each other, and are each independently hydrogen; deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted alkoxy group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group,
R9는 중수소; 니트릴기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이고,R9 is deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted alkoxy group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group,
Y1 내지 Y3은 서로 동일하거나 상이하고, 각각 독립적으로 C 또는 Si이고, Y1 to Y3 are the same or different from each other, and are each independently C or Si,
R11 내지 R14, Ar21 내지 Ar32, 및 Z1 내지 Z6은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 시아노기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 알케닐기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하며,R11 to R14, Ar21 to Ar32, and Z1 to Z6 are the same as or different from each other, and each independently represents hydrogen; deuterium; a halogen group; a cyano group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted silyl group; a substituted or unsubstituted alkenyl group; a substituted or unsubstituted aryl group; a substituted or unsubstituted heterocyclic group; or a substituted or unsubstituted amine group, or are combined with adjacent substituents to form a substituted or unsubstituted ring,
a는 0 내지 9의 정수이고, a가 복수일 때, R9는 서로 같거나 상이하고, 복수의 R9 중 하나 이상은 중수소가 아니고,a is an integer from 0 to 9, and when a is plural, R9 is the same or different, and at least one of the plural R9 is not deuterium,
r1은 0 내지 4의 정수이고, r1 is an integer from 0 to 4,
r1', r2 및 r3은 각각 0 내지 3의 정수이고, r1', r2 and r3 are integers from 0 to 3, respectively.
r1 및 r1'이 각각 복수일 때, R11은 서로 같거나 상이하고,When r1 and r1' are plural, R11 is equal to or different from each other,
r2가 복수일 때, R12는 서로 같거나 상이하고,When r2 is plural, R12 is equal to or different from each other,
r3이 복수일 때, R11은 서로 같거나 상이하고,When r3 is plural, R11 is equal to or different from each other,
r4은 0 내지 5의 정수이고,r4 is an integer from 0 to 5,
r4가 복수일 때, R14는 서로 같거나 상이하고,When r4 is plural, R14 is equal to or different from each other,
p1 내지 p3은 각각 0 또는 1이고,p1 to p3 are 0 or 1, respectively,
p1 내지 p3이 0일 때, Y1 내지 Y3은 직접결합이다.When p1 to p3 are 0, Y1 to Y3 are direct bonds.
본 발명의 유기 발광 소자는 고효율, 저전압 및 장수명 특성을 가지며, 본 발명의 화합물을 유기 발광 소자의 발광층에 포함하는 경우, 높은 색재현율을 가지는 유기 발광 소자를 제조할 수 있다.The organic light-emitting device of the present invention has high efficiency, low voltage, and long life characteristics, and when the compound of the present invention is included in the light-emitting layer of the organic light-emitting device, an organic light-emitting device having high color reproducibility can be manufactured.
도 1 및 2는 본 발명에 따른 유기 발광 소자의 예를 도시한 것이다.Figures 1 and 2 illustrate examples of organic light-emitting devices according to the present invention.
이하 본 명세서에 대하여 더욱 상세히 설명한다. The following describes this specification in more detail.
본 명세서에 있어서, 어떤 부분이 어떤 구성요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다.In this specification, when a part is said to "include" a certain component, this does not mean that other components are excluded, but rather that other components may be included, unless otherwise specifically stated.
본 명세서에 있어서, 어떤 부재가 다른 부재 "상에" 위치하고 있다고 할 때, 이는 어떤 부재가 다른 부재에 접해 있는 경우뿐 아니라 두 부재 사이에 또 다른 부재가 존재하는 경우도 포함한다.In this specification, when it is said that a member is located "on" another member, this includes not only cases where a member is in contact with another member, but also cases where another member exists between the two members.
본 명세서에서 치환기의 예시들은 아래에서 설명하나, 이에 한정되는 것은 아니다.Examples of substituents in this specification are described below, but are not limited thereto.
상기 "치환" 이라는 용어는 화합물의 탄소 원자에 결합된 수소 원자가 다른 치환기로 바뀌는 것을 의미하며, 치환되는 위치는 수소 원자가 치환되는 위치 즉, 치환기가 치환 가능한 위치라면 한정하지 않으며, 2 이상 치환되는 경우, 2 이상의 치환기는 서로 동일하거나 상이할 수 있다.The term "substitution" above means that a hydrogen atom bonded to a carbon atom of a compound is replaced with another substituent, and the position of the substitution is not limited as long as it is a position where the hydrogen atom is replaced, that is, a position where the substituent can be replaced, and when two or more are substituted, the two or more substituents may be the same or different from each other.
본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 시아노기(-CN); 실릴기; 붕소기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 아민기; 치환 또는 비치환된 아릴기; 및 치환 또는 비치환된 헤테로아릴기로 이루어진 군에서 선택된 1 또는 2 이상의 치환기로 치환되었거나 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환기로 치환되거나, 또는 어떠한 치환기도 갖지 않는 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 바이페닐기일 수 있다. 즉, 바이페닐기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수 도 있다.The term "substituted or unsubstituted" as used herein means substituted with one or more substituents selected from the group consisting of deuterium; a halogen group; a cyano group (-CN); a silyl group; a boron group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted amine group; a substituted or unsubstituted aryl group; and a substituted or unsubstituted heteroaryl group, or substituted with a substituent in which two or more substituents are linked among the above-mentioned substituents, or has no substituents. For example, "a substituent linked with two or more substituents" may be a biphenyl group. That is, the biphenyl group may be an aryl group, or may be interpreted as a substituent in which two phenyl groups are linked.
상기 치환기들의 예시들은 아래에서 설명하나, 이에 한정되는 것은 아니다. Examples of the above substituents are described below, but are not limited thereto.
본 명세서에 있어서, 할로겐기의 예로는 불소(F), 염소(Cl), 브롬(Br) 또는 요오드(I)가 있다.In this specification, examples of halogen groups include fluorine (F), chlorine (Cl), bromine (Br), or iodine (I).
본 명세서에 있어서, 실릴기는 -SiYaYbYc의 화학식으로 표시될 수 있고, 상기 Ya, Yb 및 Yc는 각각 수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기일 수 있다. 상기 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다. In the present specification, a silyl group can be represented by a chemical formula of -SiYaYbYc, wherein Ya, Yb and Yc can each be hydrogen; a substituted or unsubstituted alkyl group; or a substituted or unsubstituted aryl group. Specific examples of the silyl group include, but are not limited to, a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, and a phenylsilyl group.
본 명세서에 있어서, 붕소기는 -BY4Y5의 화학식으로 표시될 수 있고, 상기 Y4 및Y5는 각각 수소; 치환 또는 비치환된 알킬기; 또는 치환 또는 비치환된 아릴기일 수 있다. 상기 붕소기는 구체적으로 트리메틸붕소기, 트리에틸붕소기, t-부틸디메틸붕소기, 트리페닐붕소기, 페닐붕소기 등이 있으나 이에 한정되지 않는다.In the present specification, the boron group can be represented by the chemical formula of -BY4Y5, wherein Y4 and Y5 can each be hydrogen; a substituted or unsubstituted alkyl group; or a substituted or unsubstituted aryl group. The boron group specifically includes, but is not limited to, a trimethyl boron group, a triethyl boron group, a t-butyldimethyl boron group, a triphenyl boron group, and a phenyl boron group.
본 명세서에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 60인 것이 바람직하다. 일 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 30이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 10이다. 알킬기의 구체적인 예로는 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, tert-부틸기, 펜틸기, 헥실기, 헵틸기, 옥틸기 등이 있으나, 이들에 한정되지 않는다.In the present specification, the alkyl group may be linear or branched, and the carbon number is not particularly limited, but is preferably 1 to 60. According to one embodiment, the alkyl group has 1 to 30 carbon atoms. According to another embodiment, the alkyl group has 1 to 20 carbon atoms. According to another embodiment, the alkyl group has 1 to 10 carbon atoms. Specific examples of the alkyl group include, but are not limited to, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, a pentyl group, a hexyl group, a heptyl group, an octyl group, and the like.
본 명세서에 있어서, 아민기는 -NH2; 알킬아민기; N-알킬아릴아민기; 아릴아민기; N-아릴헤테로아릴아민기; N-알킬헤테로아릴아민기 및 헤테로아릴아민기로 이루어진 군으로부터 선택될 수 있으며, 탄소수는 특별히 한정되지 않으나, 1 내지 30인 것이 바람직하다. 아민기의 구체적인 예로는 메틸아민기; 디메틸아민기; 에틸아민기; 디에틸아민기; 페닐아민기; 나프틸아민기; 바이페닐아민기; 안트라세닐아민기; 9-메틸안트라세닐아민기; 디페닐아민기; N-페닐나프틸아민기; 디톨릴아민기; N-페닐톨릴아민기; 트리페닐아민기; N-페닐바이페닐아민기; N-페닐나프틸아민기; N-바이페닐나프틸아민기; N-나프틸플루오레닐아민기; N-페닐페난트레닐아민기; N-바이페닐페난트레닐아민기; N-페닐플루오레닐아민기; N-페닐터페닐아민기; N-페난트레닐플루오레닐아민기; N-바이페닐플루오레닐아민기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the amine group may be selected from the group consisting of -NH 2 ; an alkylamine group; an N-alkylarylamine group; an arylamine group; an N-arylheteroarylamine group; an N-alkylheteroarylamine group and a heteroarylamine group, and the number of carbon atoms is not particularly limited, but is preferably 1 to 30. Specific examples of the amine group include a methylamine group; a dimethylamine group; an ethylamine group; a diethylamine group; a phenylamine group; a naphthylamine group; a biphenylamine group; anthracenylamine group; a 9-methylanthracenylamine group; a diphenylamine group; an N-phenylnaphthylamine group; a ditolylamine group; an N-phenyltolylamine group; a triphenylamine group; an N-phenylbiphenylamine group; an N-phenylnaphthylamine group; an N-biphenylnaphthylamine group; an N-naphthylfluorenylamine group; an N-phenylphenanthrenylamine group; an N-biphenylphenanthrenylamine group; Examples thereof include, but are not limited to, N-phenylfluorenylamine group; N-phenylterphenylamine group; N-phenanthrenylfluorenylamine group; N-biphenylfluorenylamine group.
본 명세서에 있어서, N-알킬아릴아민기는 아민기의 N에 알킬기 및 아릴기가 치환된 아민기를 의미한다.In this specification, an N-alkylarylamine group means an amine group in which an alkyl group and an aryl group are substituted on N of the amine group.
본 명세서에 있어서, N-아릴헤테로아릴아민기는 아민기의 N에 아릴기 및 헤테로아릴기가 치환된 아민기를 의미한다.In this specification, an N-arylheteroarylamine group means an amine group in which an aryl group and a heteroaryl group are substituted on N of the amine group.
본 명세서에 있어서, N-알킬헤테로아릴아민기는 아민기의 N에 알킬기 및 헤테로아릴기가 치환된 아민기를 의미한다.In this specification, an N-alkylheteroarylamine group means an amine group in which an alkyl group and a heteroaryl group are substituted on N of the amine group.
본 명세서에 있어서, 알킬아민기, N-아릴알킬아민기, 알킬티옥시기, 알킬술폭시기, N-알킬헤테로아릴아민기 중의 알킬기는 전술한 알킬기의 예시와 같다. 구체적으로 알킬티옥시기로는 메틸티옥시기; 에틸티옥시기; tert-부틸티옥시기; 헥실티옥시기; 옥틸티옥시기 등이 있고, 알킬술폭시기로는 메실; 에틸술폭시기; 프로필술폭시기; 부틸술폭시기 등이 있으나, 이에 한정되는 것은 아니다.In the present specification, the alkyl group among the alkylamine group, N-arylalkylamine group, alkylthioxy group, alkylsulfoxy group, and N-alkylheteroarylamine group is the same as the examples of the alkyl group described above. Specifically, the alkylthioxy group includes a methylthioxy group; an ethylthioxy group; a tert-butylthioxy group; a hexylthioxy group; an octylthioxy group, etc., and the alkylsulfoxy group includes, but is not limited to, a mesyl group; an ethylsulfoxy group; a propylsulfoxy group; a butylsulfoxy group.
본 명세서에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 일 실시상태에 따르면, 상기 시클로알킬기의 탄소수는 3 내지 30이다. 또 하나의 실시상태에 따르면, 상기 시클로알킬기의 탄소수는 3 내지 20이다. 또 하나의 실시상태에 따르면, 상기 시클로알킬기의 탄소수는 3 내지 6이다. 구체적으로 시클로프로필기, 시클로부틸기, 시클로펜틸기, 시클로헥실기, 시클로헵틸기, 시클로옥틸기 등이 있으나, 이에 한정되지 않는다. In the present specification, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms. According to one embodiment, the cycloalkyl group has 3 to 30 carbon atoms. According to another embodiment, the cycloalkyl group has 3 to 20 carbon atoms. According to another embodiment, the cycloalkyl group has 3 to 6 carbon atoms. Specifically, examples thereof include, but are not limited to, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and a cyclooctyl group.
본 명세서에 있어서, 아릴기는 특별히 한정되지 않으나 탄소수 6 내지 60인 것이 바람직하며, 단환식 아릴기 또는 다환식 아릴기일 수 있다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 30이다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 20이다. 상기 아릴기가 단환식 아릴기로는 페닐기, 바이페닐기, 터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. 상기 다환식 아릴기로는 나프틸기, 안트라세닐기, 페난트레닐기, 파이레닐기, 페릴레닐기, 트리페닐기, 크라이세닐기, 플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the aryl group is not particularly limited, but preferably has 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to one embodiment, the aryl group has 6 to 30 carbon atoms. According to one embodiment, the aryl group has 6 to 20 carbon atoms. The monocyclic aryl group may be a phenyl group, a biphenyl group, a terphenyl group, or the like, but is not limited thereto. The polycyclic aryl group may be a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, a perylenyl group, a triphenyl group, a chrysenyl group, a fluorenyl group, or the like, but is not limited thereto.
본 명세서에 있어서, 헤테로아릴기는 이종원자로 N, O, P, S, Si 및 Se 중 1개 이상을 포함하는 고리기로서, 탄소수는 특별히 한정되지 않으나 탄소수 2 내지 60인 것이 바람직하다. 일 실시상태에 따르면, 상기 헤테로아릴기의 탄소수는 2 내지 30이다. 헤테로아릴기의 예로는 피리딘기, 피롤기, 피리미딘기, 피리다지닐기, 퓨란기, 티오펜기, 이미다졸기, 피라졸기, 디벤조퓨란기, 디벤조티오펜기, 카바졸기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present specification, a heteroaryl group is a ring group containing at least one of N, O, P, S, Si, and Se as a heteroatom, and the number of carbon atoms is not particularly limited, but is preferably 2 to 60 carbon atoms. According to one embodiment, the number of carbon atoms of the heteroaryl group is 2 to 30. Examples of the heteroaryl group include, but are not limited to, a pyridine group, a pyrrole group, a pyrimidine group, a pyridazinyl group, a furan group, a thiophene group, an imidazole group, a pyrazole group, a dibenzofuran group, a dibenzothiophene group, a carbazole group, and the like.
본 명세서에 있어서, 헤테로고리기는 탄소가 아닌 원자, 즉 이종원자를 1 이상 포함하는 것으로서, 구체적으로 상기 이종원자는 O, N, Se 및 S 등으로 이루어진 군에서 선택되는 원자를 1 이상 포함하고, 방향족 헤테로고리기, 또는 지방족 헤테로고리기를 포함한다. 상기 방향족 헤테로고리기는 헤테로아릴기로 표시될 수 있다. 지방족 헤테로고리기는 예컨대, 테트라히드로퓨란, 피롤리딘 등 지방족탄화수소고리에 이종원자가 포함되거나, 이소인돌린과 같이 방향족과 지방족고리가 축합된 형태의 고리에 이종원자를 포함하는 경우를 일컫는다. 상기 헤테로아릴기도 헤테로고리의 범위에 포함되는 것이다. 헤테로고리기의 탄소수는 특별히 한정되지 않으나, 탄소수 2 내지 30인 것이 바람직하며, 탄소수 2 내지 20인 것이 더 바람직하고, 상기 헤테로아릴기는 단환식 또는 다환식일 수 있다In the present specification, a heterocyclic group is one that includes at least one atom other than carbon, i.e., a heteroatom, and specifically, the heteroatom includes at least one atom selected from the group consisting of O, N, Se, and S, and includes an aromatic heterocyclic group or an aliphatic heterocyclic group. The aromatic heterocyclic group can be represented by a heteroaryl group. An aliphatic heterocyclic group refers to a case where a heteroatom is included in an aliphatic hydrocarbon ring such as tetrahydrofuran or pyrrolidine, or a ring in which an aromatic and aliphatic ring are condensed, such as isoindoline, and a heteroatom is included. The heteroaryl group is also included in the scope of the heterocycle. The number of carbon atoms in the heterocyclic group is not particularly limited, but is preferably 2 to 30 carbon atoms, more preferably 2 to 20 carbon atoms, and the heteroaryl group can be monocyclic or polycyclic.
본 명세서에 있어서, 고리는 지방족 탄화수소고리, 방향족 탄화수소고리, 또는 헤테로고리를 말한다. In this specification, a ring refers to an aliphatic hydrocarbon ring, an aromatic hydrocarbon ring, or a heterocycle.
본 명세서에 있어서, 탄화수소고리는 탄소와 수소로 이루어진 고리를 통칭힌다. 탄화수소고리의 종류로는 지방족 탄화수소고리, 방향족 탄화수소고리, 또는 지방족과 방향족이 서로 축합된 형태의 탄화수소고리 등이 있으나, 이에 한정하는 것은 아니다.In this specification, a hydrocarbon ring is a general term for a ring composed of carbon and hydrogen. Types of hydrocarbon rings include, but are not limited to, an aliphatic hydrocarbon ring, an aromatic hydrocarbon ring, or a hydrocarbon ring in which an aliphatic and an aromatic are condensed with each other.
본 명세서에 있어서, 상기 방향족 탄화수소고리는 1가가 아닌 점을 제외하고 상기 아릴기와 정의가 같다.In this specification, the aromatic hydrocarbon ring has the same definition as the aryl group, except that it is not monovalent.
본 명세서에 있어서, 상기 지방족 탄화수소고리는, 단결합의 탄화수소고리, 다중결합을 포함하는 탄화수소고리, 또는 단결합과 다중결합을 포함하는 고리가 축합된 형태의 고리를 모두 포함한다. 따라서, 지방족 탄화수소고리 중 단일결합으로 이루어진 고리는 상기 시클로알킬기를 포함한다. 시클로헥센 등 단일결합과 이중결합을 포함하나 방향족 고리가 아닌 탄화수소고리도 지방족 탄화수소고리에 속한다.In the present specification, the aliphatic hydrocarbon ring includes a hydrocarbon ring having a single bond, a hydrocarbon ring including multiple bonds, or a ring in which rings including single bonds and multiple bonds are condensed. Therefore, among the aliphatic hydrocarbon rings, a ring formed by a single bond includes the cycloalkyl group. A hydrocarbon ring that includes a single bond and a double bond but is not an aromatic ring, such as cyclohexene, also belongs to the aliphatic hydrocarbon ring.
본 명세서에 있어서, 헤테로고리는 탄소가 아닌 원자, 이종원자를 1 이상 포함하는 것으로서, 구체적으로 상기 이종 원자는 O, N, Se 및 S 등으로 이루어진 군에서 선택되는 원자를 1 이상 포함할 수 있다. 상기 헤테로고리는 단환 또는 다환일 수 있으며, 방향족, 지방족 또는 방향족과 지방족의 축합고리일 수 있으며, 상기 방향족 헤테로고리는 1가가 아닌 것을 제외하고 상기 헤테로고리기 중 헤테로아릴기의 예시 중에서 선택될 수 있다.In the present specification, a heterocycle includes one or more non-carbon atoms, heteroatoms, and specifically, the heteroatoms may include one or more atoms selected from the group consisting of O, N, Se, and S. The heterocycle may be monocyclic or polycyclic, and may be an aromatic, aliphatic, or a condensed ring of aromatic and aliphatic groups, and the aromatic heterocycle may be selected from examples of heteroaryl groups among the heterocyclic groups, except that it is not monovalent.
본 명세서에 있어서, 지방족 헤테로고리란 헤테로원자 중 1개 이상을 포함하는 지방족 고리를 의미한다. 지방족 헤테로고리의 예로는, 옥시레인(oxirane), 테트라하이드로퓨란, 1,4-디옥세인(1,4-dioxane), 피롤리딘, 피페리딘, 모르폴린(morpholine), 옥세판, 아조케인, 티오케인, 테트라하이드로나프토티오펜, 테트라하이드로나프토퓨란, 테트라하이드로벤조티오펜, 및 테트라하이드로벤조퓨란 등이 있으나, 이에 한정되지 않는다.In the present specification, an aliphatic heterocycle means an aliphatic ring containing at least one heteroatom. Examples of aliphatic heterocycles include, but are not limited to, oxirane, tetrahydrofuran, 1,4-dioxane, pyrrolidine, piperidine, morpholine, oxepane, azocaine, thiocane, tetrahydronaphthothiophene, tetrahydronaphthofuran, tetrahydrobenzothiophene, and tetrahydrobenzofuran.
본 명세서에 있어서, 상기 지방족 탄화수소고리기는 1가인 것을 제외하고 상기 지방족 탄화수소고리의 정의와 같다.In this specification, the aliphatic hydrocarbon ring group is defined as the aliphatic hydrocarbon ring group, except that it is monovalent.
본 명세서에 있어서, 아릴렌기는 2가기인 것을 제외하고, 상기 아릴기에서 정의한 바와 같다.In this specification, an arylene group is as defined for the above aryl group, except that it is divalent.
본 명세서에 있어서, 헤테로아릴렌기는 2가기인 것을 제외하고, 상기 헤테로아릴기에서 정의한 바와 같다.In this specification, a heteroarylene group is as defined for the heteroaryl group, except that it is divalent.
본 명세서에 있어서, 상기 화학식 1은 하기 화학식 1-1 내지 화학식 1-3 중 어느 하나이다.In this specification, the chemical formula 1 is any one of the following chemical formulas 1-1 to 1-3.
[화학식 1-1][Chemical Formula 1-1]
[화학식 1-2] [Chemical Formula 1-2]
[화학식 1-3][Chemical Formula 1-3]
상기 화학식 1-1 내지 1-3에 있어서, R1 내지 R9, L, Ar1, 및 a의 정의는 상기 화학식 1에서 정의한 바와 같다.In the above chemical formulas 1-1 to 1-3, the definitions of R1 to R9, L, Ar1, and a are as defined in the above chemical formula 1.
본 명세서에 있어서, 상기 R1 내지 R8은 서로 같거나 상이하고, 각각 독립적으로 수소 또는 중수소이다.In this specification, R1 to R8 are the same as or different from each other, and are each independently hydrogen or deuterium.
본 명세서에 있어서, 상기 R1 내지 R8은 수소이다.In this specification, R1 to R8 are hydrogen.
본 명세서에 있어서, 상기 R1 내지 R8은 중수소이다.In this specification, R1 to R8 are deuterium.
본 명세서에 있어서, 상기 R1 내지 R8 중 하나 이상은 수소이고, 나머지는 중수소이다.In the present specification, at least one of R1 to R8 is hydrogen, and the rest are deuterium.
본 명세서에 있어서, 상기 R1 내지 R8 중 하나 이상은 중수소이고, 나머지는 수소이다.In the present specification, at least one of R1 to R8 is deuterium, and the others are hydrogen.
본 명세서에 있어서, 상기 R1 내지 R8 중 하나는 수소이고, 나머지는 중수소이다.In the present specification, one of R1 to R8 is hydrogen and the others are deuterium.
본 명세서에 있어서, 상기 R1 내지 R8 중 하나는 중수소이고, 나머지는 수소이다.In the present specification, one of R1 to R8 is deuterium and the others are hydrogen.
본 명세서에 있어서, 상기 R1 내지 R8 중 2개는 수소이고, 나머지는 중수소이다.In the present specification, two of R1 to R8 are hydrogen and the rest are deuterium.
본 명세서에 있어서, 상기 R1 내지 R8 중 2개는 중수소이고, 나머지는 수소이다.In the present specification, two of R1 to R8 are deuterium and the remainder are hydrogen.
본 명세서에 있어서, 상기 R1 내지 R8 중 3개는 수소이고, 나머지는 중수소이다.In the present specification, three of R1 to R8 are hydrogen and the rest are deuterium.
본 명세서에 있어서, 상기 R1 내지 R8 중 3개는 중수소이고, 나머지는 수소이다.In the present specification, three of R1 to R8 are deuterium and the remainder are hydrogen.
본 명세서에 있어서, 상기 R1 내지 R8 중 4개는 중수소이고, 나머지는 수소이다.In the present specification, four of R1 to R8 are deuterium and the remainder are hydrogen.
본 명세서에 있어서, 상기 R1 내지 R4는 수소이고, R5 내지 R8은 중수소이다.In this specification, R1 to R4 are hydrogen, and R5 to R8 are deuterium.
본 명세서에 있어서, 상기 R1 내지 R4는 중수소이고, R5 내지 R8은 수소이다.In this specification, R1 to R4 are deuterium, and R5 to R8 are hydrogen.
본 명세서에 있어서, 상기 R9는 중수소, 중수소로 치환 또는 비치환된 아릴기, 또는 헤테로아릴기이다.In the present specification, R9 is deuterium, an aryl group substituted or unsubstituted with deuterium, or a heteroaryl group.
본 명세서에 있어서, 상기 R9는 중수소, 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기, 또는 탄소수 3 내지 30의 헤테로아릴기이다.In the present specification, R9 is deuterium, an aryl group having 6 to 30 carbon atoms substituted or unsubstituted with deuterium, or a heteroaryl group having 3 to 30 carbon atoms.
본 명세서에 있어서, 상기 R9는 중수소, 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In the present specification, R9 is a deuterium, an aryl group having 6 to 30 carbon atoms, which is unsubstituted or substituted with deuterium.
본 명세서에 있어서, 상기 R9는 중수소, 페닐기, 중수소로 치환된 페닐기, 나프틸기, 비페닐기, 또는 디벤조퓨란기이다.In the present specification, R9 is deuterium, a phenyl group, a phenyl group substituted with deuterium, a naphthyl group, a biphenyl group, or a dibenzofuran group.
본 명세서에 있어서, 상기 R9는 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In the present specification, R9 is an aryl group having 6 to 30 carbon atoms, which is unsubstituted or substituted with deuterium.
본 명세서에 있어서, 상기 R9는 페닐기, 중수소로 치환된 페닐기, 나프틸기, 비페닐기, 또는 디벤조퓨란기이다.In the present specification, R9 is a phenyl group, a phenyl group substituted with deuterium, a naphthyl group, a biphenyl group, or a dibenzofuran group.
본 명세서에 있어서, 상기 a가 복수일 때, 복수의 R9 중 적어도 하나는 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기, 또는 탄소수 3 내지 30의 헤테로아릴기이다.In the present specification, when a is plural, at least one of the plural R9 is an aryl group having 6 to 30 carbon atoms, unsubstituted or substituted with deuterium, or a heteroaryl group having 3 to 30 carbon atoms.
본 명세서에 있어서, 상기 a가 1일 때, R9는 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기, 또는 탄소수 3 내지 30의 헤테로아릴기이다.In the present specification, when a is 1, R9 is an aryl group having 6 to 30 carbon atoms, unsubstituted or substituted with deuterium, or a heteroaryl group having 3 to 30 carbon atoms.
본 명세서에 있어서, 상기 L은 직접결합 또는 비치환된 아릴렌기이다.In this specification, L is a direct bond or an unsubstituted arylene group.
본 명세서에 있어서, 상기 L은 직접결합 또는 비치환된 탄소수 6 내지 30의 아릴렌기이다.In this specification, L is a direct bond or unsubstituted arylene group having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 L은 직접결합 또는 비치환된 탄소수 6 내지 20의 아릴렌기이다.In this specification, L is a direct bond or unsubstituted arylene group having 6 to 20 carbon atoms.
본 명세서에 있어서, 상기 L은 직접결합 또는 비치환된 탄소수 6 내지 15의 아릴렌기이다.In this specification, L is a direct bond or unsubstituted arylene group having 6 to 15 carbon atoms.
본 명세서에 있어서, 상기 L은 직접결합, 페닐렌기, 2가의 비페닐기, 또는 2가의 나프틸기이다.In this specification, L is a direct bond, a phenylene group, a divalent biphenyl group, or a divalent naphthyl group.
본 명세서에 있어서, 상기 L은 직접결합이다. In this specification, L is a direct bond.
본 명세서에 있어서, 상기 L은 페닐렌기이다.In this specification, L is a phenylene group.
본 명세서에 있어서, 상기 L은 2가의 비페닐기이다.In this specification, L is a divalent biphenyl group.
본 명세서에 있어서, 상기 L은 2가의 나프틸기이다.In this specification, L is a divalent naphthyl group.
본 명세서의 일 실시상태에 있어서, 상기 L의 치환가능한 위치의 40% 이상은 중수소로 치환된다. In one embodiment of the present specification, more than 40% of the substitutable positions of L are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 L의 치환가능한 위치의 50% 이상은 중수소로 치환된다. In another embodiment, more than 50% of the substitutable positions of L are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 L의 치환가능한 위치의 60% 이상은 중수소로 치환된다. In another embodiment, more than 60% of the substitutable positions of L are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 L의 치환가능한 위치의 70% 이상은 중수소로 치환된다. In another embodiment, more than 70% of the substitutable positions of L are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 L의 치환가능한 위치의 80% 이상은 중수소로 치환된다. In another embodiment, more than 80% of the substitutable positions of L are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 L의 치환가능한 위치의 90% 이상은 중수소로 치환된다. In another embodiment, more than 90% of the substitutable positions of L are substituted with deuterium.
본 명세서에 있어서, 상기 Ar1은 치환 또는 비치환된 탄소수 6 내지 30의 아릴기, 치환 또는 비치환된 탄소수 6 내지 30의 탄화수소고리기; 또는 치환 또는 비치환된 탄소수 3 내지 30의 헤테로아릴기이다.In the present specification, Ar1 is a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted hydrocarbon ring group having 6 to 30 carbon atoms; or a substituted or unsubstituted heteroaryl group having 3 to 30 carbon atoms.
본 명세서에 있어서, 상기 Ar1은 중수소로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기, 아릴기로 치환 또는 비치환된 탄소수 6 내지 30의 아릴기, 또는 아릴기로 치환 또는 비치환된 탄소수 6 내지 30의 헤테로아릴기이다.In the present specification, Ar1 is an aryl group having 6 to 30 carbon atoms which is unsubstituted or substituted with deuterium, an aryl group having 6 to 30 carbon atoms which is unsubstituted or substituted with an aryl group, or a heteroaryl group having 6 to 30 carbon atoms which is unsubstituted or substituted with an aryl group.
본 명세서에 있어서, 상기 Ar1은 치환된 페닐기; 치환된 나프틸기; 터페닐기; 치환된 비페닐기; 페난트렌기; 트리페닐렌기; 디벤조퓨란기; 디벤조티오펜기; 치환된 카바졸기; 벤조나프토퓨란기; 또는 2,3-디히드로인덴기이다.In the present specification, Ar1 is a substituted phenyl group; a substituted naphthyl group; a terphenyl group; a substituted biphenyl group; a phenanthrene group; a triphenylene group; a dibenzofuran group; a dibenzothiophene group; a substituted carbazole group; a benzonaphthofuran group; or a 2,3-dihydroindene group.
본 명세서에 있어서, 상기 Ar1은 중수소, 아릴기 또는 헤테로아릴기로 치환된 페닐기; 중수소, 또는 아릴기로 치환된 나프틸기; 터페닐기; 중수소로 치환된 비페닐기; 페난트렌기; 트리페닐렌기; 디벤조퓨란기; 디벤조티오펜기; 아릴기로 치환된 카바졸기; 벤조나프토퓨란기; 또는 2,3-디히드로인덴기이다.In the present specification, Ar1 is a phenyl group substituted with deuterium, an aryl group or a heteroaryl group; a naphthyl group substituted with deuterium or an aryl group; a terphenyl group; a biphenyl group substituted with deuterium; a phenanthrene group; a triphenylene group; a dibenzofuran group; a dibenzothiophene group; a carbazole group substituted with an aryl group; a benzonaphthofuran group; or a 2,3-dihydroindene group.
본 명세서에 있어서, 상기 Ar1은 중수소, 페닐기, 나프틸기 또는 디벤조퓨란기로 치환된 페닐기; 중수소, 페닐, 또는 나프틸기로 치환된 나프틸기; 터페닐기; 중수소로 치환된 비페닐기; 페난트렌기; 트리페닐렌기; 디벤조퓨란기; 디벤조티오펜기; 페닐기로 치환된 카바졸기; 벤조나프토퓨란기; 또는 2,3-디히드로인덴기이다.In the present specification, Ar1 is a phenyl group substituted with deuterium, a phenyl group, a naphthyl group or a dibenzofuran group; a naphthyl group substituted with deuterium, a phenyl group or a naphthyl group; a terphenyl group; a biphenyl group substituted with deuterium; a phenanthrene group; a triphenylene group; a dibenzofuran group; a dibenzothiophene group; a carbazole group substituted with a phenyl group; a benzonaphthofuran group; or a 2,3-dihydroindene group.
본 명세서의 일 실시상태에 있어서, 상기 Ar1의 치환가능한 위치의 40% 이상은 중수소로 치환된다. In one embodiment of the present specification, 40% or more of the substitutable positions of Ar1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 Ar1의 치환가능한 위치의 50% 이상은 중수소로 치환된다. In another embodiment, more than 50% of the substitutable positions of Ar1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 Ar1의 치환가능한 위치의 60% 이상은 중수소로 치환된다.In another embodiment, more than 60% of the substitutable positions of Ar1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 Ar1의 치환가능한 위치의 70% 이상은 중수소로 치환된다. In another embodiment, more than 70% of the substitutable positions of Ar1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 Ar1의 치환가능한 위치의 80% 이상은 중수소로 치환된다. In another embodiment, more than 80% of the substitutable positions of Ar1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 Ar1의 치환가능한 위치의 90% 이상은 중수소로 치환된다. In another embodiment, more than 90% of the substitutable positions of Ar1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 Ar1의 치환가능한 위치는 100% 중수소로 치환된다.In another embodiment, the substitutable positions of Ar1 are 100% substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 R9의 치환가능한 위치의 50% 이상은 중수소로 치환된다. In another embodiment, more than 50% of the substitutable positions of R9 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 R9의 치환가능한 위치의 60% 이상은 중수소로 치환된다. In another embodiment, more than 60% of the substitutable positions of R9 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 R9의 치환가능한 위치의 70% 이상은 중수소로 치환된다. In another embodiment, more than 70% of the substitutable positions of R9 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 R9의 치환가능한 위치의 80% 이상은 중수소로 치환된다. In another embodiment, more than 80% of the substitutable positions of R9 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 R9의 치환가능한 위치의 90% 이상은 중수소로 치환된다. In another embodiment, more than 90% of the substitutable positions of R9 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 R9의 치환가능한 위치는 100% 중수소로 치환된다.In another embodiment, the substitutable positions of R9 are 100% substituted with deuterium.
본 명세서의 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 20% 이상은 중수소로 치환된다. In one embodiment of the present specification, 20% or more of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 하나의 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 30% 이상은 중수소로 치환된다. In another embodiment, 30% or more of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 하나의 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 40% 이상은 중수소로 치환된다. In another embodiment, more than 40% of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 50% 이상은 중수소로 치환된다. In another embodiment, more than 50% of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 60% 이상은 중수소로 치환된다. In another embodiment, more than 60% of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 70% 이상은 중수소로 치환된다. In another embodiment, more than 70% of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 80% 이상은 중수소로 치환된다. In another embodiment, more than 80% of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치의 90% 이상은 중수소로 치환된다. In another embodiment, more than 90% of the substitutable positions of the compound represented by the chemical formula 1 are substituted with deuterium.
또 다른 일 실시상태에 있어서, 상기 화학식 1로 표시되는 화합물의 치환가능한 위치는 100% 중수소로 치환된다.In another embodiment, the substitutable positions of the compound represented by the chemical formula 1 are 100% substituted with deuterium.
본 명세서에 있어서, 상기 화학식 202는 하기 화학식 2-1 내지 2-3 중 어느 하나이다.In this specification, the chemical formula 202 is any one of the following chemical formulas 2-1 to 2-3.
[화학식 2-1][Chemical Formula 2-1]
[화학식 2-2][Chemical Formula 2-2]
[화학식 2-3][Chemical Formula 2-3]
상기 화학식 2-1 내지 2-3에 있어서, Y1, R11 내지 R14, r1 내지 r4, Z1 및 Z2는 상기 화학식 202에서 정의한 바와 같고,In the chemical formulas 2-1 to 2-3 above, Y1, R11 to R14, r1 to r4, Z1 and Z2 are as defined in the chemical formula 202 above,
R15 내지 R17은 서로 같거나 상이하고, 각각 수소, 중수소, 니트릴기, 할로겐기, 치환 또는 비치환된 알킬기, 치환 또는 비치환된 아릴기, 또는 치환 또는 비치환된 헤테로아릴기이고, R15 to R17 are the same as or different from each other and are each hydrogen, deuterium, a nitrile group, a halogen group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group,
r5 및 r7은 각각 0 내지 4의 정수이고, r5 and r7 are integers from 0 to 4, respectively.
r5이 복수일 때, R15는 서로 같거나 상이하고, When r5 is plural, R15 is equal to or different from each other,
r7이 복수일 때, R17은 서로 같거나 상이하고,When r7 is plural, R17 is equal to or different from each other,
r6은 0 내지 8의 정수이고, r6이 복수일 때, R16은 서로 같거나 상이하다.r6 is an integer from 0 to 8, and when r6 is plural, R16 is equal to or different from each other.
본 명세서에 있어서, 상기 상기 화학식 203은 하기 화학식 2-4 내지 2-12 중 어느 하나이다.In this specification, the chemical formula 203 is any one of the following chemical formulas 2-4 to 2-12.
[화학식 2-4][Chemical Formula 2-4]
[화학식 2-5][Chemical Formula 2-5]
[화학식 2-6][Chemical Formula 2-6]
[화학식 2-7][Chemical Formula 2-7]
[화학식 2-8][Chemical Formula 2-8]
[화학식 2-9][Chemical Formula 2-9]
[화학식 2-10][Chemical Formula 2-10]
[화학식 2-11][Chemical Formula 2-11]
[화학식 2-12][Chemical Formula 2-12]
상기 화학식 2-4 내지 2-12에 있어서, R11 내지 R13, r2, r3, Y2, Y3, 및 Z3 내지 Z6은 상기 화학식 203에서 정의한 바와 같고, In the chemical formulas 2-4 to 2-12 above, R11 to R13, r2, r3, Y2, Y3, and Z3 to Z6 are as defined in the chemical formula 203 above,
R15 내지 R20은 서로 같거나 상이하고, 각각 수소, 중수소, 니트릴기, 할로겐기, 치환 또는 비치환된 알킬기, 치환 또는 비치환된 아릴기 또는 치환 또는 비치환된 헤테로아릴기이고,R15 to R20 are the same as or different from each other and are each hydrogen, deuterium, a nitrile group, a halogen group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group,
r1은 0 내지 3의 정수이고, r1 is an integer from 0 to 3,
r1이 복수일 때, R11은 서로 같거나 상이하고,When r1 is plural, R11 is equal to or different from each other,
r5, r7, r8, 및 r10은 각각 0 내지 4의 정수이고, r5, r7, r8, and r10 are integers from 0 to 4, respectively,
r5이 복수일 때, R15는 서로 같거나 상이하고, When r5 is plural, R15 is equal to or different from each other,
r7이 복수일 때, R17은 서로 같거나 상이하고,When r7 is plural, R17 is equal to or different from each other,
r8이 복수일 때, R18은 서로 같거나 상이하고,When r8 is plural, R18 is equal to or different from each other,
r10이 복수일 때, R20은 서로 같거나 상이하고,When r10 is plural, R20 is equal to or different from each other,
r6 및 r9은 각각 0 내지 8의 정수이고, r6 and r9 are integers from 0 to 8, respectively.
r6이 복수일 때, R16은 서로 같거나 상이하고,When r6 is plural, R16 is equal to or different from each other,
r9가 복수일 때, R19는 서로 같거나 상이하다.When r9 is plural, R19 is equal to or different from each other.
본 명세서에 있어서, 상기 화학식 202는 하기 화학식 2-13이다.In this specification, the chemical formula 202 is the following chemical formula 2-13.
[화학식 2-13][Chemical Formula 2-13]
상기 화학식 2-13에 있어서, R11 내지 R14 및 r1 내지 r4는 상기 화학식 202에서 정의한 바와 같고,In the chemical formula 2-13 above, R11 to R14 and r1 to r4 are as defined in the chemical formula 202 above,
Y4는 O 또는 S이고,Y4 is O or S,
R21은 수소, 중수소, 니트릴기, 할로겐기, 치환 또는 비치환된 알킬기, 치환 또는 비치환된 아릴기 또는 치환 또는 비치환된 헤테로아릴기이고,R21 is hydrogen, deuterium, a nitrile group, a halogen group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group,
r11은 0 내지 4의 정수이고,r11 is an integer from 0 to 4,
r11이 복수일 때, R21은 서로 같거나 상이하다When r11 is plural, R21 is equal to or different from each other.
본 명세서에 있어서, 상기 Y1은 C이다.In this specification, Y1 is C.
본 명세서에 있어서, 상기 Y2는 C이다.In this specification, Y2 is C.
본 명세서에 있어서, 상기 Y3은 C이다.In this specification, Y3 is C.
본 명세서에 있어서, 상기 Y1은 Si이다.In this specification, Y1 is Si.
본 명세서에 있어서, 상기 Y2는 Si이다.In this specification, Y2 is Si.
본 명세서에 있어서, 상기 Y3은 Si이다.In this specification, Y3 is Si.
본 명세서에 있어서, 상기 R11 및 R12는 서로 같거나 상이하고, 각각 독립적으로 수소; 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 알킬기로 치환 또는 비치환된 실릴기; 아릴기로 치환 또는 비치환된 아민기; 또는 치환 또는 비치환된 탄소수 3 내지 30의 헤테로고리기이다.In the present specification, R11 and R12 are the same as or different from each other, and each independently represents hydrogen; a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; a substituted or unsubstituted aryl group having 6 to 30 carbon atoms; a silyl group substituted or unsubstituted with an alkyl group; an amine group substituted or unsubstituted with an aryl group; or a substituted or unsubstituted heterocyclic group having 3 to 30 carbon atoms.
본 명세서에 있어서, 상기 R11 및 R12는 서로 같거나 상이하고, 각각 독립적으로 수소; 알킬기 또는 아릴기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 치환 또는 비치환된 탄소수 6 내지 30의 아릴기; 탄소수 1 내지 10의 알킬기로 치환 또는 비치환된 실릴기; 탄소수 6 내지 30의 아릴기로 치환 또는 비치환된 아민기; 또는 탄소수 1 내지 10의 알킬기로 치환 또는 비치환된 탄소수 3 내지 30의 헤테로고리기이다.In the present specification, R11 and R12 are the same as or different from each other, and each independently represent hydrogen; an alkyl group having 1 to 10 carbon atoms substituted or unsubstituted with an alkyl group or an aryl group; a substituted or unsubstituted aryl group having 6 to 30 carbon atoms; a silyl group substituted or unsubstituted with an alkyl group having 1 to 10 carbon atoms; an amine group substituted or unsubstituted with an aryl group having 6 to 30 carbon atoms; or a heterocyclic group having 3 to 30 carbon atoms substituted or unsubstituted with an alkyl group having 1 to 10 carbon atoms.
본 명세서에 있어서, 상기 R11 및 R12는 서로 같거나 상이하고, 각각 독립적으로 수소; 메틸기; 메틸기 또는 페닐기로 치환된 메틸기; 터부틸기; 메틸기로 치환된 실릴기; 페닐기; 헥사히드로카바졸기; 또는 페닐기로 치환된 아민기이다.In the present specification, R11 and R12 are the same as or different from each other, and each independently represent hydrogen; a methyl group; a methyl group substituted with a methyl group or a phenyl group; a terbutyl group; a silyl group substituted with a methyl group; a phenyl group; a hexahydrocarbazole group; or an amine group substituted with a phenyl group.
본 명세서에 있어서, 상기 R13은 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 아릴기로 치환 또는 비치환된 아민기이다.In the present specification, R13 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; or an amine group substituted or unsubstituted with an aryl group.
본 명세서에 있어서, 상기 R13은 탄소수 6 내지 30의 아릴기로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기; 또는 탄소수 6 내지 30의 아릴기로 치환 또는 비치환된 아민기이다.In the present specification, R13 is an alkyl group having 1 to 10 carbon atoms, unsubstituted or substituted with an aryl group having 6 to 30 carbon atoms; or an amine group substituted or unsubstituted with an aryl group having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 R13은 페닐기로 치환 또는 비치환된 메틸기; 또는 페닐기 또는 터부틸페닐기로 치환된 아민기이다.In the present specification, R13 is a methyl group substituted or unsubstituted with a phenyl group; or an amine group substituted with a phenyl group or a terbutylphenyl group.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬기 또는 치환 또는 비치환된 아릴기이다.In the present specification, Z1 to Z6 are the same as or different from each other, and each independently represents a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 또는 치환 또는 비치환된 탄소수 6 내지 30의 아릴기이다.In the present specification, Z1 to Z6 are the same as or different from each other, and each independently represents a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, or a substituted or unsubstituted aryl group having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 10의 직쇄 또는 분지쇄의 알킬기, 또는 치환 또는 비치환된 탄소수 6 내지 30의 단환 또는 다환의 아릴기이다.In the present specification, Z1 to Z6 are the same as or different from each other, and each independently represents a substituted or unsubstituted straight-chain or branched-chain alkyl group having 1 to 10 carbon atoms, or a substituted or unsubstituted monocyclic or polycyclic aryl group having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 탄소수 1 내지 10의 직쇄 또는 분지쇄의 알킬기, 또는 탄소수 6 내지 30의 단환 또는 다환의 아릴기이다.In the present specification, Z1 to Z6 are the same as or different from each other, and each independently represents a straight-chain or branched-chain alkyl group having 1 to 10 carbon atoms, or a monocyclic or polycyclic aryl group having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 메틸기, 에틸기, 프로필기, 부틸기, 터부틸기, 페닐기, 비페닐기, 터페닐기, 나프틸기, 안트라센기, 또는 페난트렌기이다.In the present specification, Z1 to Z6 are the same as or different from each other, and are each independently a methyl group, an ethyl group, a propyl group, a butyl group, a terbutyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, an anthracene group, or a phenanthrene group.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 메틸기, 에틸기, 페닐기 또는 나프틸기이다.In the present specification, Z1 to Z6 are the same as or different from each other, and are each independently a methyl group, an ethyl group, a phenyl group, or a naphthyl group.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 메틸기, 또는 페닐기이다.In the present specification, Z1 to Z6 are the same as or different from each other, and each independently represents a methyl group or a phenyl group.
본 명세서에 있어서, 상기 Z1 및 Z2는 서로 결합하여 고리를 형성한다. In the present specification, Z1 and Z2 are combined with each other to form a ring.
본 명세서에 있어서, 상기 Z3 및 Z4는 서로 결합하여 고리를 형성한다. In the present specification, Z3 and Z4 are combined with each other to form a ring.
본 명세서에 있어서, 상기 Z5 및 Z6은 서로 결합하여 고리를 형성한다. In the present specification, Z5 and Z6 are combined with each other to form a ring.
본 명세서에 있어서, 상기 Z1 및 Z2는 서로 결합하여 탄소수 6 내지 30의 탄화수소고리 또는 탄소수 6 내지 30의 헤테로고리를 형성한다. In the present specification, Z1 and Z2 are combined with each other to form a hydrocarbon ring having 6 to 30 carbon atoms or a heterocycle having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 Z3 및 Z4는 서로 결합하여 탄소수 6 내지 30의 탄화수소고리 또는 탄소수 6 내지 30의 헤테로고리를 형성한다.In the present specification, Z3 and Z4 are combined with each other to form a hydrocarbon ring having 6 to 30 carbon atoms or a heterocycle having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 Z5 및 Z6은 서로 결합하여 탄소수 6 내지 30의 탄화수소고리 또는 탄소수 6 내지 30의 헤테로고리를 형성한다.In the present specification, Z5 and Z6 are combined with each other to form a hydrocarbon ring having 6 to 30 carbon atoms or a heterocycle having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 Z1 및 Z2는 서로 결합하여 탄소수 6 내지 30의 탄화수소고리 또는 탄소수 6 내지 20의 헤테로고리를 형성한다. In the present specification, Z1 and Z2 are combined with each other to form a hydrocarbon ring having 6 to 30 carbon atoms or a heterocycle having 6 to 20 carbon atoms.
본 명세서에 있어서, 상기 Z3 및 Z4는 서로 결합하여 탄소수 6 내지 30의 탄화수소고리 또는 탄소수 6 내지 20의 헤테로고리를 형성한다.In the present specification, Z3 and Z4 are combined with each other to form a hydrocarbon ring having 6 to 30 carbon atoms or a heterocycle having 6 to 20 carbon atoms.
본 명세서에 있어서, 상기 Z5 및 Z6은 서로 결합하여 탄소수 6 내지 30의 탄화수소고리 또는 탄소수 6 내지 20의 헤테로고리를 형성한다.In the present specification, Z5 and Z6 are combined with each other to form a hydrocarbon ring having 6 to 30 carbon atoms or a heterocycle having 6 to 20 carbon atoms.
본 명세서에 있어서, 상기 Z1 및 Z2는 서로 결합하여 플루오렌고리, 잔텐고리, 또는 디벤조실롤고리(dibenzosilole)를 형성한다.In the present specification, Z1 and Z2 are combined with each other to form a fluorene ring, a xanthene ring, or a dibenzosilole ring.
본 명세서에 있어서, 상기 Z3 및 Z4는 서로 결합하여 플루오렌고리, 잔텐고리, 또는 디벤조실롤고리(dibenzosilole)를 형성한다.In the present specification, Z3 and Z4 are combined with each other to form a fluorene ring, a xanthene ring, or a dibenzosilole ring.
본 명세서에 있어서, 상기 Z5 및 Z6은 서로 결합하여 플루오렌고리, 잔텐고리, 또는 디벤조실롤고리(dibenzosilole)를 형성한다.In the present specification, Z5 and Z6 are combined with each other to form a fluorene ring, a xanthene ring, or a dibenzosilole ring.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬기 또는 치환 또는 비치환된 아릴기이거나, 서로 결합하여 탄소수 6 내지 30의 탄화수소고리 또는 탄소수 6 내지 30의 헤테로고리를 형성한다.In the present specification, Z1 to Z6 are the same as or different from each other, and are each independently a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group, or are combined with each other to form a hydrocarbon ring having 6 to 30 carbon atoms or a heterocycle having 6 to 30 carbon atoms.
본 명세서에 있어서, 상기 Z1 내지 Z6은 서로 같거나 상이하고, 각각 독립적으로 탄소수 1 내지 10의 직쇄 또는 분지쇄의 알킬기, 또는 탄소수 6 내지 30의 단환 또는 다환의 아릴기이거나, 서로 결합하여 플루오렌고리, 잔텐고리, 또는 디벤조실롤고리(dibenzosilole)를 형성한다.In the present specification, Z1 to Z6 are the same as or different from each other, and are each independently a straight-chain or branched-chain alkyl group having 1 to 10 carbon atoms, or a monocyclic or polycyclic aryl group having 6 to 30 carbon atoms, or are combined with each other to form a fluorene ring, a xanthene ring, or a dibenzosilole ring.
본 명세서에 있어서, 상기 Ar21 내지 Ar32는 인접한 치환기와 서로 결합하여 고리를 형성한다. In the present specification, Ar21 to Ar32 are bonded to adjacent substituents to form a ring.
청구항 1에 있어서, 상기 화학식 1은 하기 화합물 중에서 선택되는 어느 하나이다.In claim 1, the chemical formula 1 is any one selected from the following compounds.
본 명세서에 있어서, 상기 화학식 2는 하기 화합물 중에서 선택되는 어느 하나이다.In this specification, the chemical formula 2 is one selected from the following compounds.
상기 화학식 1, 202 및 203의 화합물의 치환기는 당 기술분야에 알려져 있는 방법에 의하여 결합될 수 있으며, 치환기의 종류, 위치 또는 개수는 당 기술분야에 알려져 있는 기술에 따라 변경될 수 있다.The substituents of the compounds of the above chemical formulae 1, 202 and 203 can be combined by a method known in the art, and the type, position or number of the substituents can be changed according to a technique known in the art.
상기 헤테로고리 화합물의 컨쥬게이션 길이와 에너지 밴드갭은 밀접한 관계가 있다. 구체적으로, 화합물의 컨쥬게이션 길이가 길수록 에너지 밴드갭이 작아진다. The conjugation length and energy band gap of the above heterocyclic compound are closely related. Specifically, the longer the conjugation length of the compound, the smaller the energy band gap.
본 발명에서는 상기와 같이 코어 구조에 다양한 치환기를 도입함으로써 다양한 에너지 밴드갭을 갖는 화합물을 합성할 수 있다. 또한, 본 발명에서는 상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 화합물의 HOMO 및 LUMO 에너지 준위도 조절할 수 있다.In the present invention, compounds having various energy band gaps can be synthesized by introducing various substituents into the core structure as described above. In addition, in the present invention, HOMO and LUMO energy levels of the compound can also be controlled by introducing various substituents into the core structure having the structure described above.
또한, 상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 도입된 치환기의 고유 특성을 갖는 화합물을 합성할 수 있다. 예컨대, 유기 발광 소자 제조시 사용되는 정공 주입층 물질, 정공 수송용 물질, 발광층 물질 및 전자 수송층 물질에 주로 사용되는 치환기를 상기 코어 구조에 도입함으로써 각 유기물층에서 요구하는 조건들을 충족시키는 물질을 합성할 수 있다.In addition, by introducing various substituents into the core structure having the structure as described above, it is possible to synthesize a compound having the unique characteristics of the introduced substituent. For example, by introducing a substituent mainly used in hole injection layer materials, hole transport materials, light-emitting layer materials, and electron transport layer materials used in the manufacture of organic light-emitting devices into the core structure, it is possible to synthesize a material satisfying the conditions required for each organic layer.
또한, 본 발명에 따른 유기 발광 소자는 제1 전극; 상기 제1 전극과 대향하여 구비되는 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비되는 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상은 상기 전술한 화합물을 포함하는 것을 특징으로 한다.In addition, the organic light-emitting device according to the present invention is an organic light-emitting device including a first electrode; a second electrode provided opposite the first electrode; and one or more organic layers provided between the first electrode and the second electrode, characterized in that one or more of the organic layers includes the compound described above.
본 발명의 유기 발광 소자는 전술한 화합물을 이용하여 한 층 이상의 유기물층을 형성하는 것을 제외하고는, 통상의 유기 발광 소자의 제조방법 및 재료에 의하여 제조될 수 있다.The organic light-emitting device of the present invention can be manufactured using a conventional method and material for manufacturing an organic light-emitting device, except that one or more organic layers are formed using the above-described compound.
상기 헤테로고리 화합물은 유기 발광 소자의 제조시 진공 증착법 뿐만 아니라 용액 도포법에 의하여 유기물층으로 형성될 수 있다. 여기서, 용액 도포법이라 함은 스핀 코팅, 딥 코팅, 잉크젯 프린팅, 스크린 프린팅, 스프레이법, 롤 코팅 등을 의미하지만, 이들만으로 한정되는 것은 아니다.The above heterocyclic compound can be formed into an organic layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light-emitting device. Here, the solution coating method refers to spin coating, dip coating, inkjet printing, screen printing, spraying, roll coating, etc., but is not limited thereto.
본 발명의 유기 발광 소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 본 발명의 유기 발광 소자는 유기물층으로서 정공주입층, 정공수송층, 정공주입 및 정공수송을 동시에 하는 층, 발광층, 전자수송층, 전자주입층 등을 포함하는 구조를 가질 수 있다. 그러나, 유기 발광 소자의 구조는 이에 한정되지 않고 더 적은 수의 유기물층 또는 더 많은 수의 유기물층을 포함할 수 있다.The organic layer of the organic light-emitting device of the present invention may be formed as a single-layer structure, but may be formed as a multilayer structure in which two or more organic layers are laminated. For example, the organic light-emitting device of the present invention may have a structure including, as organic layers, a hole injection layer, a hole transport layer, a layer that simultaneously injects holes and transports holes, a light-emitting layer, an electron transport layer, an electron injection layer, etc. However, the structure of the organic light-emitting device is not limited thereto, and may include a smaller number of organic layers or a larger number of organic layers.
본 발명의 유기 발광 소자에서, 상기 유기물층은 발광층을 포함할 수 있고, 상기 발광층에 상기 화학식 1의 화합물 및 상기 화학식 202의 화합물을 포함할 수 있다.In the organic light-emitting device of the present invention, the organic layer may include a light-emitting layer, and the light-emitting layer may include a compound of chemical formula 1 and a compound of chemical formula 202.
본 발명의 유기 발광 소자에서, 상기 유기물층은 발광층을 포함할 수 있고, 상기 발광층에 상기화학식 1의 화합물 및 상기 화학식 203의 화합물을 포함할 수 있다.In the organic light-emitting device of the present invention, the organic layer may include a light-emitting layer, and the light-emitting layer may include a compound of the chemical formula 1 and a compound of the chemical formula 203.
본 발명의 유기 발광 소자에서, 상기 발광층은 상기 화학식 202의 화합물 및 상기 화학식 1의 화합물을 각각 발광층의 도펀트 및 호스트로 포함한다.In the organic light-emitting device of the present invention, the light-emitting layer contains the compound of the chemical formula 202 and the compound of the chemical formula 1 as a dopant and a host of the light-emitting layer, respectively.
본 발명의 유기 발광 소자에서, 상기 발광층은 상기 화학식 203의 화합물 및 상기 화학식 1의 화합물을 각각 발광층의 도펀트 및 호스트로 포함한다.In the organic light-emitting device of the present invention, the light-emitting layer contains the compound of the chemical formula 203 and the compound of the chemical formula 1 as a dopant and a host of the light-emitting layer, respectively.
본 발명의 유기 발광 소자에서, 상기 발광층은 호스트와 도펀트를 각각 99:1 내지 50:50의 질량비로 포함한다.In the organic light-emitting device of the present invention, the light-emitting layer contains the host and the dopant in a mass ratio of 99:1 to 50:50, respectively.
본 발명의 유기 발광 소자에서, 상기 발광층은 호스트와 도펀트를 각각 99:1 내지 80:20의 질량비로 포함한다.In the organic light-emitting device of the present invention, the light-emitting layer contains the host and the dopant in a mass ratio of 99:1 to 80:20, respectively.
본 발명의 유기 발광 소자에서, 상기 발광층은 호스트와 도펀트를 각각 99:1 내지 90:10의 질량비로 포함한다.In the organic light-emitting device of the present invention, the light-emitting layer contains the host and the dopant in a mass ratio of 99:1 to 90:10, respectively.
본 발명의 유기 발광 소자에서, 상기 유기물층은 전자수송층, 전자주입층 및 전자주입과 전자수송을 동시에 하는 층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 화학식 1의 화합물 및 상기 화학식 202의 화합물을 포함할 수 있다.In the organic light-emitting device of the present invention, the organic layer may include at least one layer among an electron transport layer, an electron injection layer, and a layer that simultaneously injects electrons and transports electrons, and at least one layer among the layers may include the compound of the chemical formula 1 and the compound of the chemical formula 202.
본 발명의 유기 발광 소자에서, 상기 유기물층은 전자수송층 또는 전자주입층을 포함하고, 상기 전자수송층 또는 전자주입층은 상기 화학식 1의 화합물 및 상기 화학식 202의 화합물을 포함한다.In the organic light-emitting device of the present invention, the organic layer includes an electron transport layer or an electron injection layer, and the electron transport layer or the electron injection layer includes a compound of the chemical formula 1 and a compound of the chemical formula 202.
본 발명의 유기 발광 소자에서, 상기 유기물층은 전자수송층을 포함하고, 상기 전자수송층은 상기 화학식 1의 화합물 및 상기 화학식 202의 화합물을 포함한다.In the organic light-emitting device of the present invention, the organic layer includes an electron transport layer, and the electron transport layer includes a compound of chemical formula 1 and a compound of chemical formula 202.
본 발명의 유기 발광 소자에서, 상기 유기물층은 정공주입층, 정공수송층 및 정공주입과 정공수송을 동시에 하는 층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 화학식 1의 화합물 및 상기 화학식 202의 화합물을 포함한다.In the organic light-emitting device of the present invention, the organic layer may include at least one layer selected from a hole injection layer, a hole transport layer, and a layer that simultaneously injects holes and transports holes, and at least one layer among the layers includes the compound of the chemical formula 1 and the compound of the chemical formula 202.
본 발명의 유기 발광 소자에서, 상기 유기물층은 전자수송층, 전자주입층 및 전자주입과 전자수송을 동시에 하는 층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 화학식 1의 화합물 및 상기 화학식 203의 화합물을 포함할 수 있다.In the organic light-emitting device of the present invention, the organic layer may include at least one layer among an electron transport layer, an electron injection layer, and a layer that simultaneously injects electrons and transports electrons, and at least one layer among the layers may include the compound of the chemical formula 1 and the compound of the chemical formula 203.
본 발명의 유기 발광 소자에서, 상기 유기물층은 전자수송층 또는 전자주입층을 포함하고, 상기 전자수송층 또는 전자주입층은 상기 화학식 1의 화합물 및 상기 화학식 203의 화합물을 포함한다.In the organic light-emitting device of the present invention, the organic layer includes an electron transport layer or an electron injection layer, and the electron transport layer or the electron injection layer includes a compound of the chemical formula 1 and a compound of the chemical formula 203.
본 발명의 유기 발광 소자에서, 상기 유기물층은 전자수송층을 포함하고, 상기 전자수송층은 상기 화학식 1의 화합물 및 상기 화학식 203의 화합물을 포함한다.In the organic light-emitting device of the present invention, the organic layer includes an electron transport layer, and the electron transport layer includes a compound of chemical formula 1 and a compound of chemical formula 203.
본 발명의 유기 발광 소자에서, 상기 유기물층은 정공주입층, 정공수송층 및 정공주입과 정공수송을 동시에 하는 층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 화학식 1의 화합물 및 상기 화학식 203의 화합물을 포함한다.In the organic light-emitting device of the present invention, the organic layer may include at least one layer selected from a hole injection layer, a hole transport layer, and a layer that simultaneously injects holes and transports holes, and at least one layer among the layers includes the compound of the chemical formula 1 and the compound of the chemical formula 203.
본 명세서의 일 실시상태에 있어서, 상기 제1 전극은 양극이고, 제2 전극은 음극이다.In one embodiment of the present specification, the first electrode is an anode and the second electrode is a cathode.
또 하나의 일 실시상태에 따르면, 상기 제1 전극은 음극이고, 제2 전극은 양극이다.In another embodiment, the first electrode is a cathode and the second electrode is an anode.
(1) 양극/정공수송층/발광층/음극(1) Anode/hole transport layer/light emitting layer/cathode
(2) 양극/정공주입층/정공수송층/발광층/음극(2) Anode/hole injection layer/hole transport layer/light emitting layer/cathode
(3) 양극/정공주입층/정공버퍼층/정공수송층/발광층/음극(3) Anode/hole injection layer/hole buffer layer/hole transport layer/light emitting layer/cathode
(4) 양극/정공수송층/발광층/전자수송층/음극(4) Anode/hole transport layer/light emitting layer/electron transport layer/cathode
(5) 양극/정공수송층/발광층/전자수송층/전자주입층/음극(5) Anode/hole transport layer/light emitting layer/electron transport layer/electron injection layer/cathode
(6) 양극/정공주입층/정공수송층/발광층/전자수송층/음극(6) Anode/hole injection layer/hole transport layer/light emitting layer/electron transport layer/cathode
(7) 양극/정공주입층/정공수송층/발광층/전자수송층/전자주입층/음극(7) Anode/hole injection layer/hole transport layer/light emitting layer/electron transport layer/electron injection layer/cathode
(8) 양극/정공주입층/정공버퍼층/정공수송층/발광층/전자수송층/음극(8) Anode/hole injection layer/hole buffer layer/hole transport layer/light emitting layer/electron transport layer/cathode
(9) 양극/정공주입층/정공버퍼층/정공수송층/발광층/전자수송층/전자주입층 /음극(9) Anode/hole injection layer/hole buffer layer/hole transport layer/light emitting layer/electron transport layer/electron injection layer/cathode
(10) 양극/ 정공수송층/전자억제층/발광층/전자수송층/음극(10) Anode/hole transport layer/electron suppression layer/light emitting layer/electron transport layer/cathode
(11) 양극/ 정공수송층/전자억제층/발광층/전자수송층/전자주입층/음극(11) Anode/hole transport layer/electron suppression layer/light emitting layer/electron transport layer/electron injection layer/cathode
(12) 양극/정공주입층/정공수송층/전자억제층/발광층/전자수송층/음극(12) Anode/hole injection layer/hole transport layer/electron suppression layer/light emitting layer/electron transport layer/cathode
(13)양극/정공주입층/정공수송층/전자억제층/발광층/전자수송층/전자주입 층/음극(13) Anode/hole injection layer/hole transport layer/electron suppression layer/light emitting layer/electron transport layer/electron injection layer/cathode
(14) 양극/정공수송층/발광층/정공억제층/전자수송층/음극(14) Anode/hole transport layer/light emitting layer/hole suppression layer/electron transport layer/cathode
(15) 양극/정공수송층/발광층/ 정공억제층/전자수송층/전자주입층/음극(15) Anode/hole transport layer/light emitting layer/hole suppression layer/electron transport layer/electron injection layer/cathode
(16) 양극/정공주입층/정공수송층/발광층/정공억제층/전자수송층/음극(16) Anode/hole injection layer/hole transport layer/light emitting layer/hole suppression layer/electron transport layer/cathode
(17)양극/정공주입층/정공수송층/발광층/정공억제층/전자수송층/전자주입 층/음극(17) Anode/hole injection layer/hole transport layer/light emitting layer/hole suppression layer/electron transport layer/electron injection layer/cathode
(18)양극/정공주입층/정공수송층/전자억제층/발광층/정공저지층/전자주입및 수송층/음극(18) Anode/hole injection layer/hole transport layer/electron suppression layer/light emitting layer/hole blocking layer/electron injection and transport layer/cathode
본 발명의 유기 발광 소자의 구조는 도 1에 나타낸 것과 같은 구조를 가질 수 있으나, 이에만 한정되는 것은 아니다.The structure of the organic light-emitting device of the present invention may have a structure as shown in Fig. 1, but is not limited thereto.
본 발명의 유기 발광 소자의 구조는 도 2에 나타낸 것과 같은 구조를 가질 수 있으나, 이에만 한정되는 것은 아니다.The structure of the organic light-emitting device of the present invention may have a structure as shown in Fig. 2, but is not limited thereto.
도 1에는 기판(1) 위에 양극(2), 발광층(3) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층(3)에 포함될 수 있다.Figure 1 illustrates the structure of an organic light-emitting device in which an anode (2), a light-emitting layer (3), and a cathode (4) are sequentially laminated on a substrate (1). In this structure, the compound represented by the chemical formula 1 may be included in the light-emitting layer (3).
도 2에는 기판(1) 위에 양극(2), 정공주입층(5), 정공수송층(6), 발광층(7), 전자수송층(8), 전자주입층(9) 및 음극(4)이 순차적으로 적층된 유기 발광 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층(7)에 포함될 수 있다.FIG. 2 illustrates the structure of an organic light-emitting device in which an anode (2), a hole injection layer (5), a hole transport layer (6), a light-emitting layer (7), an electron transport layer (8), an electron injection layer (9), and a cathode (4) are sequentially laminated on a substrate (1). In this structure, the compound represented by the chemical formula 1 may be included in the light-emitting layer (7).
예컨대, 본 발명에 따른 유기 발광 소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공주입층, 정공수송층, 정공수송 및 정공주입을 동시에 하는 층, 발광층, 전자수송층, 전자주입층, 및 전자수송 및 전자주입을 동시에하는 층으로 이루어진 군으로부터 선택된 1층 이상을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 만들 수도 있다.For example, the organic light-emitting device according to the present invention can be manufactured by forming an anode by depositing a metal or a conductive metal oxide or an alloy thereof on a substrate using a PVD (physical vapor deposition) method such as sputtering or e-beam evaporation, and then forming an organic layer including at least one layer selected from the group consisting of a hole injection layer, a hole transport layer, a layer that simultaneously transports and injects holes, an emission layer, an electron transport layer, an electron injection layer, and a layer that simultaneously transports and injects electrons, and then depositing a material that can be used as a cathode thereon. In addition to this method, the organic light-emitting device can also be manufactured by sequentially depositing a cathode material, an organic layer, and an anode material on a substrate.
상기 유기물층은 정공주입층, 정공수송층, 발광층 및 전자수송층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 용매 공정(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다.The above organic layer may have a multilayer structure including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer, but is not limited thereto and may have a single layer structure. In addition, the organic layer may be manufactured with a smaller number of layers by using various polymer materials and a solvent process other than a deposition method, such as spin coating, dip coating, doctor blading, screen printing, inkjet printing, or thermal transfer.
상기 양극은 정공을 주입하는 전극으로, 양극 물질로는 통상 유기물층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO, Indium Tin Oxide), 인듐아연 산화물(IZO, Indium Zinc Oxide)과 같은 금속 산화물; ZnO : Al 또는 SnO2 : Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.The above anode is an electrode that injects holes, and as the anode material, a material having a high work function is preferably used so that holes can be smoothly injected into the organic layer. Specific examples of the anode material that can be used in the present invention include, but are not limited to, metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; conductive polymers such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene](PEDOT), polypyrrole, and polyaniline.
상기 음극은 전자를 주입하는 전극으로, 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.The above cathode is an electrode that injects electrons, and it is preferable that the cathode material be a material having a low work function so that electrons can be easily injected into the organic layer. Specific examples of the cathode material include, but are not limited to, metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; multilayered materials such as LiF/Al or LiO 2 /Al.
상기 정공주입층은 양극으로부터 발광층으로 정공의 주입을 원활하게 하는 역할을 하는 층이며, 정공 주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입 받을 수 있는 물질로서, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴헥사아자트리페닐렌 계열의 유기물, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다. 정공주입층의 두께는 1 내지 150nm일 수 있다. 상기 정공주입층의 두께가 1nm 이상이면, 정공 주입 특성이 저하되는 것을 방지할 수 있는 이점이 있고, 150nm 이하이면, 정공주입층의 두께가 너무 두꺼워 정공의 이동을 향상시키기 위해 구동전압이 상승되는것을 방지할 수 있는 이점이 있다.The above hole injection layer is a layer that facilitates the injection of holes from the anode to the light-emitting layer, and the hole injection material is a material that can well inject holes from the anode at a low voltage. It is preferable that the HOMO (highest occupied molecular orbital) of the hole injection material is between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injection material include, but are not limited to, metal porphyrine, oligothiophene, arylamine-based organic compounds, hexanitrilehexaazatriphenylene-based organic compounds, quinacridone-based organic compounds, perylene-based organic compounds, anthraquinone, and conductive polymers of polyaniline and polythiophene-based compounds. The thickness of the hole injection layer may be 1 to 150 nm. When the thickness of the above hole injection layer is 1 nm or more, there is an advantage of being able to prevent the hole injection characteristics from being deteriorated, and when it is 150 nm or less, there is an advantage of being able to prevent the driving voltage from being increased to improve the movement of holes due to the thickness of the hole injection layer being too thick.
상기 정공수송층은 정공의 수송을 원활하게 하는 역할을 할 수 있다. 정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다. The above-mentioned hole transport layer can play a role in facilitating the transport of holes. As a hole transport material, a material that can transport holes from the anode or the hole injection layer and transfer them to the light-emitting layer is suitable, and a material with high mobility for holes is suitable. Specific examples include, but are not limited to, arylamine-based organic substances, conductive polymers, and block copolymers having both conjugated and non-conjugated portions.
정공주입층과 정공수송층 사이에 추가로 정공버퍼층이 구비될 있으며, 당 기술분야에 알려져 있는 정공주입 또는 수송재료를 포함한다. An additional hole buffer layer may be provided between the hole injection layer and the hole transport layer, and includes a hole injection or transport material known in the art.
정공수송층과 발광층 사이에 전자억제층이 구비될 수 있다. 상기 전자억제층은 전술한 스피로 화합물 또는 당 기술분야에 알려져 있는 재료가 사용될 수 있다.An electron blocking layer may be provided between the hole transport layer and the light emitting layer. The electron blocking layer may be made of the aforementioned spiro compound or a material known in the art.
상기 발광층은 적색, 녹색 또는 청색을 발광할 수 있으며, 인광 물질 또는 형광 물질로 이루어질 수 있다. 상기 발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자 효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3); 카르바졸 계열 화합물; 이량체화 스티릴(dimerized styryl) 화합물; BAlq; 10-히드록시벤조 퀴놀린-금속 화합물; 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물; 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자; 스피로(spiro) 화합물; 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The above-described light-emitting layer can emit red, green or blue light, and can be made of a phosphorescent material or a fluorescent material. The above-described light-emitting material is a material that can emit light in the visible light range by transporting holes and electrons from the hole transport layer and the electron transport layer respectively and combining them, and a material having good quantum efficiency for fluorescence or phosphorescence is preferable. Specific examples include, but are not limited to, 8-hydroxy-quinoline aluminum complex (Alq 3 ); carbazole series compounds; dimerized styryl compounds; BAlq; 10-hydroxybenzo quinoline-metal compounds; benzoxazole, benzthiazole and benzimidazole series compounds; poly(p-phenylenevinylene) (PPV) series polymers; spiro compounds; polyfluorene, rubrene, etc.
발광층의 호스트 재료로는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등이 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 카바졸 유도체, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되지 않는다.The host material of the light-emitting layer includes a condensed aromatic ring derivative or a heterocyclic compound. Specifically, the condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc., and the heterocyclic compound includes, but is not limited to, carbazole derivatives, dibenzofuran derivatives, ladder-type furan compounds, pyrimidine derivatives, etc.
발광층이 적색 발광을 하는 경우, 발광 도펀트로는 PIQIr(acac)(bis(1-phenylisoquinoline)acetylacetonateiridium), PQIr(acac)(bis(1-phenylquinoline)acetylacetonate iridium), PQIr(tris(1-phenylquinoline)iridium), PtOEP(octaethylporphyrin platinum)와 같은 인광 물질이나, Alq3(tris(8-hydroxyquinolino)aluminum)와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다. 발광층이 녹색 발광을 하는 경우, 발광 도펀트로는 Ir(ppy)3(fac tris(2-phenylpyridine)iridium)와 같은 인광물질이나, Alq3(tris(8-hydroxyquinolino)aluminum)와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다. 발광층이 청색 발광을 하는 경우, 발광 도펀트로는 (4,6-F2ppy)2Irpic와 같은 인광 물질이나, spiro-DPVBi, spiro-6P, 디스틸벤젠(DSB), 디스트릴아릴렌(DSA), PFO계 고분자, PPV계 고분자와 같은 형광 물질이 사용될 수 있으나, 이에만 한정된 것은 아니다.When the emitting layer emits red light, the emitting dopant may include, but is not limited to, a phosphorescent material such as PIQIr(acac)(bis(1-phenylisoquinoline)acetylacetonateiridium), PQIr(acac)(bis(1-phenylquinoline)acetylacetonate iridium), PQIr(tris(1-phenylquinoline)iridium), PtOEP(octaethylporphyrin platinum), or a fluorescent material such as Alq 3 (tris(8-hydroxyquinolino)aluminum). When the emitting layer emits green light, the emitting dopant may include, but is not limited to, a phosphorescent material such as Ir(ppy) 3 (fac tris(2-phenylpyridine)iridium), or a fluorescent material such as Alq3(tris(8-hydroxyquinolino)aluminum). When the emitting layer emits blue light, a phosphorescent material such as (4,6-F2ppy) 2 Irpic, or a fluorescent material such as spiro-DPVBi, spiro-6P, distilbenzene (DSB), distriarylene (DSA), PFO polymers, or PPV polymers can be used as the emitting dopant, but is not limited thereto.
전자수송층과 발광층 사이에 정공억제층이 구비될 수 있으며, 당 기술분야에 알려져 있는 재료가 사용될 수 있다.A hole-suppressing layer may be provided between the electron transport layer and the light-emitting layer, and a material known in the art may be used.
상기 전자수송층은 전자의 수송을 원활하게 하는 역할을 할 수 있다. 전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다. 전자수송층의 두께는 1 내지 50nm일 수 있다. 전자수송층의 두께가 1nm 이상이면, 전자 수송 특성이 저하되는 것을 방지할 수 있는 이점이 있고, 50nm 이하이면, 전자수송층의 두께가 너무 두꺼워 전자의 이동을 향상시키기 위해 구동전압이 상승되는 것을 방지할 수 있는 이점이 있다.The above electron transport layer can play a role in facilitating electron transport. As the electron transport material, a material that can well inject electrons from the cathode and transfer them to the light-emitting layer, and a material with high electron mobility is suitable. Specific examples include, but are not limited to, Al complexes of 8-hydroxyquinoline; complexes containing Alq 3 ; organic radical compounds; and hydroxyflavone-metal complexes. The thickness of the electron transport layer can be 1 to 50 nm. When the thickness of the electron transport layer is 1 nm or more, there is an advantage in that the electron transport characteristics can be prevented from being deteriorated, and when it is 50 nm or less, there is an advantage in that the driving voltage can be prevented from being increased to improve the movement of electrons due to the thickness of the electron transport layer being too thick.
상기 전자주입층은 전자의 주입을 원활하게 하는 역할을 할 수 있다. 전자 주입 물질로는 전자를 수송하는 능력을 갖고, 음극으로부터의 전자주입 효과, 발광층 또는 발광 재료에 대하여 우수한 전자주입 효과를 가지며, 발광층에서 생성된 여기자의 정공 주입층에의 이동을 방지하고, 또한, 박막형성능력이 우수한 화합물이 바람직하다. 구체적으로는 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 함질소 5원환 유도체 등이 있으나, 이에 한정되지 않는다. The above electron injection layer can play a role in facilitating electron injection. As the electron injection material, a compound having the ability to transport electrons, an excellent electron injection effect from the cathode, an excellent electron injection effect for the light-emitting layer or the light-emitting material, preventing movement of excitons generated in the light-emitting layer to the hole injection layer, and excellent thin film forming ability is preferable. Specific examples thereof include, but are not limited to, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, fluorenylidene methane, anthrone, and their derivatives, metal complex compounds, and nitrogen-containing 5-membered ring derivatives.
상기 금속 착체 화합물로서는 8-하이드록시퀴놀리나토 리튬, 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되지 않는다.As the above metal complex compounds, 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, tris(8-hydroxyquinolinato)aluminum, tris(2-methyl-8-hydroxyquinolinato)aluminum, tris(8-hydroxyquinolinato)gallium, bis(10-hydroxybenzo[h]quinolinato)beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)(o-cresolato)gallium, bis(2-methyl-8-quinolinato)(1-naphtholato)aluminum, Bis(2-methyl-8-quinolinato)(2-naphtholato)gallium, etc., but are not limited thereto.
상기 정공차단층은 정공의 음극 도달을 저지하는 층으로, 일반적으로 전자주입층과 동일한 조건으로 형성될 수 있다. 구체적으로 옥사디아졸 유도체나 트리아졸 유도체, 페난트롤린 유도체, BCP, 알루미늄 착물 (aluminum complex) 등이 있으나, 이에 한정되지 않는다.The above hole blocking layer is a layer that blocks holes from reaching the cathode, and can generally be formed under the same conditions as the electron injection layer. Specifically, examples thereof include, but are not limited to, oxadiazole derivatives, triazole derivatives, phenanthroline derivatives, BCP, and aluminum complexes.
본 발명에 따른 유기 발광 소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic light-emitting device according to the present invention may be a front-emitting type, a back-emitting type, or a double-sided emitting type depending on the material used.
본 발명의 유기 발광 소자는 전술한 화합물을 이용하여 한 층 이상의 유기물층을 형성하는 것을 제외하고는, 통상의 유기 발광 소자의 제조방법 및 재료에 의하여 제조될 수 있다.The organic light-emitting device of the present invention can be manufactured using a conventional method and material for manufacturing an organic light-emitting device, except that one or more organic layers are formed using the above-described compound.
상기 화학식 1의 화합물의 제조방법 및 이들을 이용한 유기 발광 소자의 제조는 이하의 실시예에서 구체적으로 설명한다. 그러나, 하기 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의하여 한정되는 것은 아니다.The method for producing the compound of the above chemical formula 1 and the production of an organic light-emitting device using the same are specifically described in the following examples. However, the following examples are intended to illustrate the present invention, and the scope of the present invention is not limited thereto.
하기 반응식에 있어서, 치환기의 종류 및 개수는 당업자가 공지된 출발물질을 적절히 선택함에 따라 다양한 종류의 중간체를 합성할 수 있다. 반응 종류 및 반응 조건은 당기술분야에 알려져 있는 것들이 이용될 수 있다. In the following reaction formula, the type and number of substituents can be selected appropriately by those skilled in the art from known starting materials to synthesize various types of intermediates. The reaction type and reaction conditions known in the art can be used.
본 명세서의 실시예에 기재된 제조식과 상기 중간체들을 통상의 기술상식을 바탕으로 적절히 조합하면, 본 명세서에 기재되어 있는 상기 화학식 1의 화합물들을 모두 제조할 수 있다. By appropriately combining the manufacturing formulas and the intermediates described in the examples of this specification based on common technical knowledge, all of the compounds of the chemical formula 1 described in this specification can be manufactured.
<합성예><Synthetic example>
1. 중간체 A 의 합성1. Synthesis of intermediate A
합성예 1-1. 중간체 A-1의 합성Synthesis Example 1-1. Synthesis of Intermediate A-1
9-브로모안트라센 (50 g, 194mmol)와 (2-(나프탈렌-1-일)페닐)보론산 (48g, 194mmol) 을 THF (1000ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.2g, 0.39mmol)와 2M K2CO3 수용액 200ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 에틸아세테이트에서 재결정하여 중간체 A-1 (57g, 수율 77%)를 얻었다.9-Bromoanthracene (50 g, 194 mmol) and (2-(naphthalen-1-yl)phenyl)boronic acid (48 g, 194 mmol) were dissolved in THF (1000 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.39 mmol) and 200 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Recrystallization from ethyl acetate gave intermediate A-1 (57 g, yield 77%).
합성예 1-2. 중간체 A의 합성Synthesis Example 1-2. Synthesis of Intermediate A
중간체 A-1 (57g, 150mmol)를 DMF 700ml에 녹인 후 DMF 100ml에 녹인 N-브로모숙신이미드 (26.7g, 150 mmol)을 천천히 적가한다. 상온에서 2시간 교반 후 물 1500ml를 적가했다. 고체가 생성되면 필터 후 클로로포름에 녹여 증류수로 여러 번 추출하였다. 에틸아세테이트에서 재결정하여 중간체 A 를 얻었다. (52g, 수율 76%)Intermediate A-1 (57 g, 150 mmol) was dissolved in 700 ml of DMF, and then N-bromosuccinimide (26.7 g, 150 mmol) dissolved in 100 ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, 1500 ml of water was added dropwise. When a solid was formed, it was filtered, dissolved in chloroform, and extracted several times with distilled water. Intermediate A was obtained by recrystallization from ethyl acetate. (52 g, yield 76%)
2. 중간체 B의 합성2. Synthesis of intermediate B
합성예 2-1. 중간체 B-1의 합성Synthesis Example 2-1. Synthesis of Intermediate B-1
합성에 1-1에서 (2-(나프탈렌-1-일)페닐)보론산 대신 디벤조[b,d]퓨란-2-일보론산을 사용한 것을 제외하고는 동일하게 합성하여 중간체 B-1를 얻었다.Intermediate B-1 was obtained through the same synthesis as in step 1-1 except that dibenzo[b,d]furan-2-ylboronic acid was used instead of (2-(naphthalen-1-yl)phenyl)boronic acid.
합성예 2-2. 중간체 B의 합성Synthesis Example 2-2. Synthesis of Intermediate B
합성예 1-2에서 중간체 A-1대신 중간체 B-1을 사용한 것을 제외하고는 동일하게 합성하여 중간체 B를 얻었다.Intermediate B was obtained through the same synthesis as in Synthesis Example 1-2, except that Intermediate B-1 was used instead of Intermediate A-1.
3. 화합물 1의 합성3. Synthesis of compound 1
합성예 3-1. 중간체 1-a의 합성Synthesis Example 3-1. Synthesis of Intermediate 1-a
1-브로모-4-클로로-3-플루오로-2-아이오도벤젠 (100g, 298mmol)과 (3-하이드록시나프탈렌-2-일)보론산 (56g, 298mml) 를 THF (1500ml)에 녹인 후, Pd(PPh3)4 (6.9g, 6.0mmol)와 2M Na2CO3 수용액 300ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 1-a (75g, 수율 71%)를 얻었다.1-Bromo-4-chloro-3-fluoro-2-iodobenzene (100 g, 298 mmol) and (3-hydroxynaphthalen-2-yl)boronic acid (56 g, 298 mmol) were dissolved in THF (1500 ml), and Pd(PPh 3 ) 4 (6.9 g, 6.0 mmol) and 300 ml of 2 M Na2CO3 aqueous solution were added, and the mixture was refluxed and stirred for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 1-a (75 g, yield 71%).
합성예 3-2. 중간체 1-b의 합성Synthesis Example 3-2. Synthesis of Intermediate 1-b
중간체 1-a (75g, 213mmol)을 DMF (1000ml)에 녹인 후, K2CO3 (88g, 640mmol)을 넣고, 2시간동안 환류 교반하였다. 반응 용액을 식힌 후, 증류수 3L에 부어서 고체를 생성시킨다. 고체를 필터한 후 클로로포름에 녹여 물로 여러 번 추출한 후 유기층을 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 1-b (54g, 76%)를 얻었다.Intermediate 1-a (75 g, 213 mmol) was dissolved in DMF (1000 ml), K 2 CO 3 (88 g, 640 mmol) was added, and the mixture was refluxed for 2 hours. After cooling the reaction solution, it was poured into 3 L of distilled water to generate a solid. The solid was filtered, dissolved in chloroform, extracted several times with water, and the organic layer was dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 1-b (54 g, 76%).
합성예 3-3. 중간체 1-c의 합성Synthesis Example 3-3. Synthesis of Intermediate 1-c
중간체 1-b (54g, 163mmol)과 페닐보론산 (20g, 163mml) 를 THF (800ml)에 녹인 후, Pd(PPh3)4 (3.8g, 3.3mmol)와 2M K2CO3 수용액 200ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 1-c (39g, 수율 73%)를 얻었다.Intermediate 1-b (54 g, 163 mmol) and phenylboronic acid (20 g, 163 mmol) were dissolved in THF (800 ml), and Pd(PPh 3 ) 4 (3.8 g, 3.3 mmol) and 200 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 1-c (39 g, yield 73%).
합성예 3-4. 중간체 1-d의 합성Synthesis Example 3-4. Synthesis of Intermediate 1-d
중간체 1-c (39g, 119mmol)와 비스(피나콜라토)디보론 (36g, 142mmol), KOAc (23g, 237mmol)을 플라스크에 다이옥세인 300ml와 함께 넣어 분산시켰다. Pd(dba)2 (1.36g, 2.4mmol), PCy3 (1.33g, 4.7mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 1-d를 얻었다. (35g, 수율 70%)Intermediate 1-c (39 g, 119 mmol) and bis(pinacolato)diboron (36 g, 142 mmol), KOAc (23 g, 237 mmol) were added to a flask with 300 ml of dioxane and dispersed. Pd(dba) 2 (1.36 g, 2.4 mmol), PCy3 (1.33 g, 4.7 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 1-d was obtained by purification using column chromatography. (35 g, yield 70%)
합성예 3-5. 화합물 1의 합성Synthesis Example 3-5. Synthesis of Compound 1
중간체 1-d (20 g, 48mmol)와 중간체 A (21.9g, 48mmol) 을 THF (250ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.05g, 0.09mmol)와 2M K2CO3 수용액 50ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 1 (16g, 수율 50%)를 얻었다. [M+H+]= 672.25Intermediate 1-d (20 g, 48 mmol) and intermediate A (21.9 g, 48 mmol) were dissolved in THF (250 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.05 g, 0.09 mmol) and 50 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 1 (16 g, yield 50%) was obtained by recrystallization from EA. [M+H + ]= 672.25
4. 화합물 2의 합성4. Synthesis of compound 2
합성예 4-1. 중간체 2-a의 합성Synthesis Example 4-1. Synthesis of Intermediate 2-a
합성예 3-1에서 1-브로모-4-클로로-3-플루오로-2-아이오도벤젠 대신 5-브로모-1-클로로-3-플루오로-2-아이오도벤젠을 사용한 것을 제외하고는 동일하게 합성하여 중간체 2-a를 얻었다.Intermediate 2-a was obtained by the same synthesis procedure as in Synthetic Example 3-1, except that 5-bromo-1-chloro-3-fluoro-2-iodobenzene was used instead of 1-bromo-4-chloro-3-fluoro-2-iodobenzene.
합성예 4-2. 중간체 2-b의 합성Synthesis Example 4-2. Synthesis of Intermediate 2-b
합성예 3-2에서 중간체 1-a 대신 중간체 2-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 2-b를 얻었다.Intermediate 2-b was obtained by the same synthesis as in Synthesis Example 3-2, except that Intermediate 2-a was used instead of Intermediate 1-a.
합성예 4-3. 중간체 2-c의 합성Synthesis Example 4-3. Synthesis of Intermediate 2-c
합성예 3-3에서 중간체 1-b 대신 중간체 2-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 2-c를 얻었다.Intermediate 2-c was obtained by the same synthesis as in Synthesis Example 3-3, except that Intermediate 2-b was used instead of Intermediate 1-b.
합성예 4-4. 중간체 2-d의 합성Synthesis Example 4-4. Synthesis of Intermediate 2-d
합성예 3-4에서 중간체 1-c 대신 중간체 2-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 2-d를 얻었다.Intermediate 2-d was obtained by the same synthesis as in Synthesis Example 3-4, except that intermediate 2-c was used instead of intermediate 1-c.
합성예 4-5. 화합물 2의 합성Synthesis Example 4-5. Synthesis of Compound 2
합성예 3-5에서 중간체 1-d 대신 중간체 2-d를, 중간체 A 대신 9-브로모-10-페닐안트라센을 사용한 것을 제외하고는 동일하게 합성하여 화합물 2를 얻었다. [M+H+]= 547.2Compound 2 was obtained by the same synthesis as in Synthesis Example 3-5, except that Intermediate 2-d was used instead of Intermediate 1-d and 9-bromo-10-phenylanthracene was used instead of Intermediate A. [M+H + ]= 547.2
5. 화합물 3의 합성5. Synthesis of compound 3
합성예 5-1. 중간체 3-a의 합성Synthesis Example 5-1. Synthesis of Intermediate 3-a
합성예 3-1에서 1-브로모-4-클로로-3-플루오로-2-아이오도벤젠 대신 5-브로모-1-클로로-3-플루오로-2-아이오도벤젠을, (3-하이드록시나프탈렌-2-일)보론산 대신 (1-하이드록시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 동일하게 합성하여 중간체 3-a를 얻었다.Intermediate 3-a was obtained by the same synthesis procedure as in Synthetic Example 3-1, except that 5-bromo-1-chloro-3-fluoro-2-iodobenzene was used instead of 1-bromo-4-chloro-3-fluoro-2-iodobenzene, and (1-hydroxynaphthalen-2-yl)boronic acid was used instead of (3-hydroxynaphthalen-2-yl)boronic acid.
합성예 5-2. 중간체 3-b의 합성Synthesis Example 5-2. Synthesis of Intermediate 3-b
합성예 3-2에서 중간체 1-a 대신 중간체 3-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 3-b를 얻었다.Intermediate 3-b was obtained by the same synthesis as in Synthesis Example 3-2, except that Intermediate 3-a was used instead of Intermediate 1-a.
합성예 5-3. 중간체 3-c의 합성Synthesis Example 5-3. Synthesis of Intermediate 3-c
합성예 3-3에서 중간체 1-b 대신 중간체 3-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 3-c를 얻었다.Intermediate 3-c was obtained by the same synthesis as in Synthesis Example 3-3, except that intermediate 3-b was used instead of intermediate 1-b.
합성예 5-4. 중간체 3-d의 합성Synthesis Example 5-4. Synthesis of Intermediate 3-d
합성예 3-4에서 중간체 1-c 대신 중간체 3-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 3-d를 얻었다.Intermediate 3-d was obtained by the same synthesis as in Synthesis Example 3-4, except that intermediate 3-c was used instead of intermediate 1-c.
합성예 5-5. 화합물 3의 합성Synthesis Example 5-5. Synthesis of Compound 3
합성예 3-5에서 중간체 1-d 대신 중간체 3-d를, 중간체 A 대신 9-브로모-10-(나프탈렌-2-일)안트라센을 사용한 것을 제외하고는 동일하게 합성하여 화합물 3를 얻었다. [M+H+]= 597.2Compound 3 was obtained by the same synthesis as in Synthesis Example 3-5, except that intermediate 3-d was used instead of intermediate 1-d and 9-bromo-10-(naphthalen-2-yl)anthracene was used instead of intermediate A. [M+H + ]= 597.2
6. 화합물 4의 합성6. Synthesis of compound 4
합성예 6-1. 중간체 4-a의 합성Synthesis Example 6-1. Synthesis of Intermediate 4-a
합성예 3-1에서 1-브로모-4-클로로-3-플루오로-2-아이오도벤젠 대신 6-브로모-1-아이오도나프탈렌-2-올을, (3-하이드록시나프탈렌-2-일)보론산 대신 (5-클로로-2-플루오로페닐)보론산을 사용한 것을 제외하고는 동일하게 합성하여 중간체 4-a를 얻었다.Intermediate 4-a was obtained by the same synthesis procedure as in Synthetic Example 3-1, except that 6-bromo-1-iodonaphthalen-2-ol was used instead of 1-bromo-4-chloro-3-fluoro-2-iodobenzene, and (5-chloro-2-fluorophenyl)boronic acid was used instead of (3-hydroxynaphthalen-2-yl)boronic acid.
합성예 6-2. 중간체 4-b의 합성Synthesis Example 6-2. Synthesis of Intermediate 4-b
합성예 3-2에서 중간체 1-a 대신 중간체 4-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 4-b를 얻었다.Intermediate 4-b was obtained by the same synthesis as in Synthesis Example 3-2, except that intermediate 4-a was used instead of intermediate 1-a.
합성예 6-3. 중간체 4-c의 합성Synthesis Example 6-3. Synthesis of Intermediate 4-c
합성예 3-3에서 중간체 1-b 대신 중간체 4-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 4-c를 얻었다.Intermediate 4-c was obtained by the same synthesis as in Synthesis Example 3-3, except that intermediate 4-b was used instead of intermediate 1-b.
합성예 6-4. 중간체 4-d의 합성Synthesis Example 6-4. Synthesis of Intermediate 4-d
합성예 3-4에서 중간체 1-c 대신 중간체 4-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 4-d를 얻었다.Intermediate 4-d was obtained by the same synthesis as in Synthesis Example 3-4, except that intermediate 4-c was used instead of intermediate 1-c.
합성예 6-5. 화합물 4의 합성Synthesis Example 6-5. Synthesis of Compound 4
합성예 3-5에서 중간체 1-d 대신 중간체 4-d를, 중간체 A 대신 중간체 B를 사용한 것을 제외하고는 동일하게 합성하여 화합물 4를 얻었다. [M+H+]= 637.2Compound 4 was obtained by the same synthesis as in Synthesis Example 3-5, except that Intermediate 4-d was used instead of Intermediate 1-d and Intermediate B was used instead of Intermediate A. [M+H + ]= 637.2
7. 화합물 5의 합성7. Synthesis of compound 5
합성예 7-1. 중간체 5-a의 합성Synthesis Example 7-1. Synthesis of Intermediate 5-a
합성예 3-1에서 1-브로모-4-클로로-3-플루오로-2-아이오도벤젠 대신 5-브로모-1-클로로-3-플루오로-2-아이오도벤젠을, (3-하이드록시나프탈렌-2-일)보론산 대신 (2-하이드록시나프탈렌-1-일)보론산을 사용한 것을 제외하고는 동일하게 합성하여 중간체 5-a를 얻었다.Intermediate 5-a was obtained by the same synthesis procedure as in Synthetic Example 3-1, except that 5-bromo-1-chloro-3-fluoro-2-iodobenzene was used instead of 1-bromo-4-chloro-3-fluoro-2-iodobenzene, and (2-hydroxynaphthalen-1-yl)boronic acid was used instead of (3-hydroxynaphthalen-2-yl)boronic acid.
합성예 7-2. 중간체 5-b의 합성Synthesis Example 7-2. Synthesis of Intermediate 5-b
합성예 3-2에서 중간체 1-a 대신 중간체 5-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 5-b를 얻었다.Intermediate 5-b was obtained by the same synthesis as in Synthesis Example 3-2, except that intermediate 5-a was used instead of intermediate 1-a.
합성예 7-3. 중간체 5-c의 합성Synthesis Example 7-3. Synthesis of Intermediate 5-c
합성예 3-3에서 중간체 1-b 대신 중간체 5-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 5-c를 얻었다.Intermediate 5-c was obtained by the same synthesis as in Synthesis Example 3-3, except that intermediate 5-b was used instead of intermediate 1-b.
합성예 7-4. 중간체 5-d의 합성Synthesis Example 7-4. Synthesis of Intermediate 5-d
합성예 3-4에서 중간체 1-c 대신 중간체 5-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 5-d를 얻었다.Intermediate 5-d was obtained by the same synthesis as in Synthesis Example 3-4, except that intermediate 5-c was used instead of intermediate 1-c.
합성예 7-5. 화합물 5의 합성Synthesis Example 7-5. Synthesis of Compound 5
합성예 3-5에서 중간체 1-d 대신 중간체 5-d를, 중간체 A 대신 9-{[1,1'-비페닐]-3-일}-10-브로모안트라센을 사용한 것을 제외하고는 동일하게 합성하여 화합물 5를 얻었다. [M+H+]= 623.2Compound 5 was obtained by the same synthesis as in Synthetic Example 3-5, except that intermediate 5-d was used instead of intermediate 1-d and 9-{[1,1'-biphenyl]-3-yl}-10-bromoanthracene was used instead of intermediate A. [M+H + ]= 623.2
8. 화합물 6의 합성8. Synthesis of compound 6
합성예 8-1. 중간체 6-a의 합성Synthesis Example 8-1. Synthesis of Intermediate 6-a
2-브로모-4-클로로-1-플루오로벤젠 (100g, 477mmol)과 (3-하이드록시나프탈렌-2-일)보론산 (90g, 477mml) 를 THF (1600ml)에 녹인 후, Pd(PPh3)4 (11.0g, 9.5mmol)와 2M K2CO3 수용액 400ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 6-a (95g, 수율 73%)를 얻었다.2-Bromo-4-chloro-1-fluorobenzene (100 g, 477 mmol) and (3-hydroxynaphthalen-2-yl)boronic acid (90 g, 477 mmol) were dissolved in THF (1600 ml), Pd(PPh 3 ) 4 (11.0 g, 9.5 mmol) and 400 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was refluxed and stirred for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 6-a (95 g, yield 73%).
합성예 8-2. 중간체 6-b의 합성Synthesis Example 8-2. Synthesis of Intermediate 6-b
중간체 6-a (95g, 348mmol)를 DMF 1000ml에 녹인 후 DMF 200ml에 녹인 N-브로모숙신이미드 (62g, 348 mmol)을 천천히 적가한다. 상온에서 2시간 교반 후 DMF를 감압 증류하여 제거하였다. 클로로포름에 녹여 증류수로 여러 번 추출한 후 감압 증류하여 용매를 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 화합물 6-b를 얻었다. (55g, 수율 45%)Intermediate 6-a (95 g, 348 mmol) was dissolved in 1000 ml of DMF, and then N-bromosuccinimide (62 g, 348 mmol) dissolved in 200 ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, DMF was removed by distillation under reduced pressure. Dissolved in chloroform, extracted several times with distilled water, and then distilled under reduced pressure to remove the solvent. Compound 6-b was obtained by purification using column chromatography. (55 g, yield 45%)
합성예 8-3. 중간체 6-c의 합성Synthesis Example 8-3. Synthesis of Intermediate 6-c
중간체 6-b (55g, 156 mmol)을 DMF (800ml)에 녹인 후, K2CO3 (65g, 470mmol)을 넣고, 2시간동안 환류 교반하였다. 반응 용액을 식힌 후, 증류수 2L에 부어서 고체를 생성시킨다. 고체를 필터한 후 클로로포름에 녹여 물로 여러 번 추출한 후 유기층을 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 6-c (35g, 67%)를 얻었다.Intermediate 6-b (55 g, 156 mmol) was dissolved in DMF (800 ml), and K 2 CO 3 (65 g, 470 mmol) was added and stirred under reflux for 2 hours. After cooling the reaction solution, it was poured into 2 L of distilled water to generate a solid. The solid was filtered, dissolved in chloroform, extracted several times with water, and the organic layer was dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 6-c (35 g, 67%).
합성예 8-4. 중간체 6-d의 합성Synthesis Example 8-4. Synthesis of Intermediate 6-d
중간체 6-c (35g, 106 mmol)과 나프탈-1-일보론산 (18g, 106 mml) 를 THF (500ml)에 녹인 후, Pd(PPh3)4 (2.4g, 2.1mmol)와 2M K2CO3 수용액 100ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 6-d (27 g, 수율 68%)를 얻었다.Intermediate 6-c (35 g, 106 mmol) and naphthal-1-ylboronic acid (18 g, 106 mmol) were dissolved in THF (500 ml), and Pd(PPh 3 ) 4 (2.4 g, 2.1 mmol) and 100 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 6-d (27 g, yield 68%).
합성예 8-5. 중간체 6-e의 합성Synthesis Example 8-5. Synthesis of Intermediate 6-e
중간체 6-d (27g, 71mmol)와 비스(피나콜라토)디보론 (22g, 86mmol), KOAc (14g, 143mmol)을 플라스크에 다이옥세인 200ml와 함께 넣어 분산시켰다. Pd(dba)2 (0.82g, 1.4mmol), PCy3 (0.8g, 2.9mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 6-e를 얻었다. (23g, 수율 69%)Intermediate 6-d (27 g, 71 mmol), bis(pinacolato)diboron (22 g, 86 mmol), KOAc (14 g, 143 mmol) were added to a flask with 200 ml of dioxane and dispersed. Pd(dba) 2 (0.82 g, 1.4 mmol), PCy3 (0.8 g, 2.9 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 6-e was obtained by purification using column chromatography. (23 g, yield 69%)
합성예 8-6. 화합물 6의 합성Synthesis Example 8-6. Synthesis of compound 6
중간체 6-e (20 g, 43mmol)와 9-브로모-10-페닐안트라센 (14.2 g, 43mmol) 을 THF (210ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.04g, 0.09mmol)와 2M K2CO3 수용액 50ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 6 (13g, 수율 51%)를 얻었다. [M+H+]= 597.2Intermediate 6-e (20 g, 43 mmol) and 9-bromo-10-phenylanthracene (14.2 g, 43 mmol) were dissolved in THF (210 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.04 g, 0.09 mmol) and 50 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 6 (13 g, yield 51%) was obtained by recrystallization from EA. [M+H + ]= 597.2
9. 화합물 7의 합성9. Synthesis of compound 7
합성예 9-1. 중간체 7-a의 합성Synthesis Example 9-1. Synthesis of Intermediate 7-a
2-브로모나프탈렌-1-올 (100g, 448mmol)과 (5-클로로-2-플루오로페닐)보론산 (78g, 448mml) 를 THF (1500ml)에 녹인 후, Pd(PPh3)4 (10.4g, 9.0mmol)와 2M K2CO3수용액 400ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 7-a (106g, 수율 86%)를 얻었다.2-Bromonaphthalen-1-ol (100 g, 448 mmol) and (5-chloro-2-fluorophenyl)boronic acid (78 g, 448 mmol) were dissolved in THF (1500 ml), and Pd(PPh 3 ) 4 (10.4 g, 9.0 mmol) and 400 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was refluxed and stirred for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 7-a (106 g, yield 86%).
합성예 9-2. 중간체 7-b의 합성Synthesis Example 9-2. Synthesis of Intermediate 7-b
중간체 7-a (106g, 389 mmol)을 DMF (2000ml)에 녹인 후, K2CO3 (161g, 1166mmol)을 넣고, 2시간동안 환류 교반하였다. 반응 용액을 식힌 후, 증류수 5L에 부어서 고체를 생성시킨다. 고체를 필터한 후 클로로포름에 녹여 물로 여러 번 추출한 후 유기층을 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 7-b (75g, 76%)를 얻었다.Intermediate 7-a (106 g, 389 mmol) was dissolved in DMF (2000 ml), and K 2 CO 3 (161 g, 1166 mmol) was added and stirred under reflux for 2 hours. After cooling the reaction solution, it was poured into 5 L of distilled water to generate a solid. The solid was filtered, dissolved in chloroform, extracted several times with water, and the organic layer was dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 7-b (75 g, 76%).
합성예 9-3. 중간체 7-c의 합성Synthesis Example 9-3. Synthesis of Intermediate 7-c
중간체 7-b (75g, 297mmol)를 DMF 1000ml에 녹인 후 DMF 100ml에 녹인 N-브로모숙신이미드 (53g, 297 mmol)을 천천히 적가한다. 상온에서 2시간 교반 후 DMF를 감압 증류하여 제거하였다. 클로로포름에 녹여 증류수로 여러 번 추출한 후 감압 증류하여 용매를 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 화합물 7-c를 얻었다. (71g, 수율 72%)Intermediate 7-b (75 g, 297 mmol) was dissolved in 1000 ml of DMF, and then N-bromosuccinimide (53 g, 297 mmol) dissolved in 100 ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, DMF was removed by distillation under reduced pressure. Dissolved in chloroform, extracted several times with distilled water, and then distilled under reduced pressure to remove the solvent. Compound 7-c was obtained by purification using column chromatography. (71 g, yield 72%)
합성예 9-4. 중간체 7-d의 합성Synthesis Example 9-4. Synthesis of Intermediate 7-d
중간체 7-c (71g, 214 mmol)과 페닐보론산 (26g, 214 mml) 를 THF (1000ml)에 녹인 후, Pd(PPh3)4 (4.9g, 4.3mmol)와 2M K2CO3수용액 250ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 7-d (52 g, 수율 74%)를 얻었다.Intermediate 7-c (71 g, 214 mmol) and phenylboronic acid (26 g, 214 mmol) were dissolved in THF (1000 ml), and Pd(PPh 3 ) 4 (4.9 g, 4.3 mmol) and 250 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 7-d (52 g, yield 74%).
합성예 9-5. 중간체 7-e의 합성Synthesis Example 9-5. Synthesis of Intermediate 7-e
중간체 7-d (52g, 158mmol)와 비스(피나콜라토)디보론 (48g, 190mmol), KOAc (31g, 316mmol)을 플라스크에 다이옥세인 400ml와 함께 넣어 분산시켰다. Pd(dba)2 (1.82g, 3.2mmol), PCy3 (1.77g, 6.3mmol)을 넣어준 후 24시간 동안 환류 교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 7-e를 얻었다. (41g, 수율 62%)Intermediate 7-d (52 g, 158 mmol), bis(pinacolato)diboron (48 g, 190 mmol), KOAc (31 g, 316 mmol) were added to a flask with 400 ml of dioxane and dispersed. Pd(dba) 2 (1.82 g, 3.2 mmol), PCy3 (1.77 g, 6.3 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 7-e was obtained by purification using column chromatography. (41 g, yield 62%)
합성예 9-6. 화합물 7의 합성Synthesis Example 9-6. Synthesis of Compound 7
중간체 7-e (20 g, 48mmol)와 9-브로모-10-(나프탈렌-1-일)안트라센 (18 g, 48mmol) 을 THF (250ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.05g, 0.1mmol)와 2M K2CO3 수용액 50ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 7 (15g, 수율 53%)를 얻었다. [M+H+]= 597.2Intermediate 7-e (20 g, 48 mmol) and 9-bromo-10-(naphthalen-1-yl)anthracene (18 g, 48 mmol) were dissolved in THF (250 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.05 g, 0.1 mmol) and 50 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 7 (15 g, yield 53%) was obtained by recrystallization from EA. [M+H + ]= 597.2
10. 화합물 8의 합성10. Synthesis of compound 8
합성예 10-1. 중간체 8-a의 합성Synthesis Example 10-1. Synthesis of Intermediate 8-a
3-브로모나프탈렌-2,7-다이올 (100g, 418mmol)과 (2-클로로-6-플루오로페닐)보론산 (73g, 418mml) 를 THF (1400ml)에 녹인 후, Pd(PPh3)4 (9.7g, 8.4mmol)와 2M K2CO3 수용액 400ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 8-a (92g, 수율 76%)를 얻었다.3-Bromonaphthalene-2,7-diol (100 g, 418 mmol) and (2-chloro-6-fluorophenyl)boronic acid (73 g, 418 mmol) were dissolved in THF (1400 ml), and Pd(PPh 3 ) 4 (9.7 g, 8.4 mmol) and 400 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 8-a (92 g, yield 76%).
합성예 10-2. 중간체 8-b의 합성Synthesis Example 10-2. Synthesis of Intermediate 8-b
중간체 8-a (92g, 319 mmol)을 DMF (1500ml)에 녹인 후, K2CO3 (132g, 956mmol)을 넣고, 2시간동안 환류 교반하였다. 반응 용액을 식힌 후, 증류수 3L에 부어서 고체를 생성시킨다. 고체를 필터한 후 클로로포름에 녹여 물로 여러 번 추출한 후 유기층을 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 8-b (54g, 63%)를 얻었다.Intermediate 8-a (92 g, 319 mmol) was dissolved in DMF (1500 ml), and K 2 CO 3 (132 g, 956 mmol) was added, and the mixture was stirred under reflux for 2 hours. After cooling the reaction solution, it was poured into 3 L of distilled water to generate a solid. The solid was filtered, dissolved in chloroform, extracted several times with water, and the organic layer was dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 8-b (54 g, 63%).
합성예 10-3. 중간체 8-c의 합성Synthesis Example 10-3. Synthesis of Intermediate 8-c
중간체 8-b를 아세토니트릴(1000ml)에 녹인 후, 증류수 200ml에 녹인 K2CO3 (83g, 603mmol)와 노나플루오로뷰탄-1-설포닐플로라이드 (91g, 301mmol)를 넣었다. 상온에서 3시간 교반 후, 아세토니트릴을 감압 증류하여 제거 후, 클로로포름에 녹여 물로 여러 번 추출하였다. 유기층을 무수황산마그네슘으로 건조한 후 감압증류하여 유기용매를 제거하고 컬럼크로마토그래피를 이용하여 정제하여 화합물 8-c (81g, 수율 73%)를 얻었다. Intermediate 8-b was dissolved in acetonitrile (1000 ml), and then K 2 CO 3 (83 g, 603 mmol) and nonafluorobutane-1-sulfonyl fluoride (91 g, 301 mmol) dissolved in 200 ml of distilled water were added. After stirring at room temperature for 3 hours, acetonitrile was removed by distillation under reduced pressure, and the solution was dissolved in chloroform and extracted several times with water. The organic layer was dried over anhydrous magnesium sulfate, distilled under reduced pressure to remove the organic solvent, and purified using column chromatography to obtain compound 8-c (81 g, yield 73%).
합성예 10-4. 중간체 8-d의 합성Synthesis Example 10-4. Synthesis of Intermediate 8-d
중간체 8-c (81g, 147 mmol)과 페닐보론산 (18g, 147 mml) 를 THF (500ml)에 녹인 후, Pd(PPh3)4 (3.4g, 2.9mmol)와 2M K2CO3 수용액 150ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 8-d (37 g, 수율 76%)를 얻었다.Intermediate 8-c (81 g, 147 mmol) and phenylboronic acid (18 g, 147 mmol) were dissolved in THF (500 ml), and Pd(PPh 3 ) 4 (3.4 g, 2.9 mmol) and 150 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 8-d (37 g, yield 76%).
합성예 10-5. 중간체 8-e의 합성Synthesis Example 10-5. Synthesis of Intermediate 8-e
중간체 8-d (37g, 113mmol)와 비스(피나콜라토)디보론 (34g, 135mmol), KOAc (22g, 225mmol)을 플라스크에 다이옥세인 300ml와 함께 넣어 분산시켰다. Pd(dba)2 (1.29g, 2.3mmol), PCy3 (1.26g, 4.5mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 8-e를 얻었다. (35g, 수율 74%)Intermediate 8-d (37 g, 113 mmol), bis(pinacolato)diboron (34 g, 135 mmol), KOAc (22 g, 225 mmol) were added to a flask with 300 ml of dioxane and dispersed. Pd(dba) 2 (1.29 g, 2.3 mmol), PCy3 (1.26 g, 4.5 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 8-e was obtained by purification using column chromatography. (35 g, yield 74%)
합성예 10-6. 화합물 8의 합성Synthesis Example 10-6. Synthesis of Compound 8
중간체 8-e (20 g, 48mmol)와 9-브로모-10-(나프탈렌-2-일)안트라센 (18g, 48mmol) 을 THF (250ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.05g, 0.1mmol)와 2M K2CO3 수용액 50ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 8 (16g, 수율 56%)를 얻었다. [M+H+]= 597.2 Intermediate 8-e (20 g, 48 mmol) and 9-bromo-10-(naphthalen-2-yl)anthracene (18 g, 48 mmol) were dissolved in THF (250 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.05 g, 0.1 mmol) and 50 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 h. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The mixture was recrystallized from EA to obtain compound 8 (16 g, yield 56%). [M+H + ]= 597.2
11. 화합물 9의 합성11. Synthesis of compound 9
합성예 11-1. 중간체 9-a의 합성Synthesis Example 11-1. Synthesis of Intermediate 9-a
합성예 10-1에서 3-브로모나프탈렌-2,7-다이올 대신 3-브로모-5-클로로-2-플루오로페놀을, (2-클로로-6-플루오로페닐)보론산 대신 (3-하이드록시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 동일하게 합성하여 중간체 9-a를 얻었다.Intermediate 9-a was obtained by the same synthesis procedure as in Synthetic Example 10-1, except that 3-bromo-5-chloro-2-fluorophenol was used instead of 3-bromonaphthalene-2,7-diol and (3-hydroxynaphthalen-2-yl)boronic acid was used instead of (2-chloro-6-fluorophenyl)boronic acid.
합성예 11-2. 중간체 9-b의 합성Synthesis Example 11-2. Synthesis of Intermediate 9-b
합성예 10-2에서 중간체 8-a 대신 중간체 9-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 9-b를 얻었다. Intermediate 9-b was obtained by the same synthesis as in Synthesis Example 10-2, except that intermediate 9-a was used instead of intermediate 8-a.
합성예 11-3. 중간체 9-c의 합성Synthesis Example 11-3. Synthesis of Intermediate 9-c
합성예 10-3에서 중간체 8-b 대신 중간체 9-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 9-c를 얻었다. Intermediate 9-c was obtained by the same synthesis as in Synthesis Example 10-3, except that intermediate 9-b was used instead of intermediate 8-b.
합성예 11-4. 중간체 9-d의 합성Synthesis Example 11-4. Synthesis of Intermediate 9-d
합성예 10-4에서 중간체 8-c 대신 중간체 9-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 9-d를 얻었다. Intermediate 9-d was obtained by the same synthesis as in Synthesis Example 10-4, except that intermediate 9-c was used instead of intermediate 8-c.
합성예 11-5. 중간체 9-e의 합성Synthesis Example 11-5. Synthesis of Intermediate 9-e
합성예 10-5에서 중간체 8-d 대신 중간체 9-d를 사용한 것을 제외하고는 동일하게 합성하여 중간체 9-e를 얻었다. Intermediate 9-e was obtained by the same synthesis as in Synthesis Example 10-5, except that intermediate 9-d was used instead of intermediate 8-d.
합성예 11-6. 화합물 9의 합성Synthesis Example 11-6. Synthesis of Compound 9
합성예 10-6에서 중간체 8-e 대신 중간체 9-e를, 9-브로모-10-(나프탈렌-2-일)안트라센 대신 9-브로모-10-(나프탈렌-1-일)안트라센 를 사용한 것을 제외하고는 동일하게 합성하여 화합물 9를 얻었다. [M+H+]= 597.2Compound 9 was obtained by the same synthesis as in Synthetic Example 10-6, except that intermediate 9-e was used instead of intermediate 8-e and 9-bromo-10-(naphthalen-1-yl)anthracene was used instead of 9-bromo-10-(naphthalen-2-yl)anthracene. [M+H + ]= 597.2
12. 화합물 10의 합성12. Synthesis of compound 10
합성예 12-1. 중간체 10-a의 합성Synthesis Example 12-1. Synthesis of Intermediate 10-a
합성예 10-1에서 3-브로모나프탈렌-2,7-다이올 대신 5-브로모-2-클로로-4-플루오로페놀을, (2-클로로-6-플루오로페닐)보론산 대신 (1-하이드록시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 동일하게 합성하여 중간체 10-a를 얻었다.Intermediate 10-a was obtained by the same synthesis procedure as in Synthetic Example 10-1, except that 5-bromo-2-chloro-4-fluorophenol was used instead of 3-bromonaphthalene-2,7-diol and (1-hydroxynaphthalen-2-yl)boronic acid was used instead of (2-chloro-6-fluorophenyl)boronic acid.
합성예 12-2. 중간체 10-b의 합성Synthesis Example 12-2. Synthesis of Intermediate 10-b
합성예 10-2에서 중간체 8-a 대신 중간체 10-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 10-b를 얻었다. Intermediate 10-b was obtained by the same synthesis as in Synthesis Example 10-2, except that Intermediate 10-a was used instead of Intermediate 8-a.
합성예 12-3. 중간체 10-c의 합성Synthesis Example 12-3. Synthesis of Intermediate 10-c
합성예 10-3에서 중간체 8-b 대신 중간체 10-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 10-c를 얻었다. Intermediate 10-c was obtained by the same synthesis as in Synthesis Example 10-3, except that Intermediate 10-b was used instead of Intermediate 8-b.
합성예 12-4. 중간체 10-d의 합성Synthesis Example 12-4. Synthesis of Intermediate 10-d
합성예 10-4에서 중간체 8-c 대신 중간체 10-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 10-d를 얻었다. Intermediate 10-d was obtained by the same synthesis as in Synthesis Example 10-4, except that intermediate 10-c was used instead of intermediate 8-c.
합성예 12-5. 중간체 10-e의 합성Synthesis Example 12-5. Synthesis of Intermediate 10-e
합성예 10-5에서 중간체 8-d 대신 중간체 10-d를 사용한 것을 제외하고는 동일하게 합성하여 중간체 10-e를 얻었다. Intermediate 10-e was obtained by the same synthesis as in Synthesis Example 10-5, except that intermediate 10-d was used instead of intermediate 8-d.
합성예 12-6. 화합물 10의 합성Synthesis Example 12-6. Synthesis of Compound 10
합성예 10-6에서 중간체 8-e 대신 중간체 10-e를 사용한 것을 제외하고는 동일하게 합성하여 화합물 10를 얻었다. [M+H+]= 597.2Compound 10 was obtained by the same synthesis as in Synthesis Example 10-6, except that intermediate 10-e was used instead of intermediate 8-e. [M+H + ]= 597.2
13. 화합물 11의 합성13. Synthesis of compound 11
합성예 13-1. 중간체 11-a의 합성Synthesis Example 13-1. Synthesis of Intermediate 11-a
합성예 10-1에서 3-브로모나프탈렌-2,7-다이올 대신 4-브로모나프탈렌-1,3-다이올을 사용한 것을 제외하고는 동일하게 합성하여 중간체 11-a를 얻었다.Intermediate 11-a was obtained by the same synthesis as in Synthesis Example 10-1, except that 4-bromonaphthalene-1,3-diol was used instead of 3-bromonaphthalene-2,7-diol.
합성예 13-2. 중간체 11-b의 합성Synthesis Example 13-2. Synthesis of Intermediate 11-b
합성예 10-2에서 중간체 8-a 대신 중간체 11-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 11-b를 얻었다. Intermediate 11-b was obtained by the same synthesis as in Synthesis Example 10-2, except that Intermediate 11-a was used instead of Intermediate 8-a.
합성예 13-3. 중간체 11-c의 합성Synthesis Example 13-3. Synthesis of Intermediate 11-c
합성예 10-3에서 중간체 8-b 대신 중간체 11-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 11-c를 얻었다. Intermediate 11-c was obtained by the same synthesis as in Synthesis Example 10-3, except that Intermediate 11-b was used instead of Intermediate 8-b.
합성예 13-4. 중간체 11-d의 합성Synthesis Example 13-4. Synthesis of Intermediate 11-d
합성예 10-4에서 중간체 8-c 대신 중간체 11-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 11-d를 얻었다. Intermediate 11-d was obtained by the same synthesis as in Synthesis Example 10-4, except that intermediate 11-c was used instead of intermediate 8-c.
합성예 13-5. 중간체 11-e의 합성Synthesis Example 13-5. Synthesis of Intermediate 11-e
합성예 10-5에서 중간체 8-d 대신 중간체 11-d를 사용한 것을 제외하고는 동일하게 합성하여 중간체 11-e를 얻었다. Intermediate 11-e was obtained by the same synthesis as in Synthesis Example 10-5, except that intermediate 11-d was used instead of intermediate 8-d.
합성예 13-6. 화합물 11의 합성Synthesis Example 13-6. Synthesis of Compound 11
합성예 10-6에서 중간체 8-e 대신 중간체 11-e를, 9-브로모-10-(나프탈렌-2-일)안트라센 대신 9-{[1,1'-비페닐]-4-일}-10-브로모안트라센을 사용한 것을 제외하고는 동일하게 합성하여 화합물 11를 얻었다. [M+H+]= 623.2Compound 11 was obtained by the same synthesis as in Synthetic Example 10-6, except that intermediate 11-e was used instead of intermediate 8-e and 9-{[1,1'-biphenyl]-4-yl}-10-bromoanthracene was used instead of 9-bromo-10-(naphthalen-2-yl)anthracene. [M+H + ]= 623.2
14. 화합물 12의 합성14. Synthesis of compound 12
합성예 14-1. 중간체 12-a의 합성Synthesis Example 14-1. Synthesis of Intermediate 12-a
합성예 10-1에서 3-브로모나프탈렌-2,7-다이올 대신 1-브로모나프탈렌-2,7-다이올을, (2-클로로-6-플루오로페닐)보론산 대신 (5-클로로-2-플루오로페닐)보론산을 사용한 것을 제외하고는 동일하게 합성하여 중간체 12-a를 얻었다.Intermediate 12-a was obtained by the same synthesis procedure as in Synthetic Example 10-1, except that 1-bromonaphthalene-2,7-diol was used instead of 3-bromonaphthalene-2,7-diol and (5-chloro-2-fluorophenyl)boronic acid was used instead of (2-chloro-6-fluorophenyl)boronic acid.
합성예 14-2. 중간체 12-b의 합성Synthesis Example 14-2. Synthesis of Intermediate 12-b
합성예 10-2에서 중간체 8-a 대신 중간체 12-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 12-b를 얻었다. Intermediate 12-b was obtained by the same synthesis as in Synthesis Example 10-2, except that Intermediate 12-a was used instead of Intermediate 8-a.
합성예 14-3. 중간체 12-c의 합성Synthesis Example 14-3. Synthesis of Intermediate 12-c
합성예 10-3에서 중간체 8-b 대신 중간체 12-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 12-c를 얻었다. Intermediate 12-c was obtained by the same synthesis as in Synthesis Example 10-3, except that intermediate 12-b was used instead of intermediate 8-b.
합성예 14-4. 중간체 12-d의 합성Synthesis Example 14-4. Synthesis of Intermediate 12-d
합성예 14-4에서 중간체 8-c 대신 중간체 12-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 12-d를 얻었다. Intermediate 12-d was obtained by the same synthesis as in Synthesis Example 14-4, except that intermediate 12-c was used instead of intermediate 8-c.
합성예 14-5. 중간체 12-e의 합성Synthesis Example 14-5. Synthesis of Intermediate 12-e
합성예 10-5에서 중간체 8-d 대신 중간체 12-d를 사용한 것을 제외하고는 동일하게 합성하여 중간체 12-e를 얻었다. Intermediate 12-e was obtained by the same synthesis as in Synthesis Example 10-5, except that intermediate 12-d was used instead of intermediate 8-d.
합성예 14-6. 화합물 12의 합성Synthesis Example 14-6. Synthesis of Compound 12
합성예 10-6에서 중간체 8-e 대신 중간체 12-e을, 9-브로모-10-(나프탈렌-2-일)안트라센 대신 9-브로모-10-(나프탈렌-1-일)안트라센을 사용한 것을 제외하고는 동일하게 합성하여 화합물 12를 얻었다. [M+H+]= 597.3Compound 12 was obtained by the same synthesis as in Synthetic Example 10-6, except that intermediate 12-e was used instead of intermediate 8-e and 9-bromo-10-(naphthalen-1-yl)anthracene was used instead of 9-bromo-10-(naphthalen-2-yl)anthracene. [M+H + ]= 597.3
15. 화합물 13의 합성15. Synthesis of compound 13
합성예 15-1. 중간체 13-a의 합성Synthesis Example 15-1. Synthesis of Intermediate 13-a
8-브로모나프탈렌-1-올 (100g, 448mmol)과 페닐보론산 (55g, 448mml) 를 THF (1500ml)에 녹인 후, Pd(PPh3)4 (10.4g, 9.0mmol)와 2M K2CO3 수용액 300ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 13-a (72g, 수율 73%)를 얻었다.8-Bromonaphthalen-1-ol (100 g, 448 mmol) and phenylboronic acid (55 g, 448 mmol) were dissolved in THF (1500 ml), Pd(PPh 3 ) 4 (10.4 g, 9.0 mmol) and 300 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was refluxed and stirred for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 13-a (72 g, yield 73%).
합성예 15-2. 중간체 13-b의 합성Synthesis Example 15-2. Synthesis of Intermediate 13-b
중간체 13-a (72g, 327mmol)를 DMF 1000ml에 녹인 후 DMF 100ml에 녹인 N-브로모숙신이미드 (58g, 327 mmol)을 천천히 적가한다. 상온에서 2시간 교반 후 DMF를 감압 증류하여 제거하였다. 클로로포름에 녹여 증류수로 여러 번 추출한 후 감압 증류하여 용매를 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 화합물 13-b를 얻었다. (69g, 수율 71%)Intermediate 13-a (72 g, 327 mmol) was dissolved in 1000 ml of DMF, and then N-bromosuccinimide (58 g, 327 mmol) dissolved in 100 ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, DMF was removed by distillation under reduced pressure. Dissolved in chloroform, extracted several times with distilled water, and then distilled under reduced pressure to remove the solvent. Compound 13-b was obtained by purification using column chromatography. (69 g, yield 71%)
합성예 15-3. 중간체 13-c의 합성Synthesis Example 15-3. Synthesis of Intermediate 13-c
중간체 13-b (69g, 231mmol)과 (4-클로로-2-플루오로페닐)보론산 (40g, 231mml) 를 THF (800ml)에 녹인 후, Pd(PPh3)4 (5.3g, 4.6mmol)와 2M K2CO3 수용액 200ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 13-c (54g, 수율 67%)를 얻었다.Intermediate 13-b (69 g, 231 mmol) and (4-chloro-2-fluorophenyl)boronic acid (40 g, 231 mmol) were dissolved in THF (800 ml), and Pd(PPh 3 ) 4 (5.3 g, 4.6 mmol) and 200 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 13-c (54 g, yield 67%).
합성예 15-4. 중간체 13-d의 합성Synthesis Example 15-4. Synthesis of Intermediate 13-d
중간체 13-c (54g, 155mmol)을 DMF (800ml)에 녹인 후, K2CO3 (64g, 460mmol)을 넣고, 2시간동안 환류 교반하였다. 반응 용액을 식힌 후, 증류수 3L에 부어서 고체를 생성시킨다. 고체를 필터한 후 클로로포름에 녹여 물로 여러 번 추출한 후 유기층을 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 중간체 13-d (34g, 67%)를 얻었다.Intermediate 13-c (54 g, 155 mmol) was dissolved in DMF (800 ml), K 2 CO 3 (64 g, 460 mmol) was added, and the mixture was refluxed for 2 hours. After cooling the reaction solution, it was poured into 3 L of distilled water to generate a solid. The solid was filtered, dissolved in chloroform, extracted several times with water, and the organic layer was dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain intermediate 13-d (34 g, 67%).
합성예 15-5. 중간체 13-e의 합성Synthesis Example 15-5. Synthesis of Intermediate 13-e
중간체 13-d (34g, 103mmol)와 비스(피나콜라토)디보론 (32g, 124mmol), KOAc (20g, 207mmol)을 플라스크에 다이옥세인 260ml와 함께 넣어 분산시켰다. Pd(dba)2 (1.18g, 2.1mmol), PCy3 (1.15g, 4.1mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 13-e를 얻었다. (31g, 수율 71%)Intermediate 13-d (34 g, 103 mmol) and bis(pinacolato)diboron (32 g, 124 mmol), KOAc (20 g, 207 mmol) were added to a flask with 260 ml of dioxane and dispersed. Pd(dba) 2 (1.18 g, 2.1 mmol), PCy3 (1.15 g, 4.1 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 13-e was obtained by purification using column chromatography. (31 g, yield 71%)
합성예 15-6. 화합물 13의 합성Synthesis Example 15-6. Synthesis of Compound 13
중간체 13-e (20 g, 48mmol)와 9-브로모-10-(페난트렌-9-일)안트라센 (20.6g, 48mmol) 을 THF (250ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.05g, 0.09mmol)와 2M K2CO3 수용액 50ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 13 (17g, 수율 55%)를 얻었다. [M+H+]= 647.2Intermediate 13-e (20 g, 48 mmol) and 9-bromo-10-(phenanthren-9-yl)anthracene (20.6 g, 48 mmol) were dissolved in THF (250 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.05 g, 0.09 mmol) and 50 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 h. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 13 (17 g, yield 55%) was obtained by recrystallization from EA. [M+H + ]= 647.2
16. 화합물 14의 합성16. Synthesis of compound 14
합성예 16-1. 중간체 14-a의 합성Synthesis Example 16-1. Synthesis of Intermediate 14-a
중간체 8-b (100g, 372mmol)과 페닐보론산 (45g, 372mml) 를 THF (1200ml)에 녹인 후, Pd(PPh3)4 (8.6g, 7.4mmol)와 2M K2CO3 수용액 300ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 14-a (73g, 수율 63%)를 얻었다.Intermediate 8-b (100 g, 372 mmol) and phenylboronic acid (45 g, 372 mmol) were dissolved in THF (1200 ml), and Pd(PPh 3 ) 4 (8.6 g, 7.4 mmol) and 300 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 14-a (73 g, yield 63%).
합성예 16-2. 중간체 14-b의 합성Synthesis Example 16-2. Synthesis of Intermediate 14-b
중간체 14-a (73g, 235 mmol)를 아세토니트릴(1200ml)에 녹인 후, 증류수 250ml에 녹인 K2CO3 (107g, 352mmol)와 노나플루오로뷰탄-1-설포닐플로라이드 (107g, 353mmol)을 넣었다. 상온에서 3시간 교반 후, 아세토니트릴을 감압 증류하여 제거 후, 클로로포름에 녹여 물로 여러 번 추출하였다. 유기층을 무수황산마그네슘으로 건조한 후 감압증류하여 유기용매를 제거하고 컬럼크로마토그래피를 이용하여 정제하여 화합물 14-b (97g, 수율 70%)를 얻었다. Intermediate 14-a (73 g, 235 mmol) was dissolved in acetonitrile (1200 ml), and then K 2 CO 3 (107 g, 352 mmol) and nonafluorobutane-1-sulfonyl fluoride (107 g, 353 mmol) dissolved in 250 ml of distilled water were added. After stirring at room temperature for 3 hours, acetonitrile was removed by distillation under reduced pressure, and the mixture was dissolved in chloroform and extracted several times with water. The organic layer was dried over anhydrous magnesium sulfate, distilled under reduced pressure to remove the organic solvent, and purified using column chromatography to obtain compound 14-b (97 g, yield 70%).
합성예 16-3. 중간체 14-c의 합성Synthesis Example 16-3. Synthesis of Intermediate 14-c
중간체 14-b (97g, 163mmol)와 비스(피나콜라토)디보론 (50g, 196mmol), KOAc (32g, 327mmol)을 플라스크에 다이옥세인 400ml와 함께 넣어 분산시켰다. Pd(dba)2 (1.88g, 3.3mmol), PCy3 (1.83g, 6.5mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 14-c를 얻었다. (52g, 수율 76%)Intermediate 14-b (97 g, 163 mmol), bis(pinacolato)diboron (50 g, 196 mmol), KOAc (32 g, 327 mmol) were added to a flask with 400 ml of dioxane and dispersed. Pd(dba) 2 (1.88 g, 3.3 mmol), PCy3 (1.83 g, 6.5 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 14-c was obtained by purification using column chromatography. (52 g, yield 76%)
합성예 16-4. 중간체 14-d의 합성Synthesis Example 16-4. Synthesis of Intermediate 14-d
중간체 14-c (52g, 124mmol)과 1-브로모-3-클로로벤젠 (24g, 124mml) 를 THF (400ml)에 녹인 후, Pd(PPh3)4 (2.8g, 2.5mmol)와 2M K2CO3 수용액 100ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 감압하여 유기용매를 제거하고 컬럼 크로마토그래피를 이용하여 정제하여 화합물 14-d (36g, 수율 72%)를 얻었다.Intermediate 14-c (52 g, 124 mmol) and 1-bromo-3-chlorobenzene (24 g, 124 mmol) were dissolved in THF (400 ml), and Pd(PPh 3 ) 4 (2.8 g, 2.5 mmol) and 100 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The organic solvent was removed under reduced pressure, and the residue was purified using column chromatography to obtain compound 14-d (36 g, yield 72%).
합성예 16-5. 중간체 14-e의 합성Synthesis Example 16-5. Synthesis of Intermediate 14-e
중간체 14-d (36g, 89mmol)와 비스(피나콜라토)디보론 (27g, 107mol), KOAc (17g, 178mmol)을 플라스크에 다이옥세인 250ml와 함께 넣어 분산시켰다. Pd(dba)2 (1.0g, 1.8mmol), PCy3 (1.00g, 3.6mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 14-e를 얻었다. (32g, 수율 72%)Intermediate 14-d (36 g, 89 mmol), bis(pinacolato)diboron (27 g, 107 mol), KOAc (17 g, 178 mmol) were added to a flask with 250 ml of dioxane and dispersed. Pd(dba) 2 (1.0 g, 1.8 mmol), PCy3 (1.00 g, 3.6 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 14-e was obtained by purification using column chromatography. (32 g, yield 72%)
합성예 16-6. 화합물 14의 합성Synthesis Example 16-6. Synthesis of compound 14
중간체 14-e (20 g, 40mmol)와 9-브로모-10-페닐안트라센 (13.4g, 40mmol) 을 THF (200ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.04g, 0.08mmol)와 2M K2CO3 수용액 50ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 14 (16g, 수율 64%)를 얻었다. [M+H+]= 623.2Intermediate 14-e (20 g, 40 mmol) and 9-bromo-10-phenylanthracene (13.4 g, 40 mmol) were dissolved in THF (200 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.04 g, 0.08 mmol) and 50 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 14 (16 g, yield 64%) was obtained by recrystallization from EA. [M+H + ]= 623.2
17. 화합물 15의 합성17. Synthesis of compound 15
합성예 17-1. 중간체 15-a의 합성Synthesis Example 17-1. Synthesis of Intermediate 15-a
중간체 7-c (50g, 151mmol)와 비스(피나콜라토)디보론 (46g, 181mol), KOAc (30g, 302mmol)을 플라스크에 다이옥세인 400ml와 함께 넣어 분산시켰다. Pd(dppf)Cl2 (2.2g, 3.0mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 15-a를 얻었다. (43g, 수율 75%)Intermediate 7-c (50 g, 151 mmol), bis(pinacolato)diboron (46 g, 181 mol), KOAc (30 g, 302 mmol) were added to a flask with 400 ml of dioxane and dispersed. Pd(dppf)Cl2 (2.2 g, 3.0 mmol) was added and refluxed for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, it was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 15-a was obtained by purification using column chromatography. (43 g, yield 75%)
합성예 17-2. 중간체 15-b의 합성Synthesis Example 17-2. Synthesis of Intermediate 15-b
중간체 15-a (43g, 114mmol)과 9-{[1,1'-비페닐]-4-일}-10-브로모안트라센 (46.5g, 114mml) 를 THF (400ml)에 녹인 후, Pd(PPh3)4 (2.6g, 2.3mmol)와 2M K2CO3수용액 80ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 에틸아세테이트에서 재결정으로 정제하여 화합물 15-b (44g, 수율 67%)를 얻었다.Intermediate 15-a (43 g, 114 mmol) and 9-{[1,1'-biphenyl]-4-yl}-10-bromoanthracene (46.5 g, 114 mmol) were dissolved in THF (400 ml), and Pd(PPh 3 ) 4 (2.6 g, 2.3 mmol) and 80 ml of 2 M K 2 CO 3 aqueous solution were added, followed by reflux stirring for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 15-b (44 g, yield 67%) was obtained by purification by recrystallization from ethyl acetate.
합성예 17-3. 화합물 15의 합성Synthesis Example 17-3. Synthesis of Compound 15
중간체 15-b (20 g, 34mmol)와 페닐보론산 (11.5g, 34mmol) 을 다이옥세인 (200ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.04g, 0.07mmol)와 2M K2CO3수용액 50ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 15 (16g, 수율 74%)를 얻었다. [M+H+]= 623.2Intermediate 15-b (20 g, 34 mmol) and phenylboronic acid (11.5 g, 34 mmol) were dissolved in dioxane (200 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.04 g, 0.07 mmol) and 50 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 15 (16 g, yield 74%) was obtained by recrystallization from EA. [M+H + ]= 623.2
18. 화합물 16의 합성18. Synthesis of compound 16
합성예 18-1. 화합물 16-a의 합성Synthesis Example 18-1. Synthesis of Compound 16-a
중간체 12-b (50 g, 186mmol)와 페닐보론산 (22.7g, 186mmol) 을 다이옥세인 (1000ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.19g, 0.37mmol)와 2M K2CO3 수용액 200ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. 컬럼 크로마토그래피로 정제하여 화합물 16-a (45g, 수율 78%)를 얻었다.Intermediate 12-b (50 g, 186 mmol) and phenylboronic acid (22.7 g, 186 mmol) were dissolved in dioxane (1000 ml), bis(tri-tert-butylphosphine)palladium(0) (0.19 g, 0.37 mmol) and 200 ml of 2 M K 2 CO 3 aqueous solution were added, and the mixture was stirred under reflux for 24 hours. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 16-a (45 g, yield 78%) was obtained by purification by column chromatography.
합성예 18-2. 중간체 16-b의 합성Synthesis Example 18-2. Synthesis of Intermediate 16-b
중간체 16-a (45g, 145 mmol)를 아세토니트릴(700ml)에 녹인 후, 증류수 100ml에 녹인 K2CO3 (107g, 352mmol)와 노나플루오로뷰탄-1-설포닐플로라이드 (66g, 217mmol)을 넣었다. 상온에서 3시간 교반 후, 아세토니트릴을 감압 증류하여 제거 후, 클로로포름에 녹여 물로 여러 번 추출하였다. 유기층을 무수황산마그네슘으로 건조한 후 감압증류하여 유기용매를 제거하고 컬럼크로마토그래피를 이용하여 정제하여 화합물 16-b (62g, 수율 72%)를 얻었다. Intermediate 16-a (45 g, 145 mmol) was dissolved in acetonitrile (700 ml), and then K 2 CO 3 (107 g, 352 mmol) and nonafluorobutane-1-sulfonyl fluoride (66 g, 217 mmol) dissolved in 100 ml of distilled water were added. After stirring at room temperature for 3 hours, acetonitrile was removed by distillation under reduced pressure, dissolved in chloroform, and extracted several times with water. The organic layer was dried over anhydrous magnesium sulfate, distilled under reduced pressure to remove the organic solvent, and purified using column chromatography to obtain compound 16-b (62 g, yield 72%).
합성예 18-3. 중간체 16-c의 합성Synthesis Example 18-3. Synthesis of Intermediate 16-c
중간체 16-b (62g, 104mmol)와 비스(피나콜라토)디보론 (32g, 126mol), KOAc (21g, 209mmol)을 플라스크에 다이옥세인 250ml와 함께 넣어 분산시켰다. Pd(dba)2 (1.2g, 2.1mmol), PCy3 (1.2g, 2.1mmol)을 넣어준 후 24시간 동안 환류교반하였다. 반응 종료 후 다이옥세인을 감압 증류하여 제거하였다. 클로로포름에 녹인 후 증류수로 3회 추출한 후 유기층을 감압 증류하여 클로로포름을 제거하였다. 컬럼크로마토그래피를 이용하여 정제하여 중간체 16-c를 얻었다. (30g, 수율 68%)Intermediate 16-b (62 g, 104 mmol), bis(pinacolato)diboron (32 g, 126 mol), KOAc (21 g, 209 mmol) were added to a flask with 250 ml of dioxane and dispersed. Pd(dba) 2 (1.2 g, 2.1 mmol), PCy3 (1.2 g, 2.1 mmol) were added, and the mixture was stirred under reflux for 24 hours. After completion of the reaction, dioxane was removed by distillation under reduced pressure. After dissolving in chloroform, the mixture was extracted three times with distilled water, and the organic layer was distilled under reduced pressure to remove chloroform. Intermediate 16-c was obtained by purification using column chromatography. (30 g, yield 68%)
합성예 18-4. 화합물 16의 합성Synthesis Example 18-4. Synthesis of Compound 16
중간체 16-c (30 g, 71mmol)와 9-브로모-10-(나프탈렌-2-일)안트라센 (27.4g, 71mmol) 을 THF (400ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.07g, 0.14mmol)와 2M K2CO3 수용액 80ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 16 (22g, 수율 52%)를 얻었다. [M+H+]= 597.3Intermediate 16-c (30 g, 71 mmol) and 9-bromo-10-(naphthalen-2-yl)anthracene (27.4 g, 71 mmol) were dissolved in THF (400 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.07 g, 0.14 mmol) and 80 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 h. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. Compound 16 (22 g, yield 52%) was obtained by recrystallization from EA. [M+H + ]= 597.3
19. 화합물 17의 합성19. Synthesis of compound 17
합성예 19-1. 중간체 17-a의 합성Synthesis Example 19-1. Synthesis of Intermediate 17-a
9-페닐안트라센 (50g)와 AlCl3(10g)을 C6D6 (1000ml)에 넣고 2시간 교반하였다. 반응 종료 후 D2O (75ml)를 넣고 30분 교반한 뒤 트리메틸아민(trimethylamine) (6ml)를 적가하였다. 반응액을 분액 깔대기에 옮기고, 물과 톨루엔으로 추출하였다. 추출액을 MgSO4로 건조 후, 에틸아세테이트로 재결정하여 중간체 17-a를 얻었다. (36g, 수율 72%)9-Phenylanthracene (50 g) and AlCl 3 (10 g) were added to C 6 D 6 (1000 ml) and stirred for 2 hours. After the reaction was completed, D 2 O (75 ml) was added and stirred for 30 minutes, and then trimethylamine (6 ml) was added dropwise. The reaction solution was transferred to a separatory funnel and extracted with water and toluene. The extract was dried over MgSO 4 and recrystallized from ethyl acetate to obtain intermediate 17-a. (36 g, yield 72%)
합성예 19-2. 중간체 17-b의 합성Synthesis Example 19-2. Synthesis of Intermediate 17-b
중간체 17-a (36g, 128 mmol)를 DMF 500ml에 녹인 후 DMF 100ml에 녹인 N-브로모숙신이미드 (22.8g, 128 mmol)을 천천히 적가한다. 상온에서 2시간 교반 후 물 1000ml를 적가했다. 고체가 생성되면 필터 후 클로로포름에 녹여 증류수로 여러 번 추출하였다. 에틸아세테이트에서 재결정하여 중간체 17-b 를 얻었다. (31 g, 수율 67%)Intermediate 17-a (36 g, 128 mmol) was dissolved in 500 ml of DMF, and then N-bromosuccinimide (22.8 g, 128 mmol) dissolved in 100 ml of DMF was slowly added dropwise. After stirring at room temperature for 2 hours, 1000 ml of water was added dropwise. When a solid was formed, it was filtered, dissolved in chloroform, and extracted several times with distilled water. Intermediate 17-b was obtained by recrystallization from ethyl acetate. (31 g, yield 67%)
합성예 19-3. 화합물 17의 합성Synthesis Example 19-3. Synthesis of compound 17
중간체 2-d (23.4 g, 56 mmol)와 중간체17-b (20 g, 56 mmol) 을 THF (300ml)에 녹인 후, 비스(트리-tert-부틸포스핀)팔라듐(0) (0.06g, 0.11 mmol)와 2M K2CO3 수용액 60ml를 넣고 24시간동안 환류교반시켰다. 반응 용액을 식히고, 유기층을 에틸아세테이트로 추출한 후 무수황산마그네슘으로 건조하였다. EA에서 재결정하여 화합물 17 (22g, 수율 71%)를 얻었다. [M+H+]= 560.3Intermediate 2-d (23.4 g, 56 mmol) and intermediate 17-b (20 g, 56 mmol) were dissolved in THF (300 ml), and bis(tri-tert-butylphosphine)palladium(0) (0.06 g, 0.11 mmol) and 60 ml of 2M K2CO3 aqueous solution were added, and the mixture was stirred under reflux for 24 h. The reaction solution was cooled, and the organic layer was extracted with ethyl acetate and dried over anhydrous magnesium sulfate. The compound 17 (22 g, yield 71%) was obtained by recrystallization from EA. [M+H + ]= 560.3
20. 화합물 18의 합성20. Synthesis of compound 18
합성예 20-1. 중간체 18-a의 합성Synthesis Example 20-1. Synthesis of Intermediate 18-a
합성예 19-1에서 9-페닐 안트라센 대신 9-(나프탈렌-2-일)안트라센을 사용한 것을 제외하고는 동일하게 합성하여 화합물 18-a을 얻었다.Compound 18-a was obtained by the same synthesis as in Synthetic Example 19-1, except that 9-(naphthalen-2-yl)anthracene was used instead of 9-phenylanthracene.
합성예 20-2. 중간체 18-b의 합성Synthesis Example 20-2. Synthesis of Intermediate 18-b
합성예 19-2에서 중간체 17-a 대신 중간체 18-a를 사용한 것을 제외하고는 동일하게 합성하여 화합물 18-b를 얻었다.Compound 18-b was obtained by the same synthesis as in Synthetic Example 19-2, except that intermediate 18-a was used instead of intermediate 17-a.
합성예 20-3. 화합물 18의 합성Synthesis Example 20-3. Synthesis of compound 18
합성예 19-3에서 중간체 2-b 대신 중간체 3-d를, 중간체 17-b 대신 중건채 18-b를 사용한 것을 제외하고는 동일하게 합성하여 화합물 18을 얻었다.Compound 18 was obtained through the same synthesis as in Synthetic Example 19-3, except that intermediate 3-d was used instead of intermediate 2-b, and intermediate 18-b was used instead of intermediate 17-b.
21. 화합물 19의 합성21. Synthesis of compound 19
합성예 21-1. 화합물 19의 합성Synthesis Example 21-1. Synthesis of Compound 19
합성예 19-1 에서 9-페닐 안트라센 대신 화합물 7을 사용한 것을 제외하고는 동일하게 합성하여 화합물 19를 얻었다.Compound 19 was obtained by the same synthesis as in Synthesis Example 19-1, except that compound 7 was used instead of 9-phenyl anthracene.
22. 화합물 20의 합성22. Synthesis of compound 20
합성예 22-1. 화합물 20의 합성Synthesis Example 22-1. Synthesis of Compound 20
합성예 19-1 에서 9-페닐 안트라센 대신 화합물 12을 사용한 것을 제외하고는 동일하게 합성하여 화합물 20을 얻었다.Compound 20 was obtained by the same synthesis as in Synthetic Example 19-1, except that compound 12 was used instead of 9-phenyl anthracene.
23. 화합물 21의 합성23. Synthesis of compound 21
<23-a> 중간체 21-a 의 합성<23-a> Synthesis of intermediate 21-a
질소 분위기하에서 1-브로모-3-(tert-부틸)-5-클로로벤젠 (50g, 202 mmol), 4a,9a-디메틸-2,3,4,4a,9,9a-헥사히드로-1H-카바졸 (41g, 202 mmol), 소듐-tert-부톡사이드 (29.1g, 303mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (2.06g, 4.0mmol) 을 톨루엔 700ml에 넣은 후 6시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제하여 중간체 21-a를 수득하였다 (47g, 수율 63%). Under a nitrogen atmosphere, 1-bromo-3-(tert-butyl)-5-chlorobenzene (50 g, 202 mmol), 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole (41 g, 202 mmol), sodium tert-butoxide (29.1 g, 303 mmol), and bis(tri-tert-butylphosphine)palladium(0) (2.06 g, 4.0 mmol) were added to 700 ml of toluene and stirred under reflux for 6 hours. After the reaction was completed, extraction was performed and the mixture was purified by using an ethyl acetate:hexane column to obtain intermediate 21-a (47 g, yield 63%).
<23-b> 중간체 21-b 의 합성<23-b> Synthesis of intermediate 21-b
질소 분위기하에서 21-a (47g, 128mmol), 5-(tert-부틸)페닐)-[1,1'-비페닐]-2-아민 (28.8g, 128mmol), 소듐-tert-부톡사이드 (24.5g, 255mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (1.31g, 2.6mmol)을 톨루엔 400ml에 넣은 후 12시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제 후 재결정을 통하여 중간체 21-b를 수득하였다 (41g, 수율 58%). Under a nitrogen atmosphere, 21-a (47 g, 128 mmol), 5-(tert-butyl)phenyl)-[1,1'-biphenyl]-2-amine (28.8 g, 128 mmol), sodium-tert-butoxide (24.5 g, 255 mmol), and bis(tri-tert-butylphosphine)palladium(0) (1.31 g, 2.6 mmol) were added to 400 ml of toluene and stirred under reflux for 12 hours. After the reaction was completed, extraction was performed, and the product was purified using an ethyl acetate:hexane column and recrystallized to obtain intermediate 21-b (41 g, yield 58%).
<23-c> 중간체 21-c 의 합성<23-c> Synthesis of intermediate 21-c
질소 분위기하에서 21-b (41g, 74 mmol), 1-브로모-3-클로로벤젠 (14.1g, 74mmol), 소듐-tert-부톡사이드 (10.6g, 110mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (0.75g, 1.5mmol)을 톨루엔 300ml에 넣은 후 6시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제 후 재결정을 통하여 중간체 21-c를 수득하였다 (34g, 수율 69%).Under a nitrogen atmosphere, 21-b (41 g, 74 mmol), 1-bromo-3-chlorobenzene (14.1 g, 74 mmol), sodium-tert-butoxide (10.6 g, 110 mmol), and bis(tri-tert-butylphosphine)palladium(0) (0.75 g, 1.5 mmol) were added to 300 ml of toluene and stirred under reflux for 6 hours. After the reaction was completed, extraction was performed, and the mixture was purified using an ethyl acetate:hexane column and recrystallized to obtain intermediate 21-c (34 g, yield 69%).
<23-d> 중간체 21-d 의 합성<23-d> Synthesis of intermediate 21-d
질소 분위기하에서 21-c (34g, 51mmol) 를 디클로로벤젠 500ml에 녹인 후 보론트리아이오드 9.73ml를 투입한다. 160도로 승온한 후 3시간동안 교반하였다. 반응 종료 후 디클로로벤젠을 감압증류하여 제거한 후 에틸아세테이트 /물로 추출하였다. 에틸아세테이트:헥산 컬럼으로 정제 후 재결정을 통하여 중간체 21-d를 수득하였다 (8.9g, 수율 26%). Under a nitrogen atmosphere, 21-c (34 g, 51 mmol) was dissolved in 500 ml of dichlorobenzene, and then 9.73 ml of boron triiodide was added. The temperature was raised to 160 degrees and stirred for 3 hours. After completion of the reaction, dichlorobenzene was removed by distillation under reduced pressure, and then extracted with ethyl acetate/water. After purification with an ethyl acetate:hexane column, intermediate 21-d was obtained through recrystallization (8.9 g, yield 26%).
<23-e> 화합물 21의 합성<23-e> Synthesis of compound 21
질소 분위기하에서 21-d (8.9g, 13mmol), 디페닐아민 (3.9g, 13mmol), 소듐-tert-부톡사이드 (2.53g 26mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (0.13g, 0.26mmol)을 톨루엔 50ml에 넣은 후 12시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제후 재결정을 통하여 화합물 21을 수득하였다 (5.9g, 수율 56%). MS[M+H]+ = 808.5Under a nitrogen atmosphere, 21-d (8.9 g, 13 mmol), diphenylamine (3.9 g, 13 mmol), sodium-tert-butoxide (2.53 g 26 mmol), and bis(tri-tert-butylphosphine)palladium(0) (0.13 g, 0.26 mmol) were added to 50 ml of toluene and stirred under reflux for 12 hours. After the reaction was completed, extraction was performed, and the resultant was purified using an ethyl acetate:hexane column and recrystallized to obtain compound 21 (5.9 g, yield 56%). MS[M+H]+ = 808.5
24. 화합물 22의 합성24. Synthesis of compound 22
<24-a> 중간체 22-a 의 합성<24-a> Synthesis of intermediate 22-a
질소 분위기하에서 1,3-디브로모-5-클로로벤젠 (50g, 185 mmol), 4a,9a-디메틸-2,3,4,4a,9,9a-헥사히드로-1H-카바졸 (74.5g, 370mmol), 소듐-tert-부톡사이드 (44.4g, 462mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (1.89g, 3.7mmol) 을 톨루엔 600ml에 넣은 후 6시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제하여 중간체 22-a를 수득하였다 (57g, 수율 60%). Under a nitrogen atmosphere, 1,3-Dibromo-5-chlorobenzene (50 g, 185 mmol), 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole (74.5 g, 370 mmol), sodium-tert-butoxide (44.4 g, 462 mmol), and bis(tri-tert-butylphosphine)palladium(0) (1.89 g, 3.7 mmol) were added to 600 ml of toluene and stirred under reflux for 6 hours. After the reaction was completed, extraction was performed and the mixture was purified by an ethyl acetate:hexane column to obtain intermediate 22-a (57 g, yield 60%).
<24-b> 중간체 22-b 의 합성<24-b> Synthesis of intermediate 22-b
질소 분위기하에서 22-a (57g, 112mmol) 를 디클로로벤젠 1000ml에 녹인 후 보론트리아이오드 21.3ml를 투입한다. 160도로 승온한 후 3시간동안 교반하였다. 반응 종료 후 디클로로벤젠을 감압증류하여 제거한 후 에틸아세테이트 /물로 추출하였다. 에틸아세테이트:헥산 컬럼으로 정제 후 재결정을 통하여 중간체 22-b를 수득하였다 (12.3g, 수율 21%). Under a nitrogen atmosphere, 22-a (57 g, 112 mmol) was dissolved in 1000 ml of dichlorobenzene, and 21.3 ml of boron triiodide was added. The temperature was raised to 160 degrees and stirred for 3 hours. After completion of the reaction, dichlorobenzene was removed by distillation under reduced pressure, and then extracted with ethyl acetate/water. After purification with an ethyl acetate:hexane column, intermediate 22-b was obtained through recrystallization (12.3 g, yield 21%).
<24-c> 화합물 22의 합성<24-c> Synthesis of compound 22
질소 분위기하에서 22-b (12.3g, 24mmol), 디페닐아민 (4.0g, 24mmol), 소듐-tert-부톡사이드 (4.6g 47mol), 비스(트리-tert-부틸포스핀)팔라듐(0) (0.24 0.47mmol)을 톨루엔 80ml에 넣은 후 12시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제후 재결정을 통하여 화합물 22을 수득하였다 (9.3g, 수율 60%). MS[M+H]+ = 652.4Under a nitrogen atmosphere, 22-b (12.3 g, 24 mmol), diphenylamine (4.0 g, 24 mmol), sodium-tert-butoxide (4.6 g 47 mol), and bis(tri-tert-butylphosphine)palladium(0) (0.24 0.47 mmol) were added to 80 ml of toluene and stirred under reflux for 12 hours. After the reaction was completed, extraction was performed, and the resultant was purified by an ethyl acetate:hexane column and recrystallized to obtain compound 22 (9.3 g, yield 60%). MS[M+H]+ = 652.4
25. 화합물 23의 합성25. Synthesis of compound 23
<25-a> 중간체 23-a 의 합성<25-a> Synthesis of intermediate 23-a
질소 분위기하에서 1-브로모-3,5-디클로로벤젠 (50g, 221mmol), 9,9'-디메틸-9,10-디히드로아크리딘 (46.3g, 221mmol), 소듐-tert-부톡사이드 (31.9g, 332mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (2.3g, 4.4mmol) 을 톨루엔 750ml에 넣은 후 6시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제하여 23-a를 수득하였다 (53g, 수율 67%). Under a nitrogen atmosphere, 1-bromo-3,5-dichlorobenzene (50 g, 221 mmol), 9,9'-dimethyl-9,10-dihydroacridine (46.3 g, 221 mmol), sodium tert-butoxide (31.9 g, 332 mmol), and bis(tri-tert-butylphosphine)palladium(0) (2.3 g, 4.4 mmol) were added to 750 ml of toluene and stirred under reflux for 6 hours. After the reaction was completed, extraction was performed and the mixture was purified by an ethyl acetate:hexane column to obtain 23-a (53 g, yield 67%).
<25-b> 중간체 23-b 의 합성<25-b> Synthesis of intermediate 23-b
질소 분위기하에서 23-a (53g, 148mmol), 5-(tert-부틸)-N-(3-(tert-부틸)페닐)-[1,1'-비페닐]-2-아민 (52.5g, 148mmol), 소듐-tert-부톡사이드 (28.4g, 296mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (1.51g, 3.0mmol) 을 톨루엔 500ml에 넣은 후 12시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제하여 23-b를 수득하였다 (59g, 수율 59%). Under a nitrogen atmosphere, 23-a (53 g, 148 mmol), 5-(tert-butyl)-N-(3-(tert-butyl)phenyl)-[1,1'-biphenyl]-2-amine (52.5 g, 148 mmol), sodium-tert-butoxide (28.4 g, 296 mmol), and bis(tri-tert-butylphosphine)palladium(0) (1.51 g, 3.0 mmol) were added to 500 ml of toluene and stirred under reflux for 12 hours. After the reaction was completed, extraction was performed and the mixture was purified by an ethyl acetate:hexane column to obtain 23-b (59 g, yield 59%).
<25-c> 중간체 23-c 의 합성<25-c> Synthesis of intermediate 23-c
질소 분위기하에서 화합물 23-b (59g, 87mmol) 를 디클로로벤젠 900ml에 녹인 후 보론트리아이오드 16.7ml를 투입한다. 160도로 승온한 후 3시간동안 교반하였다. 반응 종료 후 디클로로벤젠을 감압증류하여 제거한 후 에틸아세테이트 /물로 추출하였다. 에틸아세테이트:헥산 컬럼으로 정제 후 재결정을 통하여 23-c를 수득하였다 (11.7g, 수율 20%). Under a nitrogen atmosphere, compound 23-b (59 g, 87 mmol) was dissolved in 900 ml of dichlorobenzene, and then 16.7 ml of boron triiodide was added. The temperature was raised to 160 degrees and stirred for 3 hours. After completion of the reaction, dichlorobenzene was removed by distillation under reduced pressure, and then extracted with ethyl acetate/water. After purification with an ethyl acetate:hexane column, 23-c was obtained through recrystallization (11.7 g, yield 20%).
<25-d> 화합물 23의 합성<25-d> Synthesis of compound 23
질소 분위기하에서 화합물 23-c (11.7g, 17mmol), 디페닐아민 (2.9g, 17mmol), 소듐-tert-부톡사이드 (3.3g 34mmol), 비스(트리-tert-부틸포스핀)팔라듐(0) (0.17g, 0.34mmol)을 톨루엔 60ml에 넣은 후 12시간 동안 환류 교반하였다. 반응 종료 후 추출한 뒤, 에틸아세테이트:헥산 컬럼으로 정제후 재결정을 통하여 화합물 23을 수득하였다 (9.3g, 수율 67%). MS[M+H]+ = 816.4Under a nitrogen atmosphere, compound 23-c (11.7 g, 17 mmol), diphenylamine (2.9 g, 17 mmol), sodium-tert-butoxide (3.3 g 34 mmol), and bis(tri-tert-butylphosphine)palladium(0) (0.17 g, 0.34 mmol) were added to 60 ml of toluene and stirred under reflux for 12 hours. After the reaction was completed, extraction was performed, and the resultant was purified using an ethyl acetate:hexane column and recrystallized to obtain compound 23 (9.3 g, yield 67%). MS[M+H]+ = 816.4
26. 화합물 24의 합성26. Synthesis of compound 24
<26-a> 중간체 24-a의 합성<26-a> Synthesis of intermediate 24-a
합성예 23-a에서 1-브로모-3-(tert-부틸)-5-클로로벤젠 대신 1-브로모-3-클로로-5-메틸벤젠을 사용한 것을 제외하고는 동일하게 합성하여 중간체 24-a를 수득하였다.Intermediate 24-a was obtained by the same synthesis procedure as in Synthetic Example 23-a, except that 1-bromo-3-chloro-5-methylbenzene was used instead of 1-bromo-3-(tert-butyl)-5-chlorobenzene.
<26-b> 중간체 24-b의 합성<26-b> Synthesis of intermediate 24-b
합성예 23-b에서 21-a 대신 24-a를, 5-(tert-부틸)페닐)-[1,1'-비페닐]-2-아민 대신 디벤조[b,d]퓨란-1-아민을 사용한 것을 제외하고는 동일하게 합성하여 중간체 24-b를 수득하였다.Intermediate 24-b was obtained by the same synthesis procedure as in Synthetic Example 23-b, except that 24-a was used instead of 21-a and dibenzo[b,d]furan-1-amine was used instead of 5-(tert-butyl)phenyl)-[1,1'-biphenyl]-2-amine.
<26-c> 중간체 24-c의 합성<26-c> Synthesis of intermediate 24-c
합성예 23-c에서 21-b 대신 24-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 24-c를 수득하였다Intermediate 24-c was obtained by the same synthesis except that 24-b was used instead of 21-b in Synthesis Example 23-c.
<26-d> 중간체 24-d의 합성<26-d> Synthesis of intermediate 24-d
합성예 23-d에서 21-c 대신 24-c를 사용한 것을 제외하고는 동일하게 합성하여 중간체 24-d를 수득하였다.Intermediate 24-d was obtained by the same synthesis procedure except that 24-c was used instead of 21-c in Synthetic Example 23-d.
<26-e> 화합물 24의 합성<26-e> Synthesis of compound 24
합성예 23-e에서 화합물 21-d 대신 24-d를, 디페닐아민 대신 비스(4-(tert-부틸)페닐)아민을 사용한 것을 제외하고는 동일하게 합성하여 화합물 24를 수득하였다. MS[M+H]+ = 836.5Compound 24 was obtained by the same synthesis method as in Synthetic Example 23-e, except that 24-d was used instead of compound 21-d and bis(4-(tert-butyl)phenyl)amine was used instead of diphenylamine. MS[M+H]+ = 836.5
27. 화합물 25의 합성27. Synthesis of compound 25
<27-a> 중간체 25-a의 합성<27-a> Synthesis of intermediate 25-a
합성예 25-a에서 9,9'-디메틸-9,10-디히드로아크리딘 대신 4a,9a-디메틸-2,3,4,4a,9,9a-헥사히드로-1H-카바졸을 사용한 것을 제외하고는 동일하게 합성하여 중간체 25-a를 수득하였다.Intermediate 25-a was obtained by the same synthesis procedure as in Synthetic Example 25-a, except that 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole was used instead of 9,9'-dimethyl-9,10-dihydroacridine.
<27-b> 중간체 25-b의 합성<27-b> Synthesis of intermediate 25-b
합성예 25-b에서 23-a 대신 25-a를, 5-(tert-부틸)-N-(3-(tert-부틸)페닐)-[1,1'-비페닐]-2-아민 대신 9H-카바졸을 사용한 것을 제외하고는 동일하게 합성하여 중간체 25-b를 수득하였다.Intermediate 25-b was obtained by the same synthesis procedure as in Synthetic Example 25-b, except that 25-a was used instead of 23-a and 9H-carbazole was used instead of 5-(tert-butyl)-N-(3-(tert-butyl)phenyl)-[1,1'-biphenyl]-2-amine.
<27-c> 중간체 25-c의 합성<27-c> Synthesis of intermediate 25-c
합성예 25-c에서 23-b 대신 25-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 25-c를 수득하였다.Intermediate 25-c was obtained by the same synthesis process except that 25-b was used instead of 23-b in Synthetic Example 25-c.
<27-d> 화합물 25의 합성<27-d> Synthesis of compound 25
합성예 25-d에서 23-c 대신 25-c를, 디페닐아민 대신 비스(4-(tert-부틸)페닐)아민을 사용한 것을 제외하고는 동일하게 합성하여 화합물 25를 수득하였다. MS[M+H]+ = 730.4Compound 25 was obtained by the same synthesis method except that 25-c was used instead of 23-c in Synthetic Example 25-d and bis(4-(tert-butyl)phenyl)amine was used instead of diphenylamine. MS[M+H]+ = 730.4
28. 화합물 26의 합성28. Synthesis of compound 26
<28-a> 중간체 26-a의 합성<28-a> Synthesis of intermediate 26-a
합성예 25-a에서 1-브로모-3,5-디클로로벤젠 대신 1-브로모-3-클로로-5-메틸벤젠을, 9,9'-디메틸-9,10-디히드로아크리딘 대신 10H-스파이로[아크리딘-9,9'-플루오렌]을 사용한 것을 제외하고는 동일하게 합성하여 중간체 26-a를 수득하였다.Intermediate 26-a was obtained by the same synthesis procedure as in Synthetic Example 25-a, except that 1-bromo-3-chloro-5-methylbenzene was used instead of 1-bromo-3,5-dichlorobenzene and 10H-spiro[acridine-9,9'-fluorene] was used instead of 9,9'-dimethyl-9,10-dihydroacridine.
<28-b> 중간체 26-b의 합성<28-b> Synthesis of intermediate 26-b
합성예 25-b에서 23-a 대신 26-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 26-b를 수득하였다.Intermediate 26-b was obtained by the same synthesis procedure except that 26-a was used instead of 23-a in Synthetic Example 25-b.
<28-c> 화합물 26의 합성<28-c> Synthesis of compound 26
합성예 25-c에서 화합물 23-b 대신 26-b를 사용한 것을 제외하고는 동일하게 합성하여 화합물 26을 수득하였다. MS[M+H]+ = 785.4Compound 26 was obtained by the same synthesis method except that 26-b was used instead of compound 23-b in Synthesis Example 25-c. MS[M+H]+ = 785.4
29. 화합물 27의 합성29. Synthesis of compound 27
<29-a> 중간체 27-a의 합성<29-a> Synthesis of intermediate 27-a
4a,9a-디메틸-2,3,4,4a,9,9a-헥사히드로-1H-카바졸 50g, 5% Pt/C 10g, 톨루엔 300ml, D2O 700ml를 고압반응기에 넣은 후 수소를 충전시킨다. 180도로 승온한 후 24시간동안 반응을 보낸다. 반응 종료 후 촉매를 셀라이트 패드에서 필터한 후 추출하였다. 에틸아세테이트:헥산 컬럼으로 정제하여 중간체 27-a를 수득하였다. (29g, 수율 57%). 50 g of 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole, 10 g of 5% Pt/C, 300 ml of toluene, and 700 ml of D2O were placed in an autoclave, and then hydrogen was charged. After the temperature was increased to 180 degrees, the reaction was performed for 24 hours. After completion of the reaction, the catalyst was filtered through a Celite pad and then extracted. The mixture was purified by an ethyl acetate:hexane column to obtain intermediate 27-a. (29 g, yield 57%)
<29-b> 중간체 27-b의 합성<29-b> Synthesis of intermediate 27-b
합성예 29-a에서 4a,9a-디메틸-2,3,4,4a,9,9a-헥사히드로-1H-카바졸 대신 N-(4-(tert-부틸)페닐)-5,5,8,8,-테트라메틸-5,6,7,8-테트라히드로나프탈렌-2-아민을 사용한 것을 제외하고는 동일하게 합성하여 중간체 27-b를 수득하였다.Intermediate 27-b was obtained by the same synthesis procedure as in Synthetic Example 29-a, except that N-(4-(tert-butyl)phenyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine was used instead of 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole.
<29-c> 중간체 27-c의 합성<29-c> Synthesis of intermediate 27-c
합성예 25-a에서 9,9'-디메틸-9,10-디히드로아크리딘 대신 27-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 27-c를 수득하였다.Intermediate 27-c was obtained by the same synthesis procedure as in Synthetic Example 25-a, except that 27-a was used instead of 9,9'-dimethyl-9,10-dihydroacridine.
<29-d> 중간체 27-d의 합성<29-d> Synthesis of intermediate 27-d
합성예 25-b에서 23-a 대신 27-c를, 5-(tert-부틸)-N-(3-(tert-부틸)페닐)-[1,1'-비페닐]-2-아민 대신 27-b를 사용한 것을 제외하고는 동일하게 합성하여 중간체 27-d를 수득하였다.Intermediate 27-d was obtained by the same synthesis procedure as in Synthetic Example 25-b, except that 27-c was used instead of 23-a and 27-b was used instead of 5-(tert-butyl)-N-(3-(tert-butyl)phenyl)-[1,1'-biphenyl]-2-amine.
<29-e> 중간체 27-e의 합성<29-e> Synthesis of intermediate 27-e
합성예 25-c에서 23-b 대신 27-d를 사용한 것을 제외하고는 동일하게 합성하여 중간체 27-e를 수득하였다.Intermediate 27-e was obtained by the same synthesis procedure except that 27-d was used instead of 23-b in Synthetic Example 25-c.
<29-f> 화합물 27의 합성<29-f> Synthesis of compound 27
합성예 25-d에서 화합물 23-c 대신 28-e를, 디페닐아민 대신 비스(페닐-d5)아민을 사용한 것을 제외하고는 동일하게 합성하여 화합물 27을 수득하였다. MS[M+H]+ = 805.6Compound 27 was obtained by the same synthesis method except that 28-e was used instead of compound 23-c in Synthetic Example 25-d and bis(phenyl-d5)amine was used instead of diphenylamine. MS[M+H]+ = 805.6
30. 화합물 28의 합성30. Synthesis of compound 28
<30-a> 중간체 28-a의 합성<30-a> Synthesis of intermediate 28-a
합성예 29-a에서 4a,9a-디메틸-2,3,4,4a,9,9a-헥사히드로-1H-카바졸 대신 N-(4-(tert-부틸)페닐)-[1,1'-비페닐]-4-아민을 사용한 것을 제외하고는 동일하게 합성하여 중간체 28-a를 수득하였다.Intermediate 28-a was obtained by the same synthesis procedure as in Synthetic Example 29-a, except that N-(4-(tert-butyl)phenyl)-[1,1'-biphenyl]-4-amine was used instead of 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole.
<30-b> 중간체 28-b의 합성<30-b> Synthesis of intermediate 28-b
합성예 25-a에서 1-브로모-3,5-디클로로벤젠 대신 1- 브로모-3-클로로-5-(메틸-d3)벤젠을, 9,9'-디메틸-9,10-디히드로아크리딘 대신 중간체 28-a를 사용한 것을 제외하고는 동일하게 합성하여 중간체 28-b를 수득하였다.Intermediate 28-b was obtained by the same synthesis procedure as in Synthetic Example 25-a, except that 1-bromo-3-chloro-5-(methyl-d3)benzene was used instead of 1-bromo-3,5-dichlorobenzene, and Intermediate 28-a was used instead of 9,9'-dimethyl-9,10-dihydroacridine.
<30-c> 중간체 28-c의 합성<30-c> Synthesis of intermediate 28-c
합성예 25-b에서 23-a 대신 28-b를, 5-(tert-부틸)-N-(3-(tert-부틸)페닐)-[1,1'-비페닐]-2-아민 대신 4a,9a-디메틸-2,3,4,4a,9,9a-헥사히드로-1H-카바졸을 사용한 것을 제외하고는 동일하게 합성하여 중간체 28-c를 수득하였다.Intermediate 28-c was obtained by the same synthesis procedure as in Synthetic Example 25-b, except that 28-b was used instead of 23-a, and 4a,9a-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazole was used instead of 5-(tert-butyl)-N-(3-(tert-butyl)phenyl)-[1,1'-biphenyl]-2-amine.
<30-d> 화합물 28의 합성<30-d> Synthesis of compound 28
합성예 25-c에서 23-b 대신 28-d를 사용한 것을 제외하고는 동일하게 합성하여 화합물 28을 수득하였다. MS[M+H]+ = 614.7Compound 28 was obtained by the same synthesis except that 28-d was used instead of 23-b in Synthesis Example 25-c. MS[M+H]+ = 614.7
<실시예><Example>
<비교예><Comparative Example>
실시예 1Example 1
ITO(indium tin oxide)가 150 nm의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척하였다. 이때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀리포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용하였다. ITO를 30분간 세척한 후 증류수로 2회 반복하여 초음파 세척을 10분간 진행하였다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 메탄올의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 수송시켰다. 또한, 질소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다. 이렇게 준비된 ITO 투명 전극 위에 하기 HAT-CN 화합물을 5 nm의 두께로 열 진공 증착하여 정공주입층을 형성하였다. 이어서, HTL1을 100 nm의 두께로 열 진공 증착하고, 이어 HTL2를 10 nm의 두께로 열 진공 증착하여 정공수송층을 형성하였다. 이어서, 호스트로서 상기 화합물 1 및 도펀트로서 화합물 21 (중량비 95:5)를 동시에 진공 증착하여 20 nm 두께의 발광층을 형성하였다. 이어서, ETL을 20 nm의 두께로 진공 증착하여 전자수송층을 형성하였다. 이어서, LiF을 0.5 nm의 두께로 진공 증착하여 전자주입층을 형성하였다. 이어서, 알루미늄을 100 nm의 두께로 증착하여 음극을 형성하여 유기 발광 소자를 제조하였다. A glass substrate coated with a 150 nm thick ITO (indium tin oxide) film was placed in distilled water containing a detergent and ultrasonically cleaned. At this time, a Fischer Co. product was used as the detergent, and distilled water filtered twice through a Millipore Co. filter was used as the distilled water. After washing the ITO for 30 minutes, ultrasonic cleaning was performed twice with distilled water for 10 minutes. After washing with distilled water, ultrasonic cleaning was performed with a solvent of isopropyl alcohol, acetone, and methanol, and after drying, it was transported to a plasma cleaner. In addition, the substrate was cleaned for 5 minutes using nitrogen plasma and then transported to a vacuum deposition device. On the ITO transparent electrode thus prepared, the following HAT-CN compound was thermally vacuum deposited to a thickness of 5 nm to form a hole injection layer. Then, HTL1 was thermally vacuum deposited to a thickness of 100 nm, and then HTL2 was thermally vacuum deposited to a thickness of 10 nm to form a hole transport layer. Then, the compound 1 as a host and the compound 21 as a dopant (weight ratio 95:5) were simultaneously vacuum deposited to form a 20 nm thick emitting layer. Then, ETL was vacuum deposited to a thickness of 20 nm to form an electron transport layer. Then, LiF was vacuum deposited to a thickness of 0.5 nm to form an electron injection layer. Then, aluminum was deposited to a thickness of 100 nm to form a cathode, thereby manufacturing an organic light-emitting device.
실시예에서 사용된 화합물의 구조는 하기와 같다.The structures of the compounds used in the examples are as follows.
실시예 2 내지 45 및 비교예 1 내지 17 Examples 2 to 45 and Comparative Examples 1 to 17
상기 실시예 1에서 발광층의 호스트와 도판트로 화합물 1과 화합물 21 대신 하기 표 1에 기재된 화합물을 각각 사용한 것을 제외하고는 동일한 방법으로 유기 발광 소자를 제작하였다. 이 때, 하기 구조들 중 본 발명 화학식 1, 화학식 202 및 203로 표시되는 화합물은 각각 전술한 합성예 1 내지 30와 같은 과정을 통하여 제조하였다.An organic light-emitting device was manufactured in the same manner as in Example 1, except that the compounds described in Table 1 below were used instead of Compound 1 and Compound 21 as the host and dopant of the light-emitting layer, respectively. At this time, among the structures below, the compounds represented by Chemical Formula 1, Chemical Formula 202, and 203 of the present invention were manufactured through the same process as Synthesis Examples 1 to 30 described above, respectively.
상기 실시예 1 내지 45 및 비교예 1 내지 17에서 제조한 유기 발광 소자에 있어서, 10 mA/cm2 의 전류밀도에서 구동전압과 발광 효율을 측정하였고, 20 mA/cm2 의 전류밀도에서 초기 휘도 대비 95%가 되는 시간(LT)을 측정하여, 그 결과를 하기 표에 나타내었다.In the organic light-emitting devices manufactured in Examples 1 to 45 and Comparative Examples 1 to 17, the driving voltage and luminous efficiency were measured at a current density of 10 mA/cm 2 , and the time (LT) for reaching 95% of the initial luminance was measured at a current density of 20 mA/cm 2 , and the results are shown in the table below.
상기 표로부터 실시예 1 내지 45의 유기 발광 소자는 비교예 1 내지 17의 유기 발광 소자에 피해 구동전압이 낮고, 효율 및 수명이 우수한 것을 확인할 수 있다. 특히 실시예 36 내지 45은 화학식 1의 중수소 치환으로 수명이 추가적으로 개선되는 것을 보여주었고, 실시예 5, 8, 10, 13, 17, 25, 31, 33, 35, 38, 41, 43 은 화학식 2의 중수소 치환으로 수명이 추가 개선되는 것을 보여주었다. From the above table, it can be confirmed that the organic light-emitting devices of Examples 1 to 45 have lower driving voltages and superior efficiency and lifespan compared to the organic light-emitting devices of Comparative Examples 1 to 17. In particular, Examples 36 to 45 showed that the lifespan was further improved by deuterium substitution in Chemical Formula 1, and Examples 5, 8, 10, 13, 17, 25, 31, 33, 35, 38, 41, and 43 showed that the lifespan was further improved by deuterium substitution in Chemical Formula 2.
본 발명의 화학식 1과 같이 벤조나프토퓨란을 사용하지 않는 호스트 BH-A 및 BH-B를 사용한 비교예 1 내지 3과 비교하였을 때, 실시예 1 내지 45는 벤조나프토퓨란을 포함하는 호스트 물질을 사용하여 전압, 효율, 수명측면에서 우수한 효과를 보인다. When compared with Comparative Examples 1 to 3 that used host BH-A and BH-B that do not use benzonaphthofuran as in Chemical Formula 1 of the present invention, Examples 1 to 45 show superior effects in terms of voltage, efficiency, and lifespan by using a host material containing benzonaphthofuran.
구체적으로 비교예 1 과 실시예 1, 3, 및 18을 비교하면, 도펀트로 화합물 21을 공통적으로 사용함에도 불구하고, 벤조나프토퓨란을 포함하는 호스트를 사용한 실시예 1, 3, 및 18이 저전압, 고효율, 장수명의 효과를 보인다. Specifically, comparing Comparative Example 1 with Examples 1, 3, and 18, Examples 1, 3, and 18, which use a host including benzonaphthofuran, show the effects of low voltage, high efficiency, and long life, despite the common use of compound 21 as a dopant.
비교예 물질 BH-C는 벤조나프토퓨란을 포함하나, 본 발명과 달리 비치환된 벤조나프토퓨란을 포함한다. BH-C를 호스트로 사용한 비교예 4 및 5는 동일한 도펀트를 사용하고, 호스트만 치환된 벤조나프토퓨란을 포함하는 화합물을 사용한 실시예 5, 9, 10, 13, 16, 42 및 43와 비교하여 전압, 효율, 수명 면에서 불리함을 알 수 있다. 이는 호스트물질이 단순히 벤조나프토퓨란을 포함하는 것 이외에, 벤조나프토퓨란의 치환여부도 소자적용시 다른 효과를 가져옴을 알 수 있다.Comparative example material BH-C contains benzonaphthofuran, but unlike the present invention, it contains unsubstituted benzonaphthofuran. Comparative examples 4 and 5 using BH-C as a host are disadvantageous in terms of voltage, efficiency, and lifespan compared to examples 5, 9, 10, 13, 16, 42, and 43 that use the same dopant and use a compound containing only substituted benzonaphthofuran as the host. This shows that in addition to the host material simply containing benzonaphthofuran, whether or not benzonaphthofuran is substituted has a different effect when applied to a device.
본 발명의 화학식 202 및 203과 상이한 코어구조를 가진 도펀트 물질 BD-1 내지 BD-J를 사용하거나, 보론계 유기화합물 대신 아민계 화합물을 사용하는 경우의 효과는 비교예 6 내지 15에 기재되어 있다. The effects of using dopant materials BD-1 to BD-J having a core structure different from the chemical formulas 202 and 203 of the present invention or using an amine compound instead of a boron-based organic compound are described in Comparative Examples 6 to 15.
특히 도펀트 물질만 차이가 있는 비교예 6 내지 15와 실시예 1, 2, 6, 7, 11, 12, 24, 25, 32 및 33과 비교하면, 본 발명의 화학식 2의 물질을 포함하는 실시예 1, 2, 6, 7, 11, 12, 24, 25, 32 및 33이 더 저전압, 고효율, 장수명의 특성을 보이므로, 소자에 적용하였을 때 유리함을 확인할 수 있다.In particular, compared with Comparative Examples 6 to 15 and Examples 1, 2, 6, 7, 11, 12, 24, 25, 32 and 33, which differ only in the dopant material, Examples 1, 2, 6, 7, 11, 12, 24, 25, 32 and 33, which include the material of Chemical Formula 2 of the present invention, exhibit lower voltage, higher efficiency and longer lifespan, and thus can be confirmed to be advantageous when applied to devices.
1: 기판
2: 제1 전극
3: 유기물층
4: 제2전극
5: 정공주입층
6: 정공수송층
7: 발광층
8: 전자수송층
9: 전자주입층1: Substrate
2: First electrode
3: Organic layer
4: Second electrode
5: Hole injection layer
6: Hole transport layer
7: Emissive layer
8: Electron transport layer
9: Electron injection layer
Claims (12)
[화학식 1]
[화학식 202]
[화학식 2-6]
[화학식 2-9]
[화학식 2-10]
[화학식 2-11]
[화학식 2-12]
[화학식 2-13]
상기 화학식 1, 화학식 202, 화학식 2-6, 및 화학식 2-9 내지 2-13에 있어서,
Ar1은 치환 또는 비치환된 아릴기; 치환 또는 비치환된 탄화수소고리기; 또는 치환 또는 비치환된 헤테로아릴기이고,
L은 직접결합, 치환 또는 비치환된 아릴렌기, 또는 치환 또는 비치환된 헤테로아릴렌기이고,
R1 내지 R8은 서로 같거나 상이하고, 각각 독립적으로 수소; 중수소; 니트릴기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이고,
R9는 중수소; 니트릴기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 알콕시기; 치환 또는 비치환된 아릴기; 또는 치환 또는 비치환된 헤테로아릴기이고,
Y1 내지 Y3은 서로 동일하거나 상이하고, 각각 독립적으로 C 또는 Si이고,
R11 내지 R14, 및 Z1 내지 Z6은 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 시아노기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 알케닐기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하며,
Ar21 내지 Ar24는 서로 동일하거나 상이하고, 각각 독립적으로 수소; 중수소; 할로겐기; 시아노기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 알케닐기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 단환의 탄화수소고리 또는 치환 또는 비치환된 이환의 헤테로고리를 형성하며,
R15 내지 R21은 서로 같거나 상이하고, 각각 수소, 중수소, 니트릴기, 할로겐기, 치환 또는 비치환된 알킬기, 치환 또는 비치환된 아릴기 또는 치환 또는 비치환된 헤테로아릴기이고,
단, Y1가 C이면, Z1 및 Z2는 서로 결합하여 치환 또는 비치환된 고리를 형성하며,
Y1이 S이면, Z1 및 Z2는 수소; 중수소; 할로겐기; 시아노기; 치환 또는 비치환된 알킬기; 치환 또는 비치환된 시클로알킬기; 치환 또는 비치환된 실릴기; 치환 또는 비치환된 알케닐기; 치환 또는 비치환된 아릴기; 치환 또는 비치환된 헤테로고리기; 또는 치환 또는 비치환된 아민기이거나, 인접한 치환기와 서로 결합하여 치환 또는 비치환된 고리를 형성하며,
a는 0 내지 9의 정수이고, a가 복수일 때, R9는 서로 같거나 상이하고, 복수의 R9 중 하나 이상은 중수소가 아니고,
r1은 0 내지 4의 정수이고,
r2 및 r3은 각각 0 내지 3의 정수이고,
r1이 복수일 때, R11은 서로 같거나 상이하고,
r2가 복수일 때, R12는 서로 같거나 상이하고,
r3이 복수일 때, R13은 서로 같거나 상이하고,
r4은 0 내지 5의 정수이고,
r4가 복수일 때, R14는 서로 같거나 상이하고,
r5, r7, r8, 및r10은 각각 0 내지 4의 정수이고,
r5이 복수일 때, R15는 서로 같거나 상이하고,
r7이 복수일 때, R17은 서로 같거나 상이하고,
r8이 복수일 때, R18은 서로 같거나 상이하고,
r10이 복수일 때, R20은 서로 같거나 상이하고,
r6 및 r9은 각각 0 내지 8의 정수이고,
r6이 복수일 때, R16은 서로 같거나 상이하고,
r9가 복수일 때, R19는 서로 같거나 상이하고,
r11은 0 내지 4의 정수이고,
r11이 복수일 때, R21은 서로 같거나 상이하고,
p1은 1이다.An organic light-emitting device comprising a first electrode; a second electrode provided opposite the first electrode; and at least one organic layer provided between the first electrode and the second electrode, wherein at least one layer of the organic layers comprises a compound of the following chemical formula 1 and a compound of the following chemical formula 202, or an organic light-emitting device comprising a compound of any one of the following chemical formulas 2-6, and 2-9 to 2-13 and a compound of the following chemical formula 1:
[Chemical Formula 1]
[Chemical formula 202]
[Chemical Formula 2-6]
[Chemical Formula 2-9]
[Chemical Formula 2-10]
[Chemical Formula 2-11]
[Chemical Formula 2-12]
[Chemical Formula 2-13]
In the above chemical formula 1, chemical formula 202, chemical formula 2-6, and chemical formulas 2-9 to 2-13,
Ar1 is a substituted or unsubstituted aryl group; a substituted or unsubstituted hydrocarbon ring group; or a substituted or unsubstituted heteroaryl group,
L is a direct bond, a substituted or unsubstituted arylene group, or a substituted or unsubstituted heteroarylene group,
R1 to R8 are the same as or different from each other, and are each independently hydrogen; deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted alkoxy group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group,
R9 is deuterium; a nitrile group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted alkoxy group; a substituted or unsubstituted aryl group; or a substituted or unsubstituted heteroaryl group,
Y1 to Y3 are the same or different from each other, and are each independently C or Si,
R11 to R14, and Z1 to Z6 are the same as or different from each other, and are each independently hydrogen; deuterium; a halogen group; a cyano group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted silyl group; a substituted or unsubstituted alkenyl group; a substituted or unsubstituted aryl group; a substituted or unsubstituted heterocyclic group; or a substituted or unsubstituted amine group, or are combined with adjacent substituents to form a substituted or unsubstituted ring,
Ar21 to Ar24 are the same as or different from each other, and are each independently hydrogen; deuterium; a halogen group; a cyano group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted silyl group; a substituted or unsubstituted alkenyl group; a substituted or unsubstituted aryl group; a substituted or unsubstituted heterocyclic group; or a substituted or unsubstituted amine group, or are combined with adjacent substituents to form a substituted or unsubstituted monocyclic hydrocarbon ring or a substituted or unsubstituted bicyclic heterocycle,
R15 to R21 are the same as or different from each other and are each hydrogen, deuterium, a nitrile group, a halogen group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group,
However, if Y1 is C, Z1 and Z2 combine with each other to form a substituted or unsubstituted ring,
When Y1 is S, Z1 and Z2 are hydrogen; deuterium; a halogen group; a cyano group; a substituted or unsubstituted alkyl group; a substituted or unsubstituted cycloalkyl group; a substituted or unsubstituted silyl group; a substituted or unsubstituted alkenyl group; a substituted or unsubstituted aryl group; a substituted or unsubstituted heterocyclic group; or a substituted or unsubstituted amine group, or are bonded to each other with adjacent substituents to form a substituted or unsubstituted ring,
a is an integer from 0 to 9, and when a is plural, R9 is the same or different, and at least one of the plural R9 is not deuterium,
r1 is an integer from 0 to 4,
r2 and r3 are integers from 0 to 3, respectively,
When r1 is plural, R11 is equal to or different from each other,
When r2 is plural, R12 is equal to or different from each other,
When r3 is plural, R13 is equal to or different from each other,
r4 is an integer from 0 to 5,
When r4 is plural, R14 is equal to or different from each other,
r5, r7, r8, and r10 are each integers from 0 to 4,
When r5 is plural, R15 is equal to or different from each other,
When r7 is plural, R17 is equal to or different from each other,
When r8 is plural, R18 is equal to or different from each other,
When r10 is plural, R20 is equal to or different from each other,
r6 and r9 are integers from 0 to 8, respectively.
When r6 is plural, R16 is equal to or different from each other,
When r9 is plural, R19 is equal to or different from each other,
r11 is an integer from 0 to 4,
When r11 is plural, R21 is equal to or different from each other,
p1 is 1.
[화학식 2-3]
상기 화학식 2-3에 있어서, R11 내지 R14, Y1, r1 내지 r4, Z1 및 Z2는 상기 화학식 202에서 정의한 바와 같고,
R17은 서로 같거나 상이하고, 각각 수소, 중수소, 니트릴기, 할로겐기, 치환 또는 비치환된 알킬기, 치환 또는 비치환된 아릴기 또는 치환 또는 비치환된 헤테로아릴기이고,
r7은 각각 0 내지 4의 정수이고,
r7이 복수일 때, R17은 서로 같거나 상이하다.In claim 1, the chemical formula 202 is an organic light-emitting device having the following chemical formula 2-3:
[Chemical Formula 2-3]
In the chemical formula 2-3 above, R11 to R14, Y1, r1 to r4, Z1 and Z2 are as defined in the chemical formula 202 above,
R17 are the same or different from each other and are each hydrogen, deuterium, a nitrile group, a halogen group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group,
r7 is an integer from 0 to 4,
When r7 is plural, R17 is equal to or different from each other.
In claim 1, the organic light-emitting device wherein the chemical formula 1 is one selected from the following compounds:
In claim 1, the organic light-emitting device wherein the chemical formula 202, chemical formula 2-6, and chemical formulas 2-9 to 13 are any one selected from the following compounds:
An organic light-emitting device according to claim 1, wherein the organic layer includes a light-emitting layer, and the light-emitting layer includes a compound of the chemical formula 1 and a compound of the chemical formula 202, or includes a compound of any one of the chemical formulas 2-6 and 2-9 to 2-13 and a compound of the chemical formula 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200170955 | 2020-12-09 | ||
KR20200170955 | 2020-12-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220081942A KR20220081942A (en) | 2022-06-16 |
KR102716876B1 true KR102716876B1 (en) | 2024-10-14 |
Family
ID=82217420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210175890A KR102716876B1 (en) | 2020-12-09 | 2021-12-09 | Organic light emitting device |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102716876B1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102537152B1 (en) | 2015-03-25 | 2023-05-26 | 국립연구개발법인 고쿠리츠간켄큐센터 | Treatment for cholangiocarcinoma |
KR102097862B1 (en) * | 2017-04-03 | 2020-04-07 | 주식회사 엘지화학 | Compound and organic light emitting device comprising the same |
CN111868950B (en) * | 2018-06-08 | 2024-03-22 | 株式会社Lg化学 | Organic light emitting device |
KR102285556B1 (en) * | 2018-09-04 | 2021-08-04 | 주식회사 엘지화학 | Multicyclic compound and organic light emitting device comprising the same |
CN113015738A (en) * | 2018-11-19 | 2021-06-22 | Sfc株式会社 | Novel boron compound and organic light-emitting element including the same |
KR102324962B1 (en) * | 2019-02-15 | 2021-11-11 | 주식회사 엘지화학 | Organic light emitting device |
CN118742076A (en) * | 2019-05-15 | 2024-10-01 | 株式会社Lg化学 | Organic light emitting device |
-
2021
- 2021-12-09 KR KR1020210175890A patent/KR102716876B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20220081942A (en) | 2022-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102436754B1 (en) | Organic light emitting device | |
KR102097862B1 (en) | Compound and organic light emitting device comprising the same | |
KR102250388B1 (en) | Heterocyclic compound and organic light emitting device comprising the same | |
JP7251711B2 (en) | organic light emitting device | |
EP2873666A1 (en) | Heterocyclic compound and organic electronic element containing same | |
KR20220081057A (en) | Compound and organic light emitting device comprising same | |
KR102560367B1 (en) | Organic light emitting device | |
KR20190024772A (en) | Heterocyclic compound and organic light emitting device comprising same | |
JP7238967B2 (en) | organic light emitting device | |
KR20180004032A (en) | Compound and organic electronic device comprising the same | |
KR20240032784A (en) | Compound and organic light emitting device comprising same | |
KR102681349B1 (en) | Compound and organic light emitting device comprising the same | |
KR20210033434A (en) | Organic light emitting device | |
CN110922391A (en) | Nitrogen-containing compound, electronic component, and electronic device | |
KR20190085878A (en) | Multicyclic compound and organic light emitting device comprising the same | |
KR20220081059A (en) | Heterocyclic compound and organic light emitting device comprising the same | |
KR20190085880A (en) | Multicyclic compound and organic light emitting device comprising the same | |
KR102716876B1 (en) | Organic light emitting device | |
KR102716879B1 (en) | Organic light emitting device | |
KR102716874B1 (en) | Organic light emitting device | |
KR102710179B1 (en) | Organic light emitting device | |
KR102678875B1 (en) | Multicyclic compound and organic light emitting device comprising same | |
KR102551490B1 (en) | Compound and organic light emitting device comprising same | |
KR102280868B1 (en) | Polycyclic compound and organic light emitting device comprising the same | |
KR20220033019A (en) | Organic compound and organic light emitting diodes comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |